<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">29132</article-id><article-id pub-id-type="doi">10.7554/eLife.29132</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Tools and Resources</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology and Stem Cells</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Bacterial colonization stimulates a complex physiological response in the immature human intestinal epithelium</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-90193"><name><surname>Hill</surname><given-names>David R</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-1626-6079</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-81627"><name><surname>Huang</surname><given-names>Sha</given-names></name><email>shahuang@umich.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-90192"><name><surname>Nagy</surname><given-names>Melinda S</given-names></name><email>myermeli@umich.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-97834"><name><surname>Yadagiri</surname><given-names>Veda K</given-names></name><email>vyadagir@med.umich.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-89764"><name><surname>Fields</surname><given-names>Courtney</given-names></name><email>colynn@umich.edu</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-89765"><name><surname>Mukherjee</surname><given-names>Dishari</given-names></name><email>dishari@umich.edu</email><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-89766"><name><surname>Bons</surname><given-names>Brooke</given-names></name><email>bonsbh@med.umich.edu</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-62555"><name><surname>Dedhia</surname><given-names>Priya H</given-names></name><email>pdedhia@umich.edu</email><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-97833"><name><surname>Chin</surname><given-names>Alana M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-9567-6825</contrib-id><email>alanachin07@gmail.com</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-90194"><name><surname>Tsai</surname><given-names>Yu-Hwai</given-names></name><email>yuhwait@umich.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-89767"><name><surname>Thodla</surname><given-names>Shrikar</given-names></name><email>sthodla@umich.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-89771"><name><surname>Schmidt</surname><given-names>Thomas M</given-names></name><email>schmidti@med.umich.edu</email><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-89772"><name><surname>Walk</surname><given-names>Seth</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes" id="author-84097"><name><surname>Young</surname><given-names>Vincent B</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-3687-2364</contrib-id><email>youngvi@umich.edu</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes" id="author-19741"><name><surname>Spence</surname><given-names>Jason R</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-7869-3992</contrib-id><email>spencejr@umich.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Division of Gastroenterology, Department of Internal Medicine</institution><institution>University of Michigan</institution><addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Division of Infectious Disease, Department of Internal Medicine</institution><institution>University of Michigan</institution><addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution content-type="dept">Department of Microbiology and Immunology</institution><institution>University of Michigan</institution><addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution content-type="dept">Department of Surgery</institution><institution>University of Michigan</institution><addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution content-type="dept">Department of Microbiology and Immunology</institution><institution>Montana State University</institution><addr-line><named-content content-type="city">Bozeman</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution content-type="dept">Department of Cell andDevelopmental Biology</institution><institution>University of Michigan</institution><addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-13704"><name><surname>MacPherson</surname><given-names>Andrew J</given-names></name><role>Reviewing Editor</role><aff><institution>University of Bern</institution><country>Switzerland</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>07</day><month>11</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>6</volume><elocation-id>e29132</elocation-id><history><date date-type="received" iso-8601-date="2017-05-31"><day>31</day><month>05</month><year>2017</year></date><date date-type="accepted" iso-8601-date="2017-10-29"><day>29</day><month>10</month><year>2017</year></date></history><permissions><copyright-statement>© 2017, Hill et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Hill et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-29132-v2.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.29132.001</object-id><p>The human gastrointestinal tract is immature at birth, yet must adapt to dramatic changes such as oral nutrition and microbial colonization. The confluence of these factors can lead to severe inflammatory disease in premature infants; however, investigating complex environment-host interactions is difficult due to limited access to immature human tissue. Here, we demonstrate that the epithelium of human pluripotent stem-cell-derived human intestinal organoids is globally similar to the immature human epithelium and we utilize HIOs to investigate complex host-microbe interactions in this naive epithelium. Our findings demonstrate that the immature epithelium is intrinsically capable of establishing a stable host-microbe symbiosis. Microbial colonization leads to complex contact and hypoxia driven responses resulting in increased antimicrobial peptide production, maturation of the mucus layer, and improved barrier function. These studies lay the groundwork for an improved mechanistic understanding of how colonization influences development of the immature human intestine.</p></abstract><abstract abstract-type="executive-summary"><object-id pub-id-type="doi">10.7554/eLife.29132.002</object-id><title>eLife digest</title><p>Human newborns are exposed to large numbers of bacteria at birth. They must transition from the protective, sterile environment of the womb into the bacteria-rich world. The gut, in particular, must adapt as bacteria colonize it. Many of the first bacteria found in the newborn gut form the basis of the bacterial communities needed for a healthy intestine throughout life. In some premature infants, bacterial colonization of the intestine may trigger harmful inflammation and a serious illness called necrotizing enterocolitis.</p><p>It is not known exactly how the immature intestine first responds to bacteria. It is also unclear what goes wrong that causes illness in some premature infants. Learning more about how a healthy newborn intestine becomes colonized and responds to this colonization may help medical professionals to better care for normal infants and those who are at risk of intestinal disease. But it has been difficult to study because there is not much newborn intestinal tissue available for scientific research. One solution would be to grow tissue in the laboratory that is like tissue found in the newborn intestine and see how it adapts to bacteria.</p><p>Now, Hill et al. use stem cells to grow a tissue in the laboratory that is very like immature newborn intestine and show that bacterial colonization helps it to mature. In the experiments, stem cells were grown into an intestine-like tissue. Analyses showed that this laboratory-grown tissue had the same patterns of gene expression as newborn intestines. Then, a type of bacteria called <italic>Escherichia coli</italic> that is normally found in the intestines of healthy babies was introduced to the intestine-like tissue. Hill et al. show that the initial contact with bacteria and changes in oxygen levels due to bacterial activity cause shifts in gene expression. These in turn stimulate the release of mucus and other protective responses.</p><p>A protein called NF-κB plays a central role in these normal bacteria-intestine interactions. Hill et al. show that using a drug to block NF-κB interferes with these processes. The experiments show that contact with bacteria encourages the immature intestine to protect itself from potential harm. More experiments like these may help scientists understand normal bacteria-intestine interactions in early life and how they may go wrong in disease. These studies might also help identify new treatments for babies with necrotizing enterocolitis.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>intestinal epithelium</kwd><kwd>microbiota</kwd><kwd>neonatal intestinal colonization</kwd><kwd>innate defense</kwd><kwd>epithelial barrier function</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>E. coli</italic></kwd><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>U19AI116482</award-id><principal-award-recipient><name><surname>Young</surname><given-names>Vincent B</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>U01DK103141</award-id><principal-award-recipient><name><surname>Spence</surname><given-names>Jason R</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>T32AI007528</award-id><principal-award-recipient><name><surname>Hill</surname><given-names>David R</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100006108</institution-id><institution>National Center for Advancing Translational Sciences</institution></institution-wrap></funding-source><award-id>UL1TR000433</award-id><principal-award-recipient><name><surname>Hill</surname><given-names>David R</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Contact with bacteria and subsequent hypoxia promotes functional maturation of the immature gastrointestinal tract.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The epithelium of the gastrointestinal (GI) tract represents a large surface area for host-microbe interaction and mediates the balance between tolerance of mutualistic organisms and the exclusion of potential pathogens (<xref ref-type="bibr" rid="bib130">Peterson and Artis, 2014</xref>). This is accomplished, in part, through the formation of a tight physical epithelial barrier, in addition to epithelial secretion of antimicrobial peptides and mucus (<xref ref-type="bibr" rid="bib159">Veereman-Wauters, 1996</xref>; <xref ref-type="bibr" rid="bib131">Renz et al., 2011</xref>). Development and maturation of the epithelial barrier coincides with the first exposure of the GI tract to microorganisms and the establishment of a microbial community within the gut (<xref ref-type="bibr" rid="bib129">Palmer et al., 2007</xref>; <xref ref-type="bibr" rid="bib98">Koenig et al., 2011</xref>). Although microorganisms have long been appreciated as the primary drivers of the postnatal expansion of adaptive immunity (<xref ref-type="bibr" rid="bib131">Renz et al., 2011</xref>; <xref ref-type="bibr" rid="bib143">Shaw et al., 2010</xref>; <xref ref-type="bibr" rid="bib85">Hviid et al., 2011</xref>; <xref ref-type="bibr" rid="bib2">Abrahamsson et al., 2014</xref>; <xref ref-type="bibr" rid="bib10">Arrieta et al., 2015</xref>), and more recently as key stimuli in the development of digestion (<xref ref-type="bibr" rid="bib50">Erkosar et al., 2015</xref>), metabolism (<xref ref-type="bibr" rid="bib33">Cho et al., 2012</xref>), and neurocognitive function (<xref ref-type="bibr" rid="bib44">Diaz Heijtz et al., 2011</xref>; <xref ref-type="bibr" rid="bib34">Clarke et al., 2014</xref>; <xref ref-type="bibr" rid="bib21">Borre et al., 2014</xref>; <xref ref-type="bibr" rid="bib43">Desbonnet et al., 2014</xref>), it remains unclear how the human epithelial surface adapts to colonization and expansion of microorganisms within the immature GI tract.</p><p>Studies in gnotobiotic mice have improved our understanding of the importance of microbes in normal gut function since these mice exhibit profound developmental defects in the intestine (<xref ref-type="bibr" rid="bib137">Round and Mazmanian, 2009</xref>; <xref ref-type="bibr" rid="bib67">Gensollen et al., 2016</xref>; <xref ref-type="bibr" rid="bib25">Bry et al., 1996</xref>; <xref ref-type="bibr" rid="bib84">Hooper et al., 1999</xref>) including decreased epithelial turnover, impaired formation of microvilli (<xref ref-type="bibr" rid="bib3">Abrams et al., 1963</xref>), and altered mucus glycosylation at the epithelial surface (<xref ref-type="bibr" rid="bib25">Bry et al., 1996</xref>; <xref ref-type="bibr" rid="bib72">Goto et al., 2014</xref>; <xref ref-type="bibr" rid="bib30">Cash et al., 2006</xref>). However, evidence also suggests that the immature human intestine may differ significantly from the murine intestine, especially in the context of disease (<xref ref-type="bibr" rid="bib124">Nguyen et al., 2015</xref>). For example, premature infants can develop necrotizing enterocolitis (NEC), an inflammatory disease with unknown causes. Recent reports suggest a multifactorial etiology by which immature intestinal barrier function predisposes the preterm infant to intestinal injury and inflammation following postpartum microbial colonization (<xref ref-type="bibr" rid="bib123">Neu and Walker, 2011</xref>; <xref ref-type="bibr" rid="bib117">Morrow et al., 2013</xref>; <xref ref-type="bibr" rid="bib73">Greenwood et al., 2014</xref>; <xref ref-type="bibr" rid="bib76">Hackam et al., 2013</xref>; <xref ref-type="bibr" rid="bib4">Afrazi et al., 2014</xref>; <xref ref-type="bibr" rid="bib63">Fusunyan et al., 2001</xref>; <xref ref-type="bibr" rid="bib120">Nanthakumar et al., 2011</xref>). Rodent models of NEC have proven to be inadequate surrogates for studying human disease (<xref ref-type="bibr" rid="bib151">Tanner et al., 2015</xref>). Therefore, direct studies of host-microbial interactions in the immature human intestine will be important to understand the complex interactions during bacterial colonization that lead to a normal gut development or disease.</p><p>Important ethical and practical considerations have limited research on the immature human intestine. For example, neonatal surgical specimens are often severely damaged by disease and not conducive for ex vivo studies. We and others have previously demonstrated that human pluripotent stem-cell-derived human intestinal organoids (HIOs) closely resemble immature intestinal tissue (<xref ref-type="bibr" rid="bib147">Spence et al., 2011</xref>; <xref ref-type="bibr" rid="bib56">Finkbeiner et al., 2015</xref>; <xref ref-type="bibr" rid="bib165">Watson et al., 2014</xref>; <xref ref-type="bibr" rid="bib61">Forster et al., 2014</xref>; <xref ref-type="bibr" rid="bib41">Dedhia et al., 2016</xref>; <xref ref-type="bibr" rid="bib14">Aurora and Spence, 2016</xref>; <xref ref-type="bibr" rid="bib32">Chin et al., 2017</xref>) and recent work has established gastrointestinal organoids as a powerful model of microbial pathogenesis at the mucosal interface (<xref ref-type="bibr" rid="bib102">Leslie et al., 2015</xref>; <xref ref-type="bibr" rid="bib111">McCracken et al., 2014</xref>; <xref ref-type="bibr" rid="bib58">Forbester et al., 2015</xref>; <xref ref-type="bibr" rid="bib81">Hill and Spence, 2017</xref>).</p><p>In the current work, we used HIOs as a model immature intestinal epithelium and a human-derived non-pathogenic strain of <italic>E. coli</italic> as a model intestinal colonizer to examine how host-microbe interactions affected intestinal maturation and function. Although the composition of the neonatal intestinal microbiome varies between individuals, organisms within the genera <italic>Escherichia</italic> are dominant early colonizers (<xref ref-type="bibr" rid="bib71">Gosalbes et al., 2013</xref>; <xref ref-type="bibr" rid="bib29">Bäckhed et al., 2015</xref>) and non-pathogenic <italic>E. coli</italic> are widely prevalent and highly abundant components of the neonatal stool microbiome (<xref ref-type="bibr" rid="bib129">Palmer et al., 2007</xref>; <xref ref-type="bibr" rid="bib98">Koenig et al., 2011</xref>; <xref ref-type="bibr" rid="bib29">Bäckhed et al., 2015</xref>; <xref ref-type="bibr" rid="bib117">Morrow et al., 2013</xref>). Microinjection of <italic>E. coli</italic> into the lumen of three-dimensional HIOs resulted in stable bacterial colonization in vitro, and using RNA-sequencing, we monitored the global transcriptional changes in response to colonization. We observed widespread, time-dependent transcriptional responses that are the result of both bacterial contact and luminal hypoxia resulting from bacterial colonization in the HIO. Bacterial association with the immature epithelium increased antimicrobial defenses and resulted in enhanced epithelial barrier function and integrity. We observed that NF-κB is a central downstream mediator of the transcriptional changes induced by both bacterial contact and hypoxia. We further probed the bacterial contact and hypoxia-dependent epithelial responses using experimental hypoxia and pharmacological NF-κB inhibition, which allowed us to delineate which of the transcriptional and functional responses of the immature epithelium were oxygen and/or NF-κB dependent. We found that NF-κB-dependent microbe-epithelial interactions were beneficial by enhancing barrier function and protecting the epithelium from damage by inflammatory cytokines. Collectively, these studies shed light on how microbial contact with the immature human intestinal epithelium can lead to modified function.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Pluripotent stem-cell-derived intestinal epithelium transcriptionally resembles the immature human intestinal epithelium</title><p>Previous work has demonstrated that stem-cell-derived human intestinal organoids resemble immature human duodenum (<xref ref-type="bibr" rid="bib165">Watson et al., 2014</xref>; <xref ref-type="bibr" rid="bib56">Finkbeiner et al., 2015</xref>; <xref ref-type="bibr" rid="bib152">Tsai et al., 2017</xref>). Moreover, transplantation into immunocompromised mice results in HIO maturation to an adult-like state (<xref ref-type="bibr" rid="bib165">Watson et al., 2014</xref>; <xref ref-type="bibr" rid="bib56">Finkbeiner et al., 2015</xref>). These analyses compared HIOs consisting of epithelium and mesenchyme to whole-thickness human intestinal tissue, which also possessed cellular constituents lacking in HIOs such as neurons, blood vessels and immune cells (<xref ref-type="bibr" rid="bib56">Finkbeiner et al., 2015</xref>). Thus, the extent to which the HIO epithelium resembles immature/fetal intestinal epithelium remained unclear. To address this gap and further characterize the HIO epithelium relative to fetal and adult duodenal epithelium, we isolated and cultured epithelium from HIOs grown entirely in vitro, from fetal duodenum, adult duodenum, or HIOs that had been transplanted into the kidney capsule of NSG immuno-deficient mice and matured for 10 weeks. These epithelium-only derived organoids were expanded in vitro in uniform tissue culture conditions for 4–5 passages and processed for RNA-sequencing (RNA-seq) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). Comparison of global transcriptomes between all samples in addition to human embryonic stem cells (hESCs) used to generate HIOs (<xref ref-type="bibr" rid="bib56">Finkbeiner et al., 2015</xref>; E-MTAB-3158) revealed a clear hierarchy in which both in vitro grown HIO epithelium (p=5.06 × 10<sup>-9</sup>) and transplanted epithelium (p=7.79 × 10<sup>-14</sup>) shares a substantially greater degree of similarity to fetal small intestinal epithelium (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>).</p><p>While unbiased clustering demonstrated that transplanted epithelium closely resembles fetal epithelium, we noted a shift toward the adult transcriptome that resulted in a relative increase in the correlation between transplanted HIO epithelium and adult duodenum-derived epithelium grown in vitro (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>, p=1.17 × 10<sup>-4</sup>). Principle component analysis (PCA) of this multi-dimensional gene expression dataset (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>) corroborated the correlation analysis, and indicated that PC1 was correlated with developmental stage (PC1, 27.75% cumulative variance) and PC2 was correlated with tissue maturation status (PC2, 21.49% cumulative variance); cumulatively, PC1 and PC2 accounted for 49.24% of the cumulative variance between samples, suggesting that developmental stage and tissue maturation status are major sources of the transcriptional variation between samples. HIO epithelium clustered with fetal epithelium along PC2, whereas transplanted HIO epithelium clustered with adult epithelium.</p><p>We further used differential expression analysis to demonstrate that in vitro grown HIO epithelium is similar to the immature human intestine, whereas in vivo transplanted HIO epithelium is similar to the adult epithelium. To do this, we identified differentially expressed genes through two independent comparisons: (1) human fetal vs. adult epithelium; (2) HIO epithelium vs. transplanted HIO epithelium. Genes enriched in transplanted HIO epithelium relative to the HIO epithelium were compared to genes enriched in the adult duodenum relative to fetal duodenum (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>). There was a highly significant correlation between log<sub>2</sub>-transformed expression ratios where transplanted HIOs and adult epithelium shared enriched genes while HIO and fetal epithelium shared enriched genes (p=2.6 × 10<sup>-28</sup>). This analysis supports previously published data indicating that the epithelium from HIOs grown in vitro recapitulates the gene expression signature of the immature duodenum and demonstrates that the HIO epithelium is capable of adopting a transcriptional signature that more strongly resembles adult duodenum following transplantation into mice.</p></sec><sec id="s2-2"><title>HIOs can be stably associated with non-pathogenic <italic>E. coli</italic></title><p>Given that the HIO epithelium recapitulates many of the features of the immature intestinal epithelium, we set out to evaluate the effect of bacterial colonization on the naïve HIO epithelium. Previous studies have established that pluripotent stem-cell-derived intestinal organoids can be injected with live viral (<xref ref-type="bibr" rid="bib55">Finkbeiner et al., 2012</xref>) or bacterial pathogens (<xref ref-type="bibr" rid="bib102">Leslie et al., 2015</xref>; <xref ref-type="bibr" rid="bib49">Engevik et al., 2015</xref>; <xref ref-type="bibr" rid="bib58">Forbester et al., 2015</xref>); however, it was not known if HIOs could be stably co-cultured with non-pathogenic microorganisms. We co-cultured HIOs with the non-motile human-derived <italic>Esherichia coli</italic> strain ECOR2 (<xref ref-type="bibr" rid="bib126">Ochman and Selander, 1984</xref>). Whole genome sequencing and phylogentic analysis demonstrated that <italic>E. coli</italic> str. ECOR2 is closely related to other non-pathogenic human <italic>E. coli</italic> and only distantly related to pathogenic <italic>E. coli</italic> and <italic>Shigella</italic> isolates (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>). We developed a microinjection technique to introduce live <italic>E. coli</italic> into the HIO lumen in a manner that prevented contamination of the surrounding media (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). HIOs microinjected with 10<sup>5</sup> live <italic>E. coli</italic> constitutively expressing GFP exhibit robust green fluorescence within 3 hr of microinjection (<xref ref-type="fig" rid="fig1">Figure 1A</xref> and <xref ref-type="video" rid="video1">Video 1</xref>). Numerous <italic>E. coli</italic> localized to the luminal space at 48 hr post-microinjection and are present adjacent to the HIO epithelium, with some apparently residing in close opposition to the apical epithelial surface (<xref ref-type="fig" rid="fig1">Figure 1B</xref>).</p><fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.29132.003</object-id><label>Figure 1.</label><caption><title>HIOs can be stably associated with non-pathogenic E. coli.</title><p>(<bold>A</bold>) Mean fluorescent intensity of a human intestinal organoid (HIO) containing live GFP<inline-formula><mml:math id="inf1"><mml:msup><mml:mi/><mml:mo>+</mml:mo></mml:msup></mml:math></inline-formula><italic>E. coli</italic> str. ECOR2. The lower panels show representative images from the time series. Representative of three independent experiments. <xref ref-type="video" rid="video1">Video 1</xref> is an animation corresponding to this dataset. (<bold>B</bold>) Confocal micrograph of the HIO epithelium (E-cadherin) in direct association with GFP+ <italic>E. coli</italic> at 48 hr post-microinjection with 10<sup>4</sup> live <italic>E. coli</italic>. 60X magnification. (<bold>C</bold>) Luminal CFU per HIO <italic>E. coli</italic> at 24 hr post-microinjection relative to the injected concentration of 5 × 10<sup>-1</sup> to 5 × 10<sup>5</sup> CFU per HIO at the start of the experiment. <italic>N</italic> = 10 biological replicates per <italic>E. coli</italic> dose. The <italic>r<inline-formula><mml:math id="inf2"><mml:msup><mml:mi/><mml:mn mathvariant="normal">2</mml:mn></mml:msup></mml:math></inline-formula></italic> and <italic>P</italic> value shown in the figure represent the results of a linear regression analysis of the relationship between the 24 hr change in CFU/HIO and the initial number of CFU injected. (<bold>D</bold>) Luminal CFU per HIO at 0–72 hr following microinjection with 10 CFU <italic>E. coli</italic> per HIO. <italic>N</italic> = 13–17 replicate HIOs per time point. The p-value represents the results of a two-tailed Student’s <italic>t</italic>-test comparing the two conditions indicated. (<bold>E</bold>) Daily proportion of HIO cultures with no culturable <italic>E. coli</italic> in the external media following <italic>E. coli</italic> microinjection (<italic>N</italic> = 48) or PBS microinjection (<italic>N</italic> = 8).</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29132-fig1-v2"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.29132.004</object-id><label>Figure 1—figure supplement 1.</label><caption><title>Pluripotent stem-cell-derived intestinal epithelium transcriptionally resembles the immature human intestinal epithelium.</title><p>(<bold>A</bold>) Pearson’s correlation matrix with heirarchical clustering forwhole-transcriptome normalized RNA-seq gene counts from epithelium isolated from the tissuesindicated on the axes. (<bold>B</bold>) Pearson’s correlation coefficient for the comparison of whole-transcriptome normalized RNA-seq gene counts between each of the sample types listed onthe x-axis and adult small intestinal epithelium. p-Value indicates the results of an unpaired two-sided Student’s t-test. (<bold>C</bold>) Principle component analysis of whole-transcriptome RNA-seq normalized gene counts. Cumulative explained variance for PC1 and PC2 is indicated as a percentage on the x- and y-axes, respectively. (<bold>D</bold>) Density plot of the Log<sub>2</sub> -transformed Fold change in gene expression in epithelium from transplanted HIOs over epithelium from HIOs cultured in vitro plotted against the Log 2 -transformed Fold change in gene expression in adult small intestinal epithelium over fetal small intestinal epithelium. The intensity of the blue color indicates the density of points in 2-dimensional space. SI, small intestine; tx, transplanted tissue; hPSC, human pluripotent stem cell; HIO, human intestinal organoid.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29132-fig1-figsupp1-v2"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.29132.005</object-id><label>Figure 1—figure supplement 2.</label><caption><title>Phylogenetic tree based on maximum liklihood genomic distance among <italic>E.coli</italic> str.</title><p>ECOR2 (<xref ref-type="bibr" rid="bib126">Ochman and Selander, 1984</xref>), the strain used in the HIO colonization experiments, closely related <italic>E. coli</italic> isolates available on the PATRIC (<xref ref-type="bibr" rid="bib166">Wattam et al., 2017</xref>) database, and pathogenic type strains from the genera <italic>Esherichia, Shigella</italic>, and <italic>Salmonella</italic>. A PATRIC genome reference number follows name of each taxa.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29132-fig1-figsupp2-v2"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.29132.006</object-id><label>Figure 1—figure supplement 3.</label><caption><title>HIO colonization protocol.</title><p>(<bold>A</bold>) Schematic representation of the microinjection of HIOs with live <italic>E. coli</italic>. See Materials and Methods for additional details. (<bold>B</bold>) A comparison of CFU/HIO at 24 hpost-microinjection of HIOs microinjected with 10 × 10<sup>3</sup> CFU live <italic>E. coli</italic> diluted in sterile PBS or fresh LB broth. <italic>N</italic> = 5 HIOs per condition. All experiments presented in the main paper represent <italic>E. coli</italic> diluted in PBS. (<bold>C</bold>) To test for the effect of antibiotic carryover of <italic>E. coli</italic> growth in the HIO lumen, we compared CFU/HIO in HIOs cultured in antibiotic-free media ('Remove abx') or media containing penicillin and streptomycin at 24 hr post-microinjection with 10 <sup>3</sup> CFU (colony forming units) live <italic>E. coli</italic>. All experiments presented in the main paper represent HIOs cultured in antibiotic-free media due to the apparent effect of antibiotics in suppressing <italic>E. coli</italic> growth within the HIO lumen. <italic>N</italic> = 5 HIOs per condition. (<bold>D</bold>) In several experiments, bacterial translocation was measured by samplign the external HIO culture media (<xref ref-type="fig" rid="fig1">Figure 1</xref> and <xref ref-type="fig" rid="fig8">8</xref>). To evaluate the potential influence of antibiotic carryover in our estimates of bacterial translocation, we measured growth inhibition in <italic>E. coli</italic> cultures plated as a lawn of LB agar and treated with 1 μl samples of HIO media collected during the 1 hr antibiotic wash step or after HIO culture washout with PBS and replacement with fresh antibiotic-free media (see panel A). N = 6 replicates per culture condition. All p-values represent the results of unpaired one-tailed Student’s t-test comparisons.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29132-fig1-figsupp3-v2"/></fig></fig-group><media id="video1" mime-subtype="mp4" mimetype="video" xlink:href="elife-29132-video1.mp4"><object-id pub-id-type="doi">10.7554/eLife.29132.007</object-id><label>Video 1.</label><caption><title>Animation of individual epifluorescent microscopy images from a human intestinal organoid (HIO) containing live GFP<inline-formula><mml:math id="inf3"><mml:msup><mml:mi/><mml:mo>+</mml:mo></mml:msup></mml:math></inline-formula> <italic>E. coli</italic> str.</title><p>ECOR2. Images were captured at 10 min intervals over the course of 18 hr an coalated in sequential order. Representative of three independent experiments. See <xref ref-type="fig" rid="fig1">Figure 1A</xref>.</p></caption></media><p>In order to determine the minimum number of colony-forming units (CFU) of <italic>E. coli</italic> required to establish short term colonization (24 hr), we microinjected increasing numbers of live <italic>E. coli</italic> suspended in PBS into single HIOs and collected and determined the number of bacteria in the luminal contents at 24 hr post-microinjection (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Single HIOs can be stably colonized by as few as 5 CFU <italic>E. coli</italic> per HIO with 77.8% success (positive luminal culture and negative external media culture at 24 hr post-injection) and 100% success at <inline-formula><mml:math id="inf4"><mml:mo>≥</mml:mo></mml:math></inline-formula>100 CFU per HIO (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Increasing the number of CFU <italic>E. coli</italic> microinjected into each HIO at <italic>t</italic> = 0 did result in a significant increase in the mean luminal CFU per HIO at 24 hr post-microinjection at any dose (ANOVA p=0.37; <xref ref-type="fig" rid="fig1">Figure 1C</xref>). Thus, the 24 hr growth rate of <italic>E. coli</italic> within the HIO lumen <inline-formula><mml:math id="inf5"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mfrac><mml:mrow><mml:mi>C</mml:mi><mml:mi>F</mml:mi><mml:mi>U</mml:mi><mml:mo>×</mml:mo><mml:mi>H</mml:mi><mml:mi>I</mml:mi><mml:msubsup><mml:mi>O</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>24</mml:mn></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>F</mml:mi><mml:mi>U</mml:mi><mml:mo>×</mml:mo><mml:mi>H</mml:mi><mml:mi>I</mml:mi><mml:msubsup><mml:mi>O</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup></mml:mrow></mml:mfrac><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> was negatively correlated with the CFU injected (r<inline-formula><mml:math id="inf6"><mml:msup><mml:mi/><mml:mtext>2</mml:mtext></mml:msup></mml:math></inline-formula> = 0.625, p=3.1 × 10<sup>-12</sup>; <xref ref-type="fig" rid="fig1">Figure 1C</xref>).</p><p>Next, we examined the stability of HIO and <italic>E. coli</italic> co-cultures over time in vitro. HIOs were microinjected with 10 CFU <italic>E. coli</italic> and maintained for 24–72 hr (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). Rapid expansion of <italic>E. coli</italic> density within the HIO lumen was observed in the first 24 hr, with relatively stable bacterial density at 48–72 hr. A 6.25-fold increase in bacterial density was observed between 24 and 72 hr post-microinjection (p=0.036). Importantly, samples taken from the external HIO culture media were negative for <italic>E. coli</italic> growth.</p><p>Finally, we examined the stability of HIO cultures following <italic>E. coli</italic> microinjection (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). A total of 48 individual HIOs were microinjected with 10<inline-formula><mml:math id="inf7"><mml:msup><mml:mi/><mml:mtext>4</mml:mtext></mml:msup></mml:math></inline-formula> CFU <italic>E. coli</italic> each. Controls were microinjected with sterile PBS alone. We found that external culture media was sterile in 100% of control HIOs throughout the entire experiment, and in 100% of <italic>E. coli</italic> injected HIOs on days 0–2 post-microinjection. On days 3–9 post-microinjection some cultured media was positive for <italic>E. coli</italic> growth; however, 77.08% of <italic>E. coli</italic> injected HIOs were negative for <italic>E. coli</italic> in the external culture media throughout the timecourse. Additional control experiments were conducted to determine if the HIO growth media had any effect on <italic>E. coli</italic> growth. <italic>E.coli</italic>-inoculated HIO growth media showed that the media itself allowed for robust bacterial growth, and therefore the absence of <italic>E. coli</italic> growth in external media from HIO cultures could not be attributed to the media composition alone (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>). Thus, the large majority of <italic>E. coli</italic> colonized HIOs remain stable for an extended period when cultured in vitro and without antibiotics.</p></sec><sec id="s2-3"><title>Bacterial colonization elicits a broad-scale, time-dependent transcriptional response</title><p>Colonization of the immature gut by microbes is associated with functional maturation in both model systems (<xref ref-type="bibr" rid="bib100">Kremer et al., 2013</xref>; <xref ref-type="bibr" rid="bib146">Sommer et al., 2015</xref>; <xref ref-type="bibr" rid="bib23">Broderick et al., 2014</xref>; <xref ref-type="bibr" rid="bib50">Erkosar et al., 2015</xref>) and in human infants (<xref ref-type="bibr" rid="bib131">Renz et al., 2011</xref>). To evaluate if exposing HIOs to <italic>E. coli</italic> led to maturation at the epithelial interface, we evaluated the transcriptional events following microinjection of live <italic>E. coli</italic> into the HIO lumen. PBS-injected HIOs (controls) and HIOs co-cultured with <italic>E. coli</italic> were collected for transcriptional analysis after 24, 48 and 96 hr (<xref ref-type="fig" rid="fig2">Figure 2</xref>). At 24 hr post-microinjection, a total of 2018 genes were differentially expressed (adjusted-FDR &lt; 0.05), and the total number of differentially expressed genes was further increased at 48 and 96 hr post-microinjection relative to PBS-injected controls (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Principle component analysis demonstrated that global transcriptional activity in HIOs is significantly altered by exposure to <italic>E. coli</italic>, with the degree of transcriptional change relative to control HIOs increasing over time (<xref ref-type="fig" rid="fig2">Figure 2B</xref>).</p><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.29132.008</object-id><label>Figure 2.</label><caption><p>(<bold>A</bold>) Log2-transformed fold change in normalized RNA-seq gene counts in <italic>E. coli</italic> colonized HIOs at 24, 48, and 96 hr post-microinjection with 10<sup>4</sup> live <italic>E. coli</italic> relative to PBS-injected HIOs. Differentially expressed genes (FDR-adjusted p-value &lt; 0.05) are indicated in red (up-regulated) or blue (down-regulated). Plotted results are the mean fold change per gene for each group. (<bold>B</bold>) Principle component plot of HIOs at 0–96 hr post-microinjection derrived from whole-transcriptome RNA-seq normalized gene counts. Cumulative explained variance for PC1 and PC2 is indicated as a percentage on the x- and y-axes, respectively. (<bold>C</bold>) Heat map of normalized enrichment scores (NES) from GSEA of normalized RNA-seq expression data using the GO and REACTOME databases. A positive value of NES indicates activation of a given gene set and a negative value suggests relative suppression of a gene set. All NES scores are calculated relative to PBS-microinjected controls. (<bold>D</bold>) Mean log<inline-formula><mml:math id="inf8"><mml:msub><mml:mi/><mml:mn>2</mml:mn></mml:msub></mml:math></inline-formula> fold change in normalized RNA-seq gene counts at 24–96 hr post microinjection relative to PBS-injected control HIOs. (<bold>E</bold>) Protein secretion at 0–9 days post-microinjection with PBS or <italic>E. coli</italic> as measured by ELISA in the supernatant of HIO cultures. The genes given in D correspond to the proteins measured in E. <italic>N</italic> = 4 (0 hr), 5 (24 hr), 3 (48 hr), and 4 (96 hr) biological replicates consisting of 5–6 pooled HIOs per replicate for panels A-D. <italic>N</italic> = 48 <italic>E. coli</italic>-injected HIOs and <italic>N</italic> = 8 PBS-injected HIOs for panel E.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29132-fig2-v2"/></fig><p>Gene set enrichment analysis (GSEA) (<xref ref-type="bibr" rid="bib149">Subramanian et al., 2005</xref>) using the GO (<xref ref-type="bibr" rid="bib13">Ashburner et al., 2000</xref>; <xref ref-type="bibr" rid="bib66">Gene Ontology Consortium, 2015</xref>) and REACTOME (<xref ref-type="bibr" rid="bib39">Croft et al., 2014</xref>; <xref ref-type="bibr" rid="bib52">Fabregat et al., 2016</xref>) databases to evaluate RNA-seq expression data revealed coordinated changes in gene expression related to innate anti-microbial defense, epithelial barrier production, adaptation to low oxygen, and tissue maturation (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Innate antimicrobial defense pathways, including genes related to NF-κB signaling, cytokine production, and Toll-like receptor (TLR) signaling were strongly up-regulated at 24 hr post-microinjection and generally exhibited decreased activation at later time points. GSEA also revealed changes in gene expression consistent with reduced oxygen levels or hypoxia, including the induction of pro-angiogenesis signals. A number of pathways related to glycoprotein synthesis and modification, including O-linked mucins, glycosaminoglycans, and proteoglycans, were up-regulated in the initial stages of the transcriptional response (Syndecans, integrins), exhibited a somewhat delayed onset (O-linked mucins), or exhibited consistent activation at all time points post-microinjection (Keratan sulfate and glycosaminoglycan biosynthesis). Finally, genes sets associated with a range of processes involved in tissue maturation and development followed a distinct late-onset pattern of expression. This included broad gene ontology terms for organ morphogenesis, developmental maturation, and regionalization as well as more specific processes such as differentiation of mesenchymal and muscle cells, and processes associated with the nervous system (<xref ref-type="fig" rid="fig2">Figure 2C</xref>).</p><p>We also made correlations between upregulated genes in the RNA-seq data (<xref ref-type="fig" rid="fig2">Figure 2D</xref>) and protein factors present in the organoid culture media following <italic>E. coli</italic> microinjection (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). β-defensin 1 (<italic>DEFB1</italic> (gene); BD-1 (protein)) and β-defensin 2 (<italic>DEFB4A</italic> (gene); BD-2 (protein)) exhibited distinct patterns of expression, with both <italic>DEFB1</italic> and its protein product BD-1 stable at 24 hr after <italic>E. coli</italic> microinjection but relatively suppressed at later time points, and <italic>DEFB4A</italic> and BD-2 strongly induced at early time points and subsiding over time relative to PBS-injected controls. By contrast, inflammatory regulators IL-6 and IL-8 and the pro-angiogenesis factor VEGF were strongly induced at the transcriptional level within 24–48 hr of <italic>E. coli</italic> microinjection. Secretion of IL-6, IL-8, and VEGF increased over time, peaking at 5–9 days after <italic>E. coli</italic> association relative to PBS-injected controls (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). Taken together, this data demonstrates a broad-scale and time-dependent transcriptional response to <italic>E. coli</italic> association with distinct early- and late-phase patterns of gene expression and protein secretion.</p></sec><sec id="s2-4"><title>Bacterial colonization results in a transient increase in epithelial proliferation and the maturation of enterocytes</title><p>While the transcriptional analysis demonstrated strong time-dependent changes in the cells that comprise the HIO following <italic>E. coli</italic> colonization, we hypothesized that exposure to bacteria may also alter the cellular behavior and/or composition of the HIO. Previous studies have demonstrated that bacterial colonization promotes epithelial proliferation in model organisms (<xref ref-type="bibr" rid="bib17">Bates et al., 2006</xref>; <xref ref-type="bibr" rid="bib31">Cheesman et al., 2011</xref>; <xref ref-type="bibr" rid="bib121">Neal et al., 2013</xref>; <xref ref-type="bibr" rid="bib100">Kremer et al., 2013</xref>; <xref ref-type="bibr" rid="bib86">Ijssennagger et al., 2015</xref>). We examined epithelial proliferation in HIOs over a timecourse of 96 hr by treating HIOs with a single 2 hr exposure of 10 <inline-formula><mml:math id="inf9"><mml:mi>μ</mml:mi></mml:math></inline-formula>M EdU added to the culture media from 22 to 24 hr after microinjection with 10<sup>4</sup> CFU <italic>E. coli</italic> or PBS alone. HIOs were subsequently collected for immunohistochemistry at 24, 48, and 96 hr post-microinjection (<xref ref-type="fig" rid="fig3">Figure 3</xref>). The number of proliferating epithelial cells (Edu<inline-formula><mml:math id="inf10"><mml:msup><mml:mi/><mml:mrow><mml:mo>\</mml:mo><mml:mtext>+</mml:mtext></mml:mrow></mml:msup></mml:math></inline-formula> and E-cadherin<inline-formula><mml:math id="inf11"><mml:msup><mml:mi/><mml:mrow><mml:mo>\</mml:mo><mml:mtext>+</mml:mtext></mml:mrow></mml:msup></mml:math></inline-formula>) was elevated by as much as three-fold in <italic>E. coli</italic>-colonized HIOs relative to PBS-treated HIOs at 24 hr (<xref ref-type="fig" rid="fig3">Figure 3A–B</xref>). However, at 48 hr post-microinjection, the proportion of EdU + epithelial cells was significantly decreased in <italic>E. coli</italic> colonized HIOs relative to control treated HIOs. This observation was supported by another proliferation marker, KI67 (<xref ref-type="bibr" rid="bib68">Gerdes et al., 1984</xref>)(<xref ref-type="fig" rid="fig3">Figure 3B</xref>), as well as RNA-seq data demonstrating an overall suppression of cell cycle genes in <italic>E. coli</italic> colonized HIOs relative to PBS-injected HIOs at 48 hr post-microinjection (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). By 96 hr post-microinjection the proportion of EdU+ epithelial cells was nearly identical in <italic>E. coli</italic> and PBS-treated HIOs (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Collectively, these results suggest that <italic>E. coli</italic> colonization is associated with a rapid burst of epithelial proliferation, but that relatively few of the resulting daughter cells are retained subsequently within the epithelium.</p><fig-group><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.29132.009</object-id><label>Figure 3.</label><caption><title>Bacterial colonization results in a transient increase in epithelial proliferation and the maturation of enterocytes.</title><p>(<bold>A</bold>) Representative confocal micrographs of HIOs injected with PBS or 10<sup>4</sup> CFU <italic>E. coli</italic> str. ECOR2 at 24–96 hr post-microinjection and stained with fluorescent indicators for for EdU<inline-formula><mml:math id="inf12"><mml:msup><mml:mi/><mml:mo>+</mml:mo></mml:msup></mml:math></inline-formula>DNA, E-cadherin, or nuclei (DAPI) as indicated in the figure labels . All HIOs were exposed to 10 <inline-formula><mml:math id="inf13"><mml:mi>μ</mml:mi></mml:math></inline-formula>M EdU at 22 hr post-microinjection and EdU was removed at 24 hr. Panels are representative of 4 HIOs per timepoint per treatment condition. (<bold>B</bold>) Quantification of the number of EdU-positive and Ki67-positive epithelial cells (E-cadherin<inline-formula><mml:math id="inf14"><mml:msup><mml:mi/><mml:mo>+</mml:mo></mml:msup></mml:math></inline-formula> cells) per 10X confocal microscopy field. One 10X confocal microscopy field consisting of 200–1000 epithelial cells was collected from each of 4 HIOs per timepoint per treatment group. The error bars represent the standard error of the mean and the p-values reflect the results of an unpaired two-tailed Student’s <italic>t</italic>-test comparing the PBS-injected HIOs to the <italic>E. coli</italic>-injected HIOs at that timepoint. (<bold>C</bold>) Representative confocal micrographs of HIOs injected with PBS or 10<sup>4</sup> CFU <italic>E. coli</italic> str. ECOR2 at 24–96 hr post-microinjection and stained with fluorescent antibodies for Sox9, E-cadherin, or nuclei (DAPI) as indicated in the figure labels. Panels are representative of 4 HIOs per timepoint per treatment condition.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29132-fig3-v2"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.29132.010</object-id><label>Figure 3—figure supplement 1.</label><caption><title>Pathview (<xref ref-type="bibr" rid="bib106">Luo and Brouwer, 2013</xref>) plot of the KEGG (<xref ref-type="bibr" rid="bib90">Kanehisa and Goto, 2000</xref>) pathway showing the Cell mitotic cycle ('HSA 04110') superimposed with RNA-seq expression data corresponding to the log<sub>2</sub> -transformed fold change in expression of cell cycle transcripts from HIOs microinjected with <italic>E. coli</italic> relative to PBS-injected HIOs at 48 h post-microinjection.</title><p>Mean of 4 biological replicates, each representing 5-6 pooled HIOs.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29132-fig3-figsupp1-v2"/></fig></fig-group><p>The transcription factor Sox9 is expressed by progenitor cells in the murine intestinal epithelium (<xref ref-type="bibr" rid="bib16">Bastide et al., 2007</xref>; <xref ref-type="bibr" rid="bib116">Mori-Akiyama et al., 2007</xref>), and several epithelial subtypes are derived from a Sox9-expressing progenitor population in the mature intestinal epithelium (<xref ref-type="bibr" rid="bib16">Bastide et al., 2007</xref>; <xref ref-type="bibr" rid="bib62">Furuyama et al., 2011</xref>). We examined SOX9 expression in HIOs following microinjection with <italic>E. coli</italic> or PBS alone over a 96 hr time course (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). In the PBS-treated HIOs, the majority of epithelial cells exhibited robust nuclear SOX9 expression at all time points examined. However, SOX9 expression was dramatically reduced in <italic>E. coli</italic>-colonized HIOs at 48–96 hr after microinjection and was notably distributed in nuclei farthest from the lumen and adjacent to the underlying mesenchyme, mirroring the altered distribution of EdU + nuclei seen in <xref ref-type="fig" rid="fig3">Figure 3B</xref>. This observation suggests that there is a reduction in the number of progenitor cells in the HIO epithelium following <italic>E. coli</italic> colonization and implies that other epithelial types may account for a greater proportion of the HIO epithelium at later time points post-colonization. We saw no appreciable staining for epithelial cells expressing goblet, Paneth, or enteroendocrine cell markers (MUC2, DEFA5, and CHGA, respectively; negative data not shown). However, expression of the small intestinal brush border enzyme dipeptidyl peptidase-4 (DPPIV) was found to be robustly expressed in the <italic>E. coli</italic>-colonized HIOs at 48 and 96 hr post-microinjection (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). DPPIV was not detected in any of the PBS-injected HIOs at any timepoint. Lysozyme (LYZ), an antimicrobial enzyme expressed by Paneth-like progenitors in the small intestinal crypts <xref ref-type="bibr" rid="bib19">Bevins and Salzman (2011)</xref>, was widely distributed throughout the epithelium of PBS-treated HIOs as we have previously described (<xref ref-type="bibr" rid="bib147">Spence et al., 2011</xref>) (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). However, in <italic>E. coli</italic>-colonized HIOs, LYZ expression was restricted to distinct clusters of epithelial cells and, notably, never overlapped with DPPIV staining (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). Given that <italic>bona fide</italic> Paneth Cell markers (i.e. DEFA5) were not observed in any HIOs, it is likely that the LYZ expression is marking a progenitor-like population of cells. Taken together, these experiments indicate that <italic>E. coli</italic> colonization induces a substantial but transient increase in the rate of epithelial proliferation followed by a reduction and redistribution of proliferating epithelial progenitors and differentiation of a population of cells expressing small intestinal enterocyte brush boarder enzymes over a period of 2–4 days.</p></sec><sec id="s2-5"><title><italic>E. coli</italic> colonization is associated with a reduction in luminal O<inline-formula><mml:math id="inf15"><mml:msub><mml:mi/><mml:mtext>2</mml:mtext></mml:msub></mml:math></inline-formula></title><p>The mature intestinal epithelium is characterized by a steep oxygen gradient, ranging from 8% oxygen within the bowel wall to &lt;2% oxygen in the lumen of the small intestine (<xref ref-type="bibr" rid="bib57">Fisher et al., 2013</xref>). Reduction of oxygen content in the intestinal lumen occurs during the immediate perinatal period (<xref ref-type="bibr" rid="bib75">Gruette et al., 1965</xref>), resulting in changes in epithelial physiology (<xref ref-type="bibr" rid="bib70">Glover et al., 2016</xref>; <xref ref-type="bibr" rid="bib92">Kelly et al., 2015</xref>; <xref ref-type="bibr" rid="bib35">Colgan et al., 2013</xref>; <xref ref-type="bibr" rid="bib175">Zeitouni et al., 2016</xref>) that helps to shape the subsequent composition of the microbiota (<xref ref-type="bibr" rid="bib142">Schmidt and Kao, 2014</xref>; <xref ref-type="bibr" rid="bib51">Espey, 2013</xref>; <xref ref-type="bibr" rid="bib7">Albenberg et al., 2014</xref>; <xref ref-type="bibr" rid="bib129">Palmer et al., 2007</xref>; <xref ref-type="bibr" rid="bib98">Koenig et al., 2011</xref>). Analysis of the global transcriptional response to <italic>E. coli</italic> association in the immature intestinal tissue revealed pronounced and coordinated changes in gene expression consistent with the onset of hypoxia (<xref ref-type="fig" rid="fig2">Figure 2C–E</xref>). We therefore measured oxygen concentration in the lumen of control HIOs and following microinjection of live <italic>E. coli</italic> using a 50 <inline-formula><mml:math id="inf16"><mml:mi>μ</mml:mi></mml:math></inline-formula>m diameter fiberoptic optode (<xref ref-type="fig" rid="fig4">Figure 4A–B</xref>). Baseline oxygen concentration in the organoid lumen was 8.04 ± 0.48%, which was significantly reduced relative to the external culture media (18.86 ± 0.37%, p=3.6 × 10<sup>-11</sup>). At 24 and 48 hr post-microinjection, luminal oxygen concentration was significantly reduced in <italic>E. coli</italic>-injected HIOs relative to PBS-injected HIOs (p=0.04 and p=5.2 × 10<sup>-05</sup>, respectively) reaching concentrations as low as 1.67 ± 0.62% at 48 hr (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). <italic>E. coli</italic> injected HIOs were collected and CFU were enumerated from luminal contents at 24 and 48 hr post-microinjection. We observed a highly significant negative correlation between luminal CFU and luminal oxygen concentration where increased density of luminal bacteria was correlated with lower oxygen concentrations (r<sub>2</sub> = 0.842, p=6.86 × 10<sup>-5</sup>; <xref ref-type="fig" rid="fig4">Figure 4B</xref>). Finally, in order to assess relative oxygenation in the epithelium itself, we utilized a small molecule pimonidazole (PMDZ), which forms covalent conjugates with thiol groups on cytoplasmic proteins only under low-oxygen conditions (<xref ref-type="bibr" rid="bib11">Arteel et al., 1998</xref>). Fluorescent immunochemistry demonstrated enhanced PMDZ uptake in <italic>E. coli</italic> associated HIO epithelium, and in HIOs grown in 1% O<sub>2</sub> as a positive control when compared to to PBS-injected HIOs, or HIOs injected with heat killed <italic>E. coli</italic> at 48 hr post-microinjection (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). Thus, luminal and epithelial oxygen is reduced following microinjection of <italic>E. coli</italic> into the HIO, consistent with data in mice showing that the in vivo epithelium is in a similar low-oxygen state in normal physiological conditions (<xref ref-type="bibr" rid="bib142">Schmidt and Kao, 2014</xref>; <xref ref-type="bibr" rid="bib92">Kelly et al., 2015</xref>; <xref ref-type="bibr" rid="bib95">Kim et al., 2017</xref>).</p><fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.29132.011</object-id><label>Figure 4.</label><caption><title>E. coli colonization is associated with a reduction in luminal oxygen concentration.</title><p>(<bold>A</bold>) Luminal oxygen concentration in human intestinal organoids at 0–48 hr post-microinjection with 10<sup>4</sup> CFU live <italic>E. coli. </italic>p Values reflect results of unpaired one-tailed Students <italic>t</italic>-tests for the comparisons indicated. <italic>N</italic> = 6–11 replicate HIOs per treatment group per time point. (<bold>B</bold>) Linear regression analysis of luminal CFU <italic>E. coli</italic> per organoid at and luminal oxygen concentration in the same organoid 24 hr post-microinjection . (<bold>C</bold>) Confocal micrographs of the HIO epithelium in PBS- and <italic>E. coli</italic>-injected HIOs at 48 hr post-microinjection. Images are representative of the replicates detailed in the table, with 12–14 replicate HIOs per treatment group pooled from two separate experiments. Individual HIOs were scored as PMDZ<inline-formula><mml:math id="inf17"><mml:msup><mml:mi/><mml:mo>+</mml:mo></mml:msup></mml:math></inline-formula> or PMDZ<inline-formula><mml:math id="inf18"><mml:msup><mml:mi/><mml:mo>-</mml:mo></mml:msup></mml:math></inline-formula> based on the presence or absence, respectively, of PMDZ conjugates as detected by immunofluorescent microscopy. p-Values represent the results of <inline-formula><mml:math id="inf19"><mml:mrow><mml:mi>χ</mml:mi><mml:msup><mml:mi/><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:math></inline-formula> contingency tests comparing the distribution of PMDZ<inline-formula><mml:math id="inf20"><mml:msup><mml:mi/><mml:mo>+</mml:mo></mml:msup></mml:math></inline-formula> and PMDZ<inline-formula><mml:math id="inf21"><mml:msup><mml:mi/><mml:mo>-</mml:mo></mml:msup></mml:math></inline-formula> HIOs in the PBS-treated group to each of the other conditions.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29132-fig4-v2"/></fig></sec><sec id="s2-6"><title>NF-κB integrates complex microbial and hypoxic stimuli</title><p><italic>E. coli</italic> colonization elicits a robust transcriptional response in immature intestinal tissue (<xref ref-type="fig" rid="fig2">Figure 2</xref>) that is associated with the onset of luminal oxygen depletion and relative tissue hypoxia (<xref ref-type="fig" rid="fig4">Figure 4</xref>). We set out to determine whether we could assign portions of the transcriptional response to direct interaction with microbes or to the subsequent depletion of luminal oxygen. In the RNA-seq analysis (<xref ref-type="fig" rid="fig2">Figure 2</xref>), NF-κB signaling emerged as a major pathway involved in this complex host-microbe interaction, and NF-κB has been shown by others to act as a transcriptional mediator of both microbial contact and the response to tissue hypoxia (<xref ref-type="bibr" rid="bib133">Rius et al., 2008</xref>; <xref ref-type="bibr" rid="bib69">Gilmore, 2006</xref>; <xref ref-type="bibr" rid="bib169">Wullaert et al., 2011</xref>). Gene Ontology and REACTOME pathway analysis showed that NF-κB signaling components are also highly up-regulated following microinjection of <italic>E. coli</italic> into HIOs (<xref ref-type="fig" rid="fig2">Figure 2C</xref> and <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>). Thus, we assessed the role of NF-κB signaling in the microbial contact-associated transcriptional response and the hypoxia-associated response using the highly selective IKKβ inhibitor SC-514 (<xref ref-type="bibr" rid="bib96">Kishore et al., 2003</xref>; <xref ref-type="bibr" rid="bib104">Litvak et al., 2009</xref>) to inhibit phosphorylation and activation of the transcription factor p65 (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>). Another set of HIOs was simultaneously transferred to a hypoxic chamber and cultured in 1% O<sub>2</sub> with and without SC-514. At 24 hr post-treatment, HIOs were harvested for RNA isolation and RNA-seq. We devised an experimental scheme that allowed us to parse out the relative contributions of microbial contact and microbe-associated luminal hypoxia in the transcriptional response to association with live <italic>E. coli</italic> (<xref ref-type="fig" rid="fig5">Figure 5A</xref> and <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>). First, we identified a set of genes significantly up-regulated (log<sub>2</sub>FC &gt; 0 and FDR-adjusted p-value &lt; 0.05) by microinjection of either live <italic>E. coli</italic> or heat-inactivated <italic>E. coli</italic> (contact dependent genes). From this gene set, we identified a subset that was suppressed by the presence of NF-κB inhibitor SC-514 during association with either live or heat-inactivated <italic>E. coli</italic> (log<sub>2</sub>FC &lt; 0 and FDR-adjusted p-value &lt; 0.05; Gene Set I, <xref ref-type="fig" rid="fig5">Figure 5B</xref>). Thus, Gene Set I represents the NF-κB dependent transcriptional response to live or dead <italic>E. coli</italic>. Genes induced by live or heat-inactivated <italic>E. coli</italic> but not suppressed by SC-514 were considered NF-κB independent (Gene Set III, <xref ref-type="fig" rid="fig5">Figure 5B</xref>). Likewise, we compared genes commonly up-regulated by association with live <italic>E. coli</italic> and those up-regulated under 1% O<sub>2</sub> culture conditions. A subset of genes induced by either live <italic>E. coli</italic> or 1% O<sub>2</sub> culture but suppressed by the presence of NF-κB inhibitor was identified as the NF-κB-dependent hypoxia-associated transcriptional response (Gene Set II, <xref ref-type="fig" rid="fig5">Figure 5B</xref>). Genes induced by live <italic>E. coli</italic> or hypoxia but not inhibited by the presence of NF-κB inhibitor were considered NF-κB independent transcriptional responses to microbe-associated hypoxia (Gene Set IV). Gene lists for each gene set are found in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>.</p><fig-group><fig id="fig5" position="float"><object-id pub-id-type="doi">10.7554/eLife.29132.012</object-id><label>Figure 5.</label><caption><title>NF-κB integrates complex microbial and hypoxic stimuli.</title><p>(<bold>A</bold>) Analysis scheme for identifying genes sets representing the components of the transcriptional response to live <italic>E. coli</italic> that could be recapitulated with heat-inactivated <italic>E. coli</italic> (contact induced) or hypoxia (microbial-associated hypoxia induced) as well as the subsets of genes induced through NF-κB dependent signaling. HIOs were microinjected with PBS, 10<sup>4</sup> CFU <italic>E. coli</italic> or an equivalent concentration of heat-inactivated <italic>E. coli</italic> and cultured under standard cell culture conditions or hypoxic conditions (1% O<sub>2</sub>, 5% CO<sub>2</sub>, 94% N<sub>2</sub>) with and without 10 μM SC-514. (<bold>B</bold>) Scatter plots with density overlay indicating the genes meeting the <italic>a priori</italic> criteria identified in panel A with an FDR-adjusted p-value of &lt; 0.05 for the comparisons listed on the axes of the plot. (<bold>C</bold>) Bar plot of the proportion of genes in the input gene sets mapping to each pathway from the GO and REACTOME databases enrichment p-values for each of the gene sets identified in A. Pathways with enrichment p-values &gt; 0.01 were excluded from the plot. Results represent <italic>N</italic> = 4–5 biological replicates per treatment condition, with each replicate consisting of 5–6 pooled and identically treated HIOs.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29132-fig5-v2"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.29132.013</object-id><label>Figure 5—figure supplement 1.</label><caption><title>NF-κB signaling pathway acticvation in HIOs.</title><p>(<bold>A</bold>) Heatmap representation of time-dependent normalized RNA-seqgene expression for NF-κB pathway components in HIOs at 0-96 hr post-microinjection. (<bold>B</bold>) Western blot of phosphorylated p65 and total p65 in cell lysates from HIOs microinjected with PBS or live <italic>E. coli</italic> and treated with IKKβ inhibitor SC-514 (1 μM) as indicated in the figure. (<bold>C</bold>) log2-transformed fold-change in gene expression relative to PBS-injected controls for all seven experimental conditions examined in this set of experiments: live <italic>E. coli</italic> +/- SC-514, heat-killed E. coli +/- SC-514, and hypoxic culture +/- SC-514, and PBS + SC-514. Differentially expressed genes (adjusted FDR &lt; 0.05) are indicated in red (up-regulated) or blue (down-regulated). Mean of three to five replicates per experimental condition. (<bold>D</bold>) Top 10 percentile by FDR-adjusted p-value of over-represented genes sets from the GO, KEGG, and REACTOME databases in genes that were significantly up- or down-regulated by treatment with SC-514 alone relative to PBS-injected control HIOs. (<bold>E</bold>) (Copied from Figure 5 for easeof reference) Venn Diagram showing the number of genes shared between Gene Set I, Gene Set II, and the set of genes that are significantly down-regulated in PBS-injected HIOs treated with SC-514 relative to PBS-injected control HIOs. (<bold>F</bold>) Top 10 percentile by FDR-adjusted p-value of over-represented genes sets from the GO, KEGG, and REACTOME databases in genes that were shared between Gene Set I or II and the set of genes that are significantly down-regulated in HIOs treated with SC-514 relative to PBS-injected control HIOs.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-29132-fig5-figsupp1-v2"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.29132.014</object-id><label>Figure 5—figure supplement 2.</label><caption><title>Secretion of AMPs (BD-1 &amp; BD-2), cytokines (IL-6 &amp; IL-8), and thepro-angiogenesis growth factor VEGF in HIOs microinjected with PBS, 10 4 CFU <italic>E.</italic></title><p><italic>coli</italic>, or anequivalent concentration of heat-inactivated <italic>E. coli</italic> and cultured under standard cell cultureconditions or hypoxic conditions (1% O<sub>2</sub> , 5% CO<sub>2</sub> , 94% N 2) for 24 hr as measured by ELISA. <italic>N</italic> = 7-8 HIOs per condition.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29132-fig5-figsupp2-v2"/></fig></fig-group><p>Following the identification of these four gene sets, we then applied over-representation analysis using the GO and REACTOME pathway databases to identify enriched pathways for each of the four gene sets, resulting in four clearly distinguishable patterns of gene pathway enrichment (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). Contact with either live or heat-inactivated <italic>E. coli</italic> is sufficient to promote expression of genes involved in maintaining epithelial barrier integrity and mucin production, an effect that is suppressed in the presence of NF-κB inhibitor. Additionally, key developmental pathways including epithelial morphogenesis, digestive tract development, and expression of digestive enzymes appear to be driven primarily by bacterial association and are largely NF-κB dependent. Robust innate and adaptive defense requires both bacterial contact and hypoxia, with some genes associated with antigen processing and cytokine signaling being NF-κB dependent (Gene Set II) and others associated with NF-κB-independent gene sets (Gene Sets III and IV). Genes associated with antimicrobial defensin peptides were enriched only in the hypoxia-asociated, NF-κB-independent gene set (Gene Set IV), suggesting that antimicrobial peptides are regulated by mechanisms that are distinct from other aspects of epithelial barrier integrity such as mucins and epithelial junctions (Gene Set I). TLR signaling components were is broadly enhanced by live <italic>E. coli</italic> and associated with both microbial contact and hypoxia were largely NF-κB independent (Gene Sets III and IV). There was a notable transcriptional signature suggesting metabolic and mitochondrial adaptation to bacteria that was independent of NF-κB and primarily driven by bacterial contact rather than hypoxia (Gene Set III).</p><p>To interrogate the transcriptional changes influenced by SC-514 exposure, we examined over-represented genes sets from the GO and REACTOME databases in genes that were significantly up- or down-regulated by treatment with SC-514 alone (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C and D</xref>) . Notably, SC-514 alone does not appear to have a strong effect on the pathways identified in <xref ref-type="fig" rid="fig5">Figure 5C</xref> as key NF-κB-dependent responses to bacterial contact and/or hypoxia. In <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1E</xref>, we examined the degree of overlap between Gene Set I, Gene Set II, and the set of genes that are significantly down-regulated in PBS-injected HIOs treated with SC-514. This analysis demonstrates that the majority of genes in Set I and Set II are not significantly down-regulated in PBS-injected HIOs treated with SC-514. The most significant effects of SC-514 alone among Gene Set I and Gene Set II genes are related to metabolism, redox state, and ribosomal dynamics (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1F</xref>). Thus, the effect of SC-514 alone cannot account for the NF-κB-dependent changes in innate and adaptive defense, epithelial barrier integrity, angiogenesis and hypoxia signaling, or intestinal development following bacterial contact and/or hypoxia during colonization.</p><p>Finally, we also examined the role of microbial contact and hypoxia in colonization-induced changes in AMP, cytokine, and growth factor secretion using ELISA (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). Consistent with findings from the RNA-seq data, these results indicate that there are diverse responses to bacterial contact and hypoxia. We observed cases where cytokines were induced by either microbial contact or hypoxia alone (IL-6), other cases where hypoxia appeared to be the dominant stimuli (BD-1), and a third regulatory paradigm in which the response to live <italic>E. coli</italic> evidently results from the cumulative influence of bacterial contact and hypoxia (BD-2, IL-8, VEGF). Taken together, this analysis demonstrates that association of immature intestinal epithelium with live <italic>E. coli</italic> results in a complex interplay between microbial contact and microbe-associated hypoxia-induced gene expression and protein secretion.</p></sec><sec id="s2-7"><title>Bacterial colonization promotes secretion of antimicrobial peptides</title><p>Antimicrobial peptides (AMPs) are key effectors for innate defense of epithelial surfaces (<xref ref-type="bibr" rid="bib118">Muniz et al., 2012</xref>) and act to inhibit microbial growth through direct lysis of the bacterial cell wall and modulation of bacterial metabolism (<xref ref-type="bibr" rid="bib64">Ganz, 2003</xref>; <xref ref-type="bibr" rid="bib19">Bevins and Salzman, 2011</xref>; <xref ref-type="bibr" rid="bib125">O'Neil and O’Neil, 2003</xref>; <xref ref-type="bibr" rid="bib160">Vora et al., 2004</xref>; <xref ref-type="bibr" rid="bib24">Brogden, 2005</xref>). Defensin gene expression is highly up-regulated following microinjection of <italic>E. coli</italic> into HIOs (<xref ref-type="fig" rid="fig2">Figures 2D–E and</xref> and <xref ref-type="fig" rid="fig4">4C</xref>). Using an annotated database of known AMPs (<xref ref-type="bibr" rid="bib163">Wang et al., 2016</xref>) to query our RNA-seq datasets, we found that several AMPs are up-regulated in the immature intestinal epithelium following <italic>E. coli</italic> association (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). Among these, DEFB4A and DEFB4B, duplicate genes encoding the peptide human β-defensin 2 (<xref ref-type="bibr" rid="bib79">Harder et al., 1997</xref>), were the most highly up-regulated; other AMPs induced by <italic>E. coli</italic> association included multi-functional peptides CCL20, CXCL2, CXCL1, CXCL6, CXCL3, REG3A (<xref ref-type="bibr" rid="bib30">Cash et al., 2006</xref>), and LTF (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). Analysis of RNA-seq data from HIOs microinjected with live or heat-killed <italic>E .coli</italic> with and without NF-κB inhibitor or culture of HIOs under hypoxic conditions had indicated that defensin genes were enriched among the set of NF-κB-independent genes induced by hypoxia (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). We examined <italic>DEFB4A</italic> expression specifically (<xref ref-type="fig" rid="fig6">Figure 6B</xref>) and found that relative to control treatment, microinjection of live <italic>E. coli</italic> resulted in a 7.38-fold increase in normalized <italic>DEFB4A</italic> expression. Consistent with the notion that <italic>DEFB4A</italic> expression is induced by hypoxia and is not dependent on NF-κB signaling, NF-κB inhibitor treated HIOs injected with <italic>E. coli</italic> still showed an ~8-fold increase in gene expression and hypoxia-cultured HIOs showed a ~5.5-fold induction (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). On the other hand, microinjection with heat-inactivated <italic>E. coli</italic> resulted in <italic>DEFB4A</italic> induction that was significantly lower relative to microinjection with live <italic>E. coli</italic> (p=0.007. A similar pattern of expression was observed for <italic>DEFB4B</italic> (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>).</p><fig-group><fig id="fig6" position="float"><object-id pub-id-type="doi">10.7554/eLife.29132.015</object-id><label>Figure 6.</label><caption><title>Bacterial colonization promotes secretion of antimicrobial peptides.</title><p>(<bold>A</bold>) Normalized fold change in antimicrobial peptide (AMP) gene expression in <italic>E. coli</italic>-associated HIOs at 24 hr relative to PBS control treatment. (<bold>B</bold>) Normalized fold change in expression of DEFB4A, the gene encoding human β-defensin 2 (BD-2) peptide, in each of the conditions indicated relative to PBS control treatment. Results in panels A and B represent <italic>N</italic> = 4–5 biological replicates per treatment condition, with each replicate consisting of 5–6 pooled and identically treated HIOs. (<bold>C</bold>) Concentration of BD-2 peptide in culture supernatant at 24 hr as measured by ELISA in HIO cultures treated as indicated. <italic>N</italic> = 10–14 individually treated HIOs per treatment condition with data combined from three independant replicate experiments. (<bold>D</bold>) Optical density (600 nm) of <italic>E. coli</italic> suspension cultures supplemented with PBS or BD-2 at 10-min intervals over an 18 hr period at 37. (<bold>E</bold>) Carrying capacity (K) of media supplemented with varying concentrations of BD-2 derrived from the growth curves presented in panel D. <italic>N</italic> = 8 biological replicates per treatment group for panels D and E. p-Values represents the results of a two-tailed Student’s <italic>t</italic>-test for the comparisons indicated.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29132-fig6-v2"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.29132.016</object-id><label>Figure 6—figure supplement 1.</label><caption><title>Normalized fold change in expression of DEFB4B, a duplicated gene encoding human β-defensin 2 (BD-2) peptide, in each of the conditions indicated relative to PBS control treatment.</title><p>Concentration of BD-2 peptide in culture supernatant at 24 hr as measured by ELISA in HIO cultures treated as indicated. p-Values represents the results of a two-tailed Student’s t-test for the comparison indicated.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29132-fig6-figsupp1-v2"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.29132.017</object-id><label>Figure 6—figure supplement 2.</label><caption><title>BD-2 inhibits E. coli growth in vitro.</title><p>(<bold>A</bold>) Optical density (600 nm) of <italic>E. coli</italic> str. ECOR2 and <italic>E. coli</italic> str. K12suspension cultures supplemented with PBS, BD-2 (1 μg/ml), or heat-inactivated BD-2 at 10-min intervals over a 6-hr period at 37<sup>◦</sup>C. (<bold>B</bold>) Carrying capacity (<italic>K</italic>) of <italic>E. coli</italic> cultures incubated with PBS, BD-2 (1 μg/ml), or heat-inactivated BD-2 during log-phase growth (panel A). p-Values represents the results of a one-tailed Student’s t-test relative to PBS treatment. For panels A and B, N = 8 per experimental condition for each <italic>E. coli</italic> strain. (<bold>C</bold>) CFU/ml of late stationary phase <italic>E. coli</italic> str. ECOR2 cultures diluted in PBS and supplemented with BD-2 (1 μg/ml) or heat-inactivated BD-2 for 6 h at 37<sup>◦</sup>C. N = 8 (BD-2 and heat inactivated BD-2) or 16 (PBS).</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29132-fig6-figsupp2-v2"/></fig></fig-group><p>We also examined secretion of human β-defensin 2 peptide (BD-2) in the supernatant of <italic>E. coli</italic>-associated HIOs (<xref ref-type="fig" rid="fig2">Figure 2E</xref> and <xref ref-type="fig" rid="fig6">Figure 6C</xref>). BD-2 secretion was increased 3.4-fold at 24 hr following <italic>E. coli</italic> microinjection (p=2.7 × 10<sup>-8</sup>). However, heat-inactivation of <italic>E. coli</italic> or addition of NF-κB inhibitor resulted in suppression of BD-2 secretion relative to live <italic>E. coli</italic> (p=0.00051 and 1.6 × 10<sup>-6</sup>, respectively).</p><p> To determine if the levels of BD-2 produced by HIOs and secreted into the media were sufficient to retard bacterial growth, we tested the effect of BD-2 at concentrations recapitulating the baseline state in the HIO (~0.1 μg/ml) and following microinjection with <italic>E.coli</italic> (~1 μg/ml) on in vitro growth of <italic>E. coli</italic> over 18 hr (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). Although there was little effect on <italic>E. coli</italic> density during initial log-phase growth, BD-2 reduced the amount of time bacteria spent in log-phase growth, and <italic>E. coli</italic> density was significantly decreased over time in bacterial growth media supplemented BD-2 (p=0.001), resulting in a significant decrease in the effective in vitro carrying capacity, or maximum population density (<xref ref-type="fig" rid="fig6">Figure 6E</xref>, p=8 × 10<sup>-4</sup>). Furthermore, concentrations of BD-2 consistent with those found in HIO/E. coli supernatant (1 μg/ml) was significantly more inhibitory than low concentration BD-2 (0.1 μg/ml) in our in vitro growth assay (p=0.013). Additional data suggest that the inhibitory activity of BD-2 in vitro is not specific to <italic>E. coli</italic> str. ECOR2 and is dependent upon maintenance of BD-2 protein structure, since BD-2 similarly inhibited growth of <italic>E. coli</italic> str. K12, and heat-inactivated BD-2 lost these inhibitory effects (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>). From this set of experiments, we conclude that <italic>E. coli</italic> colonization promotes enhanced expression of AMPs, including BD-2, at concentrations that are sufficient to suppress microbial growth.</p></sec><sec id="s2-8"><title>Bacterial colonization promotes expression of epithelial Mucins and glycotransferases</title><p>Mucins are an essential component of epithelial integrity, serving as a formidable barrier to microbial invasion and repository for secreted AMPs (<xref ref-type="bibr" rid="bib18">Bergstrom and Xia, 2013</xref>; <xref ref-type="bibr" rid="bib37">Cornick et al., 2015</xref>; <xref ref-type="bibr" rid="bib87">Johansson and Hansson, 2016</xref>; <xref ref-type="bibr" rid="bib94">Kim and Ho, 2010</xref>). Mucin synthesis requires a complex series of post-translational modifications that add high-molecular-weight carbohydrate side chains to the core mucin protein (<xref ref-type="bibr" rid="bib158">Varki, 2017</xref>). Our RNA-seq data suggested that mucin gene expression is dependent on both bacterial contact and NF-κB signaling (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). Therefore, we examined expression of genes in control and <italic>E. coli</italic> microinjected HIOs that encode mucin core proteins as well as the glycotransferases that generate the wide variety of post-translational mucin modifications (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). Although some glycotransferases were increased at 24 hr after <italic>E. coli</italic> microinjection, expression of mucin core proteins and many glycotransferases reached peak levels at 48 hr after the introduction of <italic>E. coli</italic> to the HIO lumen (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). Periodic Acid-Schiff and Alcian blue staining (PAS/AB) of sections taken from HIOs at 48 hr after <italic>E. coli</italic> microinjection reveal the formation of a robust mucin layer at the apical epithelial surface consisting of both acidic (AB-positive) and neutral (PAS-positive) glycoprotein components, suggesting a rich matrix of O-linked mucins, glycosaminoglycans, and proteoglycans (<xref ref-type="fig" rid="fig7">Figure 7B–C</xref>). Interestingly, we observed that <italic>E. coli</italic> association caused an initial induction of <italic>MUC5AC</italic> at 48 hr that was reduced by 96 hr (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). <italic>MUC5AC</italic> is most highly expressed within the gastric mucosa but has also been reported in the duodenal epithelium (<xref ref-type="bibr" rid="bib27">Buisine et al., 1998</xref>, <xref ref-type="bibr" rid="bib28">2001</xref>; <xref ref-type="bibr" rid="bib136">Rodríguez-Piñeiro et al., 2013</xref>). On the other hand, <italic>MUC2</italic> is more commonly associated with the duodenum, and increased more slowly, showing peak expression after 96 hr of association with <italic>E. coli</italic> (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). Co-staining of control HIOs and <italic>E. coli</italic> microinjected HIOs demonstrated colocalization with <italic>Ulex europaeus</italic> agglutinin I (UEA1), a lectin with high specificity for the terminal fucose moiety Fuc<inline-formula><mml:math id="inf22"><mml:mi>α</mml:mi></mml:math></inline-formula>1-2Gal-R (<xref ref-type="fig" rid="fig7">Figure 7D</xref>). This suggests that following <italic>E. coli</italic> association, HIOs produce mucins with carbohydrate modifications associated with bacterial colonization in vivo (<xref ref-type="bibr" rid="bib30">Cash et al., 2006</xref>; <xref ref-type="bibr" rid="bib84">Hooper et al., 1999</xref>; <xref ref-type="bibr" rid="bib72">Goto et al., 2014</xref>).</p><fig-group><fig id="fig7" position="float"><object-id pub-id-type="doi">10.7554/eLife.29132.018</object-id><label>Figure 7.</label><caption><title>Bacterial colonization promotes expression of epithelial mucins and glycotransferases.</title><p>(<bold>A</bold>) Heatmap of normalized RNA-seq glycotransferase and mucin gene counts of HIOs associated with <italic>E.coli</italic> at 0–96 hr post-microinjection. <italic>N</italic> = 4 (0 hr), 5 (24 hr), 3 (48 hr), and 4 (96 hr) biological replicates consisting of 5–6 pooled HIOs per replicate. (<bold>B</bold>) Periodic acid-Schiff and Alcian Blue (PAS-AB) staining of control HIOs or HIOs microinjected with <italic>E. coli</italic> and cultured for 48 hr at 10X magnification. (<bold>C</bold>) HIO epithelium from control HIOs or HIOs microinjected with <italic>E. coli</italic> and cultured for 48 hr stained with H and E, AB, PAS, or PAS-AB and imaged under 100X light microscopy. (<bold>D</bold>) Confocal micrograph of HIO epithelium from a control HIO or an HIO microinjected with <italic>E. coli</italic> and cultured for 48 hr. Nuclei are stained blue with DAPI, and fluorescent antibody-labeled proteins E-cadherein and Mucin 5 AC are pseudocolored in white or red, respectively. UEA1 lectin is used to label the carbohydrate moiety Fucα1-2Gal-R, which is pseudo colored in green. 60X optical magnification. (<bold>E</bold>) Heatmap of normalized RNA-seq glycotransferase and mucin gene counts of HIOs associated with live or heat-inactivated <italic>E. coli</italic>, <italic>E. coli</italic> + NF-κB inhibitor (SC-514) or HIOs cultured under hypoxic conditions for 24 hr. Results represent the mean of <italic>N</italic> = 4–5 biological replicates per treatment condition, with each replicate consisting of 5–6 pooled and identically treated HIOs. (<bold>F</bold>) PAS-AB staining of HIOs treated as indicated in the figure labels for 24 hr. 10X magnification. Histological and immunofluorescent images in panels B-D and F are representative of three or more independent experiments, each consisting of 5–10 HIOs per treatment group.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29132-fig7-v2"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.29132.019</object-id><label>Figure 7—figure supplement 1.</label><caption><title>Representative confocal micrographs of HIOs treated as indicated.</title><p>Fluorescent immunostaining pseudocoloring applied as indicated in the figure legend. 40X optical magnification with 3X digital zoom.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29132-fig7-figsupp1-v2"/></fig></fig-group><p>RNA-seq data suggested that O-linked mucins were highly enriched among the subset of genes induced by bacterial contact in an NF-κB-dependent manner (<xref ref-type="fig" rid="fig5">Figure 5</xref>). We examined this phenomenon at the level of individual glycosyltransferase and mucin genes (<xref ref-type="fig" rid="fig7">Figure 7E</xref>). <italic>E. coli</italic> induced transcription of mucins and glycosyltransferases (<xref ref-type="fig" rid="fig7">Figure 7E</xref>) and mucin secretion (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>) was suppressed in the presence of NF-κB inhibitor SC-514. Furthermore, culture of HIOs under hypoxia conditions was not sufficient to promote transcription of genes involved in mucin synthesis (<xref ref-type="fig" rid="fig7">Figure 7E</xref>). This result was confirmed with PAS/AB staining of HIOs microinjected with PBS, live or heat-inactivated <italic>E. coli</italic>, or cultured under hypoxic conditions for 24 hr, where bacterial contact promoted formation of a mucus layer while PBS microinjection or culture under hypoxic conditions did not (<xref ref-type="fig" rid="fig7">Figure 7F</xref>). Taken together, these results indicate that association of the immature intestinal epithelium with <italic>E. coli</italic> promotes robust mucus secretion through an NF-κB-dependent mechanism and that hypoxia alone is not sufficient to recapitulate <italic>E. coli-</italic>induced mucus production.</p></sec><sec id="s2-9"><title>NF-κB signaling is required for the maintenance of barrier integrity following bacterial colonization</title><p>Having established that the immature intestinal epithelium in HIOs (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>) can be stably associated with non-pathogenic <italic>E. coli</italic> (<xref ref-type="fig" rid="fig1">Figure 1</xref>), resulting in broad changes in transcriptional activity (<xref ref-type="fig" rid="fig2">Figure 2</xref>) and leading to elevated production of AMPs (<xref ref-type="fig" rid="fig6">Figure 6</xref>) and epithelial mucus secretion (<xref ref-type="fig" rid="fig7">Figure 7</xref>), we hypothesized that these changes in gene and protein expression would have functional consequences for the immature epithelial barrier. RNA-seq analysis demonstrated broad up-regulation of transcription in genes involved in the formation of the adherens junction and other cell-cell interactions in HIOs after microinjection with live <italic>E. coli</italic> that was inhibited in the presence of NF-κB inhibitor SC-514 (<xref ref-type="fig" rid="fig8">Figure 8A</xref>). We utilized a modified FITC-dextran permeability assay (<xref ref-type="bibr" rid="bib102">Leslie et al., 2015</xref>) and real-time imaging of live HIO cultures to measure epithelial barrier function in HIOs microinjected with PBS, live <italic>E. coli</italic>, or live <italic>E. coli</italic> +SC-514 at 24 hr after microinjection (<xref ref-type="fig" rid="fig8">Figure 8B</xref>). While HIOs microinjected with PBS or <italic>E. coli</italic> retained 94.1 0.3% of the FITC-dextran fluorescence over the 20-hr assay period, <italic>E. coli</italic> microinjected HIOs cultured in the presence of SC-514 retained only 45.5 ± 26.3% of the fluorescent signal (p=0.02; <xref ref-type="fig" rid="fig8">Figure 8B</xref>). We also measured the rate of bacterial translocation across the HIO epithelium, which resulted in contaminated culture media (<xref ref-type="fig" rid="fig8">Figure 8C</xref>). HIOs microinjected with <italic>E. coli</italic> and treated with SC-514 were compared to <italic>E. coli</italic> microinjected HIOs treated with vehicle (DMSO controls) and PBS microinjected controls over 7 days in culture. HIOs associated with <italic>E. coli</italic> +SC-514 exhibited a rapid onset of bacterial translocation by days 2–3, with bacterial translocation detected in 96% of SC-514-treated HIOs by day 7 compared to 23% of HIOs microinjected with <italic>E. coli</italic> and cultured in DMSO (P=&lt;2 × 10<sup>-16</sup>; <xref ref-type="fig" rid="fig8">Figure 8C</xref>). Therefore, blocking NF-κB signaling inhibited epithelial barrier maturation resulting in increased bacterial translocation during <italic>E. coli</italic> association with the immature epithelium.</p><fig-group><fig id="fig8" position="float"><object-id pub-id-type="doi">10.7554/eLife.29132.020</object-id><label>Figure 8.</label><caption><title>Bacterial colonization promotes resilience of the epithelial barrier via NF-κB.</title><p>(<bold>A</bold>) Heatmap of RNA-seq data indicating the relative expression of genes associated with the Adherens junction or Cell-cell junction assembly based on annotation in the REACTOME database. Results represent the mean of <italic>N</italic> = 4–5 biological replicates per treatment condition, with each replicate consisting of 5–6 pooled and identically treated HIOs. (<bold>B</bold>) Relative fluoresscence intensity over time in HIOs microinjected with 4 kDa FITC-dextran and imaged at 10 min intervals. HIOs were pretreated by microinjection with 10<sup>4</sup> CFU <italic>E. coli</italic> in PBS or PBS alone and cultured for 24 hr prior to treatment with media containing 10 <inline-formula><mml:math id="inf23"><mml:mi>μ</mml:mi></mml:math></inline-formula>M SC-514 or PBS alone and the injection of 2 mg/ml FITC-dextran (4 kDa) at the start of imaging. Line represents the best fit to the mean fluorescent intensity values in each condition with the grey region indicating S.E. for the fit line. <italic>N</italic> = 7–9 HIOs per group. (<bold>C</bold>) Rate of bacterial translocation over time in HIOs treated as indicated in the figure legend as detected by daily collection of external HIO media and enrichment in bacterial growth broth. <italic>N</italic> = 24 (<italic>E. coli</italic> + SC-514), <italic>N</italic> = 48 (<italic>E. coli</italic>), and <italic>N</italic> = 12 (PBS and <italic>E. coli</italic> + vehicle). (<bold>D</bold>) Relative fluorescence intensity over time in HIOs microinjected with FITC-dextran and imaged at 10 min intervals. HIOs were pretreated by microinjection with 10<sup>4</sup> CFU <italic>E. coli</italic> in PBS or PBS alone and cultured for 24 hr prior to treatment with media containing 500 ng/ml TNF-α and 500 ng/ml IFN-γ or PBS alone and the injection of 2 mg/ml FITC-dextran (4 kDa) at the start of imaging. Line represents the best fit to the mean fluorescent intensity values in each condition with the grey region indicating S.E. for the fit line. <italic>N</italic> = 8–9 HIOs per group. (<bold>E</bold>) Representative confocal micrographs of HIOs treated as indicated in D. Fluorescent immunostaining pseudocoloring applied as indicated in the figure legend. 60X optical magnification with 2X digital zoom. SC-514, small molecule inhibitor of NF-κB ; HK, heat-inactivated; TNF, tumor necrosis factor-α; IFN, interferon-γ.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29132-fig8-v2"/></fig><fig id="fig8s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.29132.021</object-id><label>Figure 8—figure supplement 1.</label><caption><title>Representative confocal micrographs of HIOs treated as indicated.</title><p>Fluorescent immunostaining pseudocoloring applied as indicated in the figure legends. 60X optical magnification with 2X digital zoom.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29132-fig8-figsupp1-v2"/></fig></fig-group></sec><sec id="s2-10"><title>Bacterial colonization promotes resilience of the epithelial barrier during cytokine challenge</title><p>Finally, we assayed epithelial barrier function under circumstances recapitulating physiologic inflammation. TNFα and IFNγ are key cytokines mediating innate and adaptive immune cell activity in the gut (<xref ref-type="bibr" rid="bib154">Turner, 2009</xref>) during bacterial infection (<xref ref-type="bibr" rid="bib132">Rhee et al., 2005</xref>; <xref ref-type="bibr" rid="bib48">Emami et al., 2012</xref>) and in necrotizing enterocolitis (<xref ref-type="bibr" rid="bib150">Tan et al., 1993</xref>; <xref ref-type="bibr" rid="bib59">Ford et al., 1996</xref>, <xref ref-type="bibr" rid="bib60">1997</xref>; <xref ref-type="bibr" rid="bib77">Halpern et al., 2003</xref>; <xref ref-type="bibr" rid="bib156">Upperman et al., 2005</xref>). The combination of TNFα and IFNγ has been previously demonstrated to induce barrier permeability in a dose-dependent manner in Transwell epithelial cultures (<xref ref-type="bibr" rid="bib161">Wang et al., 2005</xref>; <xref ref-type="bibr" rid="bib162">Wang et al., 2006</xref>). Thus, HIOs were microinjected with PBS or live <italic>E. coli</italic> and cultured for 24 hr and were subsequently microinjected with FITC-dextran and treated with PBS or a cocktail of TNFα and IFNγ added to the external media to expose the basolateral epithelium (<xref ref-type="fig" rid="fig8">Figure 8D</xref>). Loss of FITC-dextran fluorescence was observed using live-imaging and indicated that treatment with TNFα and IFNγ alone resulted in a rapid and sustained decrease in luminal fluorescence relative to PBS or <italic>E. coli</italic> injected HIOs (p=5 × 10<sup>-4</sup>, <xref ref-type="fig" rid="fig8">Figure 8D</xref>). However, HIOs associated with <italic>E. coli</italic> prior to addition of the TNFα and IFNγ cocktail retained significantly more fluorescent signal relative to treatment with TNFα and IFNγ alone (p=0.042, <xref ref-type="fig" rid="fig8">Figure 8D</xref>). We examined expression and distribution of the tight junction protein ZO-1, and the basal-lateral protein E-cadherin (ECAD) in histological sections taken from PBS and <italic>E. coli</italic>-associated HIOs subjected to TNFα and IFNγ treatment (<xref ref-type="fig" rid="fig8">Figure 8E</xref>). Compared to controls, the epithelial layer is highly disorganized in HIOs treated with TNFα and IFNγ, with cytoplasmic ZO-1 staining and disorganized ECAD. By contrast, HIOs associated with <italic>E. coli</italic> prior to TNFα and IFNγ treatment retain and organized columnar epithelium with robust apical ZO-1 and properly localized ECAD staining (<xref ref-type="fig" rid="fig8">Figure 8E</xref>). Similarly, proper localization of additional markers of epithelial barrier integrity occludin (OCLN) and acetylated-tubulin are retained in HIOs associated with <italic>E. coli</italic> during TNFα and IFNγ treatment relative to HIOs treated with TNFα and IFNγ alone (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1</xref>). These results suggest that colonization of the immature epithelium with <italic>E. coli</italic> results in an epithelium that is more robust to challenge by potentially damaging inflammatory cytokines.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>The work presented here demonstrates that HIOs represent a robust model system to study the initial interactions between the gastrointestinal epithelium and colonizing microbes that occurs in the immediate postnatal period. Microorganisms introduced into the digestive tract at birth establish an intimate and mutualistic relationship with the host over time (<xref ref-type="bibr" rid="bib38">Costello et al., 2012</xref>; <xref ref-type="bibr" rid="bib129">Palmer et al., 2007</xref>; <xref ref-type="bibr" rid="bib98">Koenig et al., 2011</xref>; <xref ref-type="bibr" rid="bib29">Bäckhed et al., 2015</xref>; <xref ref-type="bibr" rid="bib168">Wopereis et al., 2014</xref>). However, the expansion of bacterial populations in the gut also presents a major challenge to intestinal homeostasis through the exposure to potentially inflammatory MAMPs (<xref ref-type="bibr" rid="bib151">Tanner et al., 2015</xref>; <xref ref-type="bibr" rid="bib131">Renz et al., 2011</xref>), consumption of tissue oxygen (<xref ref-type="bibr" rid="bib70">Glover et al., 2016</xref>; <xref ref-type="bibr" rid="bib51">Espey, 2013</xref>; <xref ref-type="bibr" rid="bib7">Albenberg et al., 2014</xref>), digestion of the mucus barrier (<xref ref-type="bibr" rid="bib108">Marcobal et al., 2013</xref>; <xref ref-type="bibr" rid="bib42">Desai et al., 2016</xref>), and competition for metabolic substrates (<xref ref-type="bibr" rid="bib134">Rivera-Chávez et al., 2016</xref>; <xref ref-type="bibr" rid="bib89">Kaiko et al., 2016</xref>). The mature intestinal epithelium serves as a crucial barrier to microbes that inhabit the lumen and mucosal surfaces (<xref ref-type="bibr" rid="bib12">Artis, 2008</xref>; <xref ref-type="bibr" rid="bib154">Turner, 2009</xref>; <xref ref-type="bibr" rid="bib42">Desai et al., 2016</xref>; <xref ref-type="bibr" rid="bib92">Kelly et al., 2015</xref>; <xref ref-type="bibr" rid="bib37">Cornick et al., 2015</xref>; <xref ref-type="bibr" rid="bib130">Peterson and Artis, 2014</xref>; <xref ref-type="bibr" rid="bib76">Hackam et al., 2013</xref>; <xref ref-type="bibr" rid="bib154">Turner, 2009</xref>). The specific function of the epithelium in adapting to initial microbial colonization, independent of innate and adaptive immune systems, remains unclear due to the lack of appropriate model systems that recapitulate host-microbe mutualism. Clarifying the role of the epithelium in colonization of the digestive tract by microorganisms is essential to understanding the molecular basis of the stable host-microbe mutualism in the mature intestine.</p><p>To examine the establishment of host-microbe mutualism, we chose to examine the interaction between the immature epithelium of HIOs and a non-pathogenic strain of <italic>E. coli</italic>. Enterobacteriaceae, including <italic>E. coli</italic>, are abundant in the newborn gut (<xref ref-type="bibr" rid="bib129">Palmer et al., 2007</xref>; <xref ref-type="bibr" rid="bib98">Koenig et al., 2011</xref>; <xref ref-type="bibr" rid="bib29">Bäckhed et al., 2015</xref>; <xref ref-type="bibr" rid="bib172">DIABIMMUNE Study Group et al., 2016</xref>). Several large-scale surveys of microbial composition have demonstrated that <italic>E. coli</italic> are among the most prevalent and abundant organisms in stool samples from newborns (<xref ref-type="bibr" rid="bib29">Bäckhed et al., 2015</xref>; <xref ref-type="bibr" rid="bib98">Koenig et al., 2011</xref>) and in meconium (<xref ref-type="bibr" rid="bib71">Gosalbes et al., 2013</xref>). Non-pathogenic <italic>E. coli</italic> strains may represent ideal model organisms for examining the impact of bacterial colonization of the immature epithelium due to their prevalence in the neonatal population and relevance to natural colonization, extensive characterization, and ease of laboratory manipulation. Microinjection of non-pathogenic <italic>E. coli</italic> into the lumen of HIOs resulted in stable, long-term co-cultures (<xref ref-type="fig" rid="fig1">Figure 1</xref>). <italic>E. coli</italic> grows rapidly within the HIO lumen (<xref ref-type="fig" rid="fig1">Figure 1</xref>), reaching densities roughly comparable to populations found in the human small intestine (<xref ref-type="bibr" rid="bib45">Donaldson et al., 2016</xref>) within 24 hr. Furthermore, the HIO is able to sustain this internal microbial population for several days while retaining the integrity of the epithelial barrier (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Implicit is this observation is the conclusion that immature epithelium, along with a loosely structured mesenchymal layer, is intrinsically capable of adapting to the challenges imposed by colonization with non-pathogenic gut bacteria.</p><p>To more closely examine these epithelial adaptations of microbial colonization, we performed transcriptional analysis of this response. HIOs colonized by <italic>E. coli</italic> exhibit widespread transcriptional activation of innate bacterial recognition pathways, including TLR signaling cascades and downstream mediators such as NF-κB (<xref ref-type="fig" rid="fig2">Figure 2</xref>). The cellular composition of the HIO epithelium is refined following <italic>E. coli</italic> colonization, with a rapid but transient increase in epithelial proliferation preceding a general reduction in the number of immature epithelial progenitor cells and the emergence of mature enterocytes expressing brush border digestive enzymes (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Together, these results suggest that bacterial stimuli exert a broad influence on the molecular and cellular composition of the immature epithelium.</p><p>Indirect stimuli resulting from microbial activity can also shape epithelial function (<xref ref-type="bibr" rid="bib26">Buffie and Pamer, 2013</xref>), and the transcriptome of <italic>E. coli</italic>-colonized HIOs reflects a cellular response to reduced oxygen availability (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Reduction of luminal O<sub>2</sub> concentration occurs in the neonatal gut (<xref ref-type="bibr" rid="bib75">Gruette et al., 1965</xref>; <xref ref-type="bibr" rid="bib57">Fisher et al., 2013</xref>; <xref ref-type="bibr" rid="bib177">Zheng et al., 2015</xref>), possibly as a result of the consumption of dissolved O<sub>2</sub> by the anaerobic and facultative anaerobic bacteria that predominate in the intestinal microbiome in early life (<xref ref-type="bibr" rid="bib51">Espey, 2013</xref>; <xref ref-type="bibr" rid="bib53">Fanaro et al., 2003</xref>; <xref ref-type="bibr" rid="bib54">Favier et al., 2002</xref>; <xref ref-type="bibr" rid="bib129">Palmer et al., 2007</xref>), and the mature intestinal epithelium is hypoxic relative to the underlying lamina propria due to the close proximity to the anaerobic luminal contents (<xref ref-type="bibr" rid="bib70">Glover et al., 2016</xref>; <xref ref-type="bibr" rid="bib92">Kelly et al., 2015</xref>; <xref ref-type="bibr" rid="bib177">Zheng et al., 2015</xref>). We measured luminal oxygen content and epithelial hypoxia in HIOs microinjected with live <italic>E. coli</italic>, finding that luminal oxygen concentration is reduced more than 10-fold relative to the surrounding media. This state of relative hypoxia extends into the epithelium itself and is correlated with increased microbial density (<xref ref-type="fig" rid="fig4">Figure 4</xref>). Thus, although HIOs lack the network of capillaries that play an essential role in tissue oxygen supply in the intestine, <italic>E. coli</italic>-colonized HIOs recapitulate in vitro the oxygen gradient present at the epithelial interface.</p><p>Colonization of the HIO by <italic>E. coli</italic> therefore comprises two broad stimuli: immediate exposure to contact-mediated signals such as MAMPs, and the onset of limiting luminal oxygen and epithelial hypoxia. Although the potential significance of exposure to microbial products in the context of tissue hypoxia is widely recognized in the setting of necrotizing enterocolitis (<xref ref-type="bibr" rid="bib151">Tanner et al., 2015</xref>; <xref ref-type="bibr" rid="bib4">Afrazi et al., 2014</xref>; <xref ref-type="bibr" rid="bib76">Hackam et al., 2013</xref>; <xref ref-type="bibr" rid="bib123">Neu and Walker, 2011</xref>; <xref ref-type="bibr" rid="bib156">Upperman et al., 2005</xref>; <xref ref-type="bibr" rid="bib120">Nanthakumar et al., 2011</xref>), this two factor signaling paradigm has not been well studied as a component of normal intestinal colonization and development. Using the HIO model system, it was possible to design experiments which separately examine the relative impact of microbial contact-mediated signals from microbe-associated hypoxic signals (<xref ref-type="fig" rid="fig5">Figure 5</xref> and <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). This approach reveals that the full transcriptional response generated by the HIO following <italic>E. coli</italic> colonization is the product of both contact-dependent and hypoxia-dependent signals, with heat-inactivated <italic>E. coli</italic> or hypoxia alone recapitulating distinct subsets of the changes in gene expression observed in HIOs colonized with live <italic>E. coli</italic> (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Future studies may examine the role of additional hypoxia-independent live microbe-associated stimuli, such as metabolic products (<xref ref-type="bibr" rid="bib89">Kaiko et al., 2016</xref>) and viability-associated MAMPs (<xref ref-type="bibr" rid="bib140">Sander et al., 2011</xref>), in mediating the epithelial response to initial bacterial colonization.</p><p>NF-κB signaling has been implicated in the downstream response to both microbial contact-mediated signals (<xref ref-type="bibr" rid="bib176">Zhang and Ghosh, 2001</xref>; <xref ref-type="bibr" rid="bib170">Xiao and Ghosh, 2005</xref>; <xref ref-type="bibr" rid="bib91">Kawai and Akira, 2007</xref>) and tissue hypoxia (<xref ref-type="bibr" rid="bib99">Koong et al., 1994</xref>; <xref ref-type="bibr" rid="bib133">Rius et al., 2008</xref>; <xref ref-type="bibr" rid="bib9">Arias-Loste et al., 2015</xref>; <xref ref-type="bibr" rid="bib127">Oliver et al., 2009</xref>; <xref ref-type="bibr" rid="bib175">Zeitouni et al., 2016</xref>; <xref ref-type="bibr" rid="bib35">Colgan et al., 2013</xref>; <xref ref-type="bibr" rid="bib74">Grenz et al., 2012</xref>). Pharmacologic inhibition of NF-κB resulted in the suppression of both microbial contact- and hypoxia-associated gene expression in HIOs, inhibiting both contact-mediated epithelial barrier defense pathways and hypoxia-associated immune activation (<xref ref-type="fig" rid="fig5">Figure 5</xref>). NF-κB appears to play a key role in integrating the complex stimuli resulting from exposure to microbial products and the onset of localized hypoxia in the immature intestinal epithelium during bacterial colonization.</p><p>The molecular and cellular maturation of the intestine that occurs during infancy ultimately results in enhanced functional capacity (<xref ref-type="bibr" rid="bib101">Lebenthal and Lebenthal, 1999</xref>; <xref ref-type="bibr" rid="bib141">Sanderson and Walker, 2000</xref>; <xref ref-type="bibr" rid="bib122">Neu, 2007</xref>). Bacterial colonization is associated with enhanced epithelial barrier function in gnotobiotic animals, including changes in the production of antimicrobial peptides and mucus (<xref ref-type="bibr" rid="bib157">Vaishnava et al., 2008</xref>; <xref ref-type="bibr" rid="bib30">Cash et al., 2006</xref>; <xref ref-type="bibr" rid="bib72">Goto et al., 2014</xref>; <xref ref-type="bibr" rid="bib65">García-Lafuente et al., 2001</xref>; <xref ref-type="bibr" rid="bib107">Malago, 2015</xref>; <xref ref-type="bibr" rid="bib119">Ménard et al., 2008</xref>). Defensins produced in the intestinal epithelium are critical mediators of the density and composition of microbial populations in the gut and protect the epithelium from microbial invasion (<xref ref-type="bibr" rid="bib97">Kisich et al., 2001</xref>; <xref ref-type="bibr" rid="bib128">Ostaff et al., 2013</xref>; <xref ref-type="bibr" rid="bib40">Cullen et al., 2015</xref>; <xref ref-type="bibr" rid="bib138">Salzman et al., 2003</xref>; <xref ref-type="bibr" rid="bib139">Salzman et al., 2010</xref>). Production of BD-2 is dramatically increased in HIOs immediately following <italic>E. coli</italic> colonization (<xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref> and <xref ref-type="fig" rid="fig6">Figure 6</xref>), reaching concentrations that are sufficient to limit overgrowth of <italic>E. coli</italic> (<xref ref-type="fig" rid="fig6">Figure 6</xref> and <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>) without completely precluding potentially beneficial bacterial colonization (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Secreted and cell-surface associated mucins form a physical barrier to microbes in the gut, act as local reservoirs of antimicrobial peptide, and serve as substrates for the growth of beneficial microorganisms (<xref ref-type="bibr" rid="bib42">Desai et al., 2016</xref>; <xref ref-type="bibr" rid="bib87">Johansson and Hansson, 2016</xref>; <xref ref-type="bibr" rid="bib37">Cornick et al., 2015</xref>; <xref ref-type="bibr" rid="bib78">Hansson, 2012</xref>; <xref ref-type="bibr" rid="bib103">Li et al., 2015</xref>; <xref ref-type="bibr" rid="bib46">Dupont et al., 2014</xref>; <xref ref-type="bibr" rid="bib18">Bergstrom and Xia, 2013</xref>). The immature HIO epithelium produces a robust mucus layer consisting of both neutral and acidic oligosaccharides with terminal carbohydrate modifications following colonization with <italic>E. coli</italic> (<xref ref-type="fig" rid="fig7">Figure 7</xref>). Importantly, hypoxia alone does not result in the production of mucus while the introduction of heat-inactivated <italic>E. coli</italic> induces mucus secretion at the apical epithelium (<xref ref-type="fig" rid="fig7">Figure 7</xref>), suggesting that microbial contact is the major stimulus eliciting mucus secretion in HIOs.</p><p>Epithelial barrier permeability is an important parameter of intestinal function reflecting the degree of selectivity in the transfer of nutrients across the epithelial layer and the exclusion of bacteria and other potentially harmful materials (<xref ref-type="bibr" rid="bib20">Bischoff et al., 2014</xref>). Increases in epithelial barrier permeability occur in the setting of inflammation (<xref ref-type="bibr" rid="bib5">Ahmad et al., 2017</xref>; <xref ref-type="bibr" rid="bib113">Michielan and D'Incà, 2015</xref>) and infectious disease (<xref ref-type="bibr" rid="bib144">Shawki and McCole, 2017</xref>). Colonization of HIOs with <italic>E. coli</italic> results in increased transcription of genes associated with the formation of the adherens junction and other cell-cell interactions in the epithelium (<xref ref-type="fig" rid="fig8">Figure 8</xref>). However, inhibition of NF-κB signaling dramatically increases both epithelial barrier permeability and the rate of bacterial translocation (<xref ref-type="fig" rid="fig8">Figure 8</xref>), suggesting that NF-κB signaling is critical to maintaining epithelial barrier integrity following colonization. Expression of genes involved in the formation of the cell junction and the production of antimicrobial defensins and mucus are NF-κB dependent (<xref ref-type="fig" rid="fig6">Figures 6</xref>–<xref ref-type="fig" rid="fig8">8</xref>, <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>, <xref ref-type="bibr" rid="bib153">Tsutsumi-Ishii and Nagaoka, 2002</xref>; <xref ref-type="bibr" rid="bib6">Ahn et al., 2005</xref>). The inability to mount an effective innate defense response in the presence of NF-κB inhibition results in the failure of the HIO epithelial barrier and the loss of co-culture stability (<xref ref-type="fig" rid="fig8">Figure 8</xref>). This result underscores the critical role of NF-κB signaling in the formation of a stable host-microbe mutualism at the immature epithelial interface.</p><p>Dysregulated production of pro-inflammatory cytokines contributes to the loss of epithelial barrier integrity in NEC (<xref ref-type="bibr" rid="bib151">Tanner et al., 2015</xref>; <xref ref-type="bibr" rid="bib76">Hackam et al., 2013</xref>; <xref ref-type="bibr" rid="bib123">Neu and Walker, 2011</xref>; <xref ref-type="bibr" rid="bib120">Nanthakumar et al., 2011</xref>; <xref ref-type="bibr" rid="bib77">Halpern et al., 2003</xref>; <xref ref-type="bibr" rid="bib60">Ford et al., 1997</xref>, <xref ref-type="bibr" rid="bib59">1996</xref>; <xref ref-type="bibr" rid="bib150">Tan et al., 1993</xref>); this is recapitulated in HIOs, as exposure to pro-inflammatory cytokines results in the rapid loss of epithelial barrier integrity and the dissolution of epithelial tight junctions (<xref ref-type="fig" rid="fig8">Figure 8</xref>). Probiotics may promote epithelial barrier integrity in NEC (<xref ref-type="bibr" rid="bib135">Robinson, 2014</xref>; <xref ref-type="bibr" rid="bib8">Alfaleh et al., 2011</xref>; <xref ref-type="bibr" rid="bib155">Underwood et al., 2014</xref>; <xref ref-type="bibr" rid="bib93">Khailova et al., 2009</xref>) and HIOs colonized by <italic>E. coli</italic> exhibit enhanced epithelial barrier resilience (<xref ref-type="fig" rid="fig8">Figure 8</xref>). Functional maturation resulting from colonization of the immature intestinal epithelium may therefore play an essential role in promoting the resolution of physiologic inflammation.</p><p>While great progress has been made in characterizing the composition of the gut microbiota in health and disease (<xref ref-type="bibr" rid="bib145">Shreiner et al., 2015</xref>; <xref ref-type="bibr" rid="bib38">Costello et al., 2012</xref>), this approach has a limited ability to discern the contributions of individual bacteria to the establishment of host-microbe symbiosis. Our work establishes an approach that recapitulates host-microbe mutualism in the immature human intestine in an experimentally tractable in vitro model system. Application of this approach may facilitate the development of mechanistic models of host-microbe interactions in human tissue in health and disease. For example, one of the major limitations in our understanding of NEC has been the lack of an appropriate model system to study colonization of the immature intestine (<xref ref-type="bibr" rid="bib123">Neu and Walker, 2011</xref>; <xref ref-type="bibr" rid="bib15">Balimane and Chong, 2005</xref>; <xref ref-type="bibr" rid="bib151">Tanner et al., 2015</xref>; <xref ref-type="bibr" rid="bib124">Nguyen et al., 2015</xref>). Our results suggest that colonization of the HIO with a non-pathogenic gut bacteria results in functional maturation of the epithelial barrier. Future work which examines the effects of organisms associated with the premature gut (<xref ref-type="bibr" rid="bib117">Morrow et al., 2013</xref>; <xref ref-type="bibr" rid="bib73">Greenwood et al., 2014</xref>; <xref ref-type="bibr" rid="bib164">Ward et al., 2016</xref>) on the molecular, cellular, and functional maturation of the immature epithelium may be instrumental in elucidating mechanisms of microbiota-associated disease pathogenesis in the immature intestine.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>HIO culture</title><p>Human ES cell line H9 (NIH registry #0062, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_9773">CVCL_9773</ext-link>) was obtained from the WiCell Research Institute. H9 cells were authenticated using Short Tandem Repeat (STR) DNA profiling (<xref ref-type="bibr" rid="bib109">Matsuo et al., 1999</xref>) at the University of Michigan DNA Sequencing Core and exhibited an STR profile identical to the STR characteristics published by (<xref ref-type="bibr" rid="bib88">Josephson et al., 2006</xref>). The H9 cell line was negative for <italic>Mycoplasma</italic> contamination. Stem cells were maintained on Matrigel (BD Biosciences, San Jose, CA) in mTeSR1 medium (STEMCELL Technologies, Vancouver, Canada). hESCs were passaged and differentiated into human intestinal organoid tissue as previously described (<xref ref-type="bibr" rid="bib147">Spence et al., 2011</xref>; <xref ref-type="bibr" rid="bib110">McCracken et al., 2011</xref>). HIOs were maintained in media containing EGF, Noggin, and R-spondin (ENR media, see [<xref ref-type="bibr" rid="bib110">McCracken et al., 2011</xref>]) in 50 μl Matrigel (8 mg/ml) without antibiotics prior to microinjection experiments. For hypoxic culture experiments, HIOs were transferred to a hydrated and sealed Modular Incubator Chamber (MIC-101, Billups-Rothenburg, Inc. Del Mar CA) filled with 1% O<inline-formula><mml:math id="inf24"><mml:msub><mml:mi/><mml:mtext>2</mml:mtext></mml:msub></mml:math></inline-formula>, 5% CO<inline-formula><mml:math id="inf25"><mml:msub><mml:mi/><mml:mtext>2</mml:mtext></mml:msub></mml:math></inline-formula>, and balance N<inline-formula><mml:math id="inf26"><mml:msub><mml:mi/><mml:mtext>2</mml:mtext></mml:msub></mml:math></inline-formula> and maintained at 37 for 24 hr.</p></sec><sec id="s4-2"><title>HIO transplantation and tissue derived enteroid culture</title><p>HIO transplantations: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All animal experiments were approved by the University of Michigan Institutional Animal Care and Use Committee (IACUC; protocol # PRO00006609). HIO transplants into the kidney capsule were performed as previously described (<xref ref-type="bibr" rid="bib56">Finkbeiner et al., 2015</xref>; <xref ref-type="bibr" rid="bib47">Dye et al., 2016</xref>) Briefly, mice were anesthetized using 2% isofluorane. The left flank was sterilized using Chlorhexidine and isopropyl alcohol, and an incision was made to expose the kidney. HIOs were manually placed in a subcapsular pocket of the kidney of male 7- to 10-week-old NOD-SCID IL2Rgnull (NSG) mice using forceps. An intraperitoneal flush of Zosyn (100 mg/kg; Pfizer Inc.) was administered prior to closure in two layers. The mice were sacrificed and transplant retrieved after 10 weeks. Human Tissue: Normal, de-identified human fetal intestinal tissue was obtained from the University of Washington Laboratory of Developmental Biology. Normal, de-identified human adult intestinal tissue was obtained from deceased organ donors through the Gift of Life, Michigan. All human tissues used in this work were obtained from non-living donors, were de-identified and were conducted with approval from the University of Michigan IRB (protocol # HUM00093465 and HUM00105750). Isolation and culture of HIO epithelium, transplanted HIO epithelium, fetal and adult human duodenal epithelium was carried out as previously described (<xref ref-type="bibr" rid="bib56">Finkbeiner et al., 2015</xref>), and was cultured in a droplet of Matrigel using L-WRN conditioned medium to stimulate epithelial growth, as previously described (<xref ref-type="bibr" rid="bib114">Miyoshi et al., 2012</xref>; <xref ref-type="bibr" rid="bib115">Miyoshi and Stappenbeck, 2013</xref>)</p></sec><sec id="s4-3"><title>Bacterial culture</title><p><italic>Escherichia coli</italic> strain ECOR2 (ATCC 35321) was cultured in Luria broth (LB) media or 1.5% LB agar plates at 37 under atmospheric oxygen conditions. Glycerol stock solutions are available upon request. The assembled and annotated genome for the isolate of <italic>Escherichia coli</italic> strain ECOR2 used in these studies is available at <ext-link ext-link-type="uri" xlink:href="https://www.patricbrc.org/view/Genome/562.18521.">https://www.patricbrc.org/view/Genome/562.18521.</ext-link> <italic>E. coli</italic> strain K-12 MG1655 (CGSC #6300) was obtained from the Coli Genetic Stock Center at Yale University (<ext-link ext-link-type="uri" xlink:href="http://cgsc2.biology.yale.edu/">http://cgsc2.biology.yale.edu/</ext-link>) and was used only in the in vitro BD-2 activity experiments. Whole genome sequencing of <italic>E. coli</italic> strain ECOR2 was performed by the University of Michigan Host Microbiome Initiative Laboratory using the Illumina MiSeq platform.</p></sec><sec id="s4-4"><title>Microinjection</title><p>Microinjections were performed using a protocol modified from <xref ref-type="bibr" rid="bib102">Leslie et al., 2015</xref>. Briefly, HIOs were injected using thin wall glass capillaries (TW100F-4, World Precision Instruments, Sarasota, FL) shaped using a P-30 micropipette puller (Sutter Instruments, Novato, CA). Pulled microcapilaries were mounted on a Xenoworks micropipette holder with analog tubing (BR-MH2 and BR-AT, Sutter Instruments) attached to a 10-ml glass syringe filled with sterile mineral oil (Fisher Scientific, Hampton, NH). Fine control of the micropippette was achieved using a micromanipulator (Narishge International Inc., East Meadow, NY) and microinjection was completed under 1-2X magnification on an SX61 stereo dissecting scope (Olympus, Tokyo, Japan). HIOs suspended in Matrigel (Corning Inc., Corning, NY) were injected with approximately 1 μl solution. A detailed and up-to-date HIO microinjection protocol is available at <xref ref-type="bibr" rid="bib83">Hill, 2017b</xref>; a copy is archived at <ext-link ext-link-type="uri" xlink:href="https://github.com/elifesciences-publications/HIO_microinjection">https://github.com/elifesciences-publications/HIO_microinjection</ext-link>). In bacterial microinjection experiments, the HIO culture media was removed immediately following microinjection and the cultures were rinsed with PBS and treated with ENR media containing penicillin and streptomycin to remove any bacteria introduced to the culture media during the microinjection process. After 1 hr at 37, the HIOs were washed again in PBS and the media was replaced with fresh antibiotic-free ENR.</p></sec><sec id="s4-5"><title>Measurement of luminal oxygen</title><p>Luminal oxygen content was measured in HIOs using an optically coated implantable microsensor with a tip tapered at &lt;50 μm (IMP-PSt1, PreSens Precision Sensing GmbH) attached to a micro fiber optic oxygen meter (Microx TX3, PreSens Precision Sensing GmbH, Regensburg, Germany). The oxygen probe was calibrated according to the manufacturer’s instructions and measurements of the external media and HIO luminal oxygen content were collected by mounting the microsensor on a micromanipulator (Narishge International Inc., East Meadow, NY) and guiding the sensor tip into position using 1-2X magnification on a stereo dissecting scope (Olympus, Tokyo, Japan). All oxygen concentration readings were analyzed using PreSens Oxygen Calculator software (TX3v531, PreSens Precision Sensing GmbH, Regensburg, Germany). For measurement of relative cytoplasmic hypoxia, HIO cultures were treated with 100 μM pimonidazol HCl (Hypoxyprobe, Inc., Burlington, MA) added to the external culture media and incubated at 37% and 5% CO<sub>2</sub> for 2 hr prior to fixation in 4% parafomaldehyde. Pimonidazole conjugates were stained in tissue sections using the Hypoxyprobe-1 mouse IgG monoclonal antibody (Hypoxyprobe, Inc., Burlington, MA, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2335667">AB_2335667</ext-link>) with appropriate secondary antibody (see antibody dilutions table).</p></sec><sec id="s4-6"><title>Immunohistochemistry</title><p>Immunostaining was carried out as previously described (<xref ref-type="bibr" rid="bib56">Finkbeiner et al., 2015</xref>). Antibody information and dilutions can be found in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>. All images were taken on a Nikon A1 confocal microscope or an Olympus IX71 epifluorescent microscope. CarboFree blocking buffer (SP-5040; Vector Laboratories, Inc. Burlingame, CA) was substituted for dilute donkey serum in PBS in staining for mucins and carbohydrate moieties. EdU treatment and EdU fluorescent labeling using Click-iT chemistry was applied according to the manufacturer’s instructions (#C10339 Thermo Fisher, Waltham, MA). <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref> contains a table of all primary and secondary antibodies, blocking conditions, and product ordering information.</p></sec><sec id="s4-7"><title>NF-κB inhibition</title><p>The NF-κB inhibitor SC-514 (<xref ref-type="bibr" rid="bib96">Kishore et al., 2003</xref>; <xref ref-type="bibr" rid="bib104">Litvak et al., 2009</xref>) (Tocris Cookson, Bristol, UK) was re-suspended in DMSO at a concentration of 25 mM. HIOs were treated with SC-514 suspended in DMSO added to the external ENR culture media at a final concentration of 1 μM. Efficacy of SC-514 was verified by Western blot of lysates from HIOs injected with PBS or live <italic>E. coli</italic> or injected with live <italic>E. coli</italic> in the presence of 1 μM SC-514 added to the external media. HIOs were collected after 24 hr in lysis buffer composed of 300 mM NaCl, 50 mM Tris base, 1 mM EDTA, 10% glycerol, 0.5% NP-40, and 1X Halt Phosphatase Inhibitor Cocktail (Pierce Biotechnology, Rockford, IL). Lysates were separated on a 10% Bis-Tris polyacrylamide gel under reducing conditions (Invitrogen, Carlsbad, CA) and transferred to PVDF using a wet transfer apparatus (Bio-Rad Laboratories, Hercules, CA) overnight at 4. The PVDF membrane was blocked in Odyssey TBS blocking buffer (LI-COR Biosciences, Lincoln, NE). The membrane was submerged in blocking buffer containing primary rabbit monoclonal antibodies against phosphorylated NF-κB p65 (1:200, Cell Signaling Technology #3033S) or total NF-κB p65 (1:400, Cell Signaling Technology #8242S) and incubated at room temperature for 2 hr. All washes were conducted in Tris-buffered saline with 1% Tween-20 (TBST). The secondary goat anti-rabbit IgG IRDye 800CW was diluted 1:15,000 in TBST and exposed to the washed membrane for 1 hr at room temperature. After additional washes, the PVDF membrane was imaged using an Odyssey Scanner (LI-COR Biosciences, Lincoln, NE).</p></sec><sec id="s4-8"><title>Bacterial translocation assay</title><p>Incidence of bacterial translocation was determined in HIOs plated individually in single wells of 24-well plates and microinjected with <italic>E. coli</italic>. The external culture media was collected and replaced daily. The collected media was diluted 1:10 in LB broth in 96 well plates and cultured at 37 overnight. Optical density (600 nm) was measured in the 96-well LB broth cultures using a VersaMax microplate reader (Molecular Devices, LLC, Sunnyvale, CA). OD<inline-formula><mml:math id="inf27"><mml:msub><mml:mi/><mml:mtext>600</mml:mtext></mml:msub></mml:math></inline-formula>&gt; sterile LB broth baseline was considered a positive culture.</p></sec><sec id="s4-9"><title>FITC-dextran permeability</title><p>For epithelial permeability assays, HIOs were microinjected with 4 kDa FITC-dextran suspended in PBS at a concentration of 2 mg/ml as described previously (<xref ref-type="bibr" rid="bib102">Leslie et al., 2015</xref>) using the microinjection system detailed above. Images were collected at 10 min intervals at 4X magnification on an Olympus IX71 epifluorescent microscope using a Deltavision RT live cell imaging system with Applied Precision softWoRx imaging software (GE Healthcare Bio-Sciences, Marlborough, MA). Cultures were maintained at 37% and 5% CO<sub>2</sub> throughout the imaging timecourse. For experiments involving cytokine treatment, recombinant TNF-α (#210-TA-010, R and D Systems) and INF-γ (#AF-300–02, Peprotech) were added to the external culture media at a concentration of 500 ng/ml at the start of the experiment. A detailed and up-to-date HIO microinjection and live imaging protocol is available at (<xref ref-type="bibr" rid="bib83">Hill, 2017b</xref>).</p></sec><sec id="s4-10"><title>In vitro antimicrobial activity assay</title><p>Recombinant human BD-2 (Abcam, Cambridge, MA) was reconstituted in sterile LB broth and diluted to 0.1–1 μg/ml. <italic>E. coli</italic> cultures were diluted 1:1000 in sterile LB containing 0–1 μg/ml BD-2 and transferred to a 96-well microplate. A VersaMax microplate reader (Molecular Devices, LLC, Sunnyvale, CA) was used to measure OD<inline-formula><mml:math id="inf28"><mml:msub><mml:mi/><mml:mtext>600</mml:mtext></mml:msub></mml:math></inline-formula> at 10 min intervals in microplates maintained at 37°C with regular shaking over a 18 hr timecourse. For stationary phase antimicrobial assays, overnight cultures of <italic>E. coli</italic> str. ECOR2 were diluted in PBS containing 1 μg/ml BD-2 or heat-inactivated BD-2 (heated at 120 for &gt; 60 min) and placed in a 37 bacterial incubator for 5 hr. Cultures were then spread on LB agar plates and cultured overnight. The number of CFU was counted manually.</p></sec><sec id="s4-11"><title>ELISA assays</title><p>Secreted cytokine, antimicrobial peptide, and growth factor concentrations were determined by ELISA (Duosets, R and D Systems, Minneapolis, MN) using the manufacturer’s recommended procedures at the Immunological Monitoring Core of the University of Michigan Cancer Center.</p></sec><sec id="s4-12"><title>RNA sequencing and analysis</title><p>RNA was isolated using the mirVana RNA isolation kit and following the 'Total RNA’ isolation protocol (Thermo-Fisher Scientific, Waltham MA). RNA library preparation and RNA-sequencing (single-end, 50 bp read length) were performed by the University of Michigan DNA Sequencing Core using the Illumina Hi-Seq 2500 platform. All sequences were deposited in the EMBL-EBI ArrayExpress database (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_004473">SCR_004473</ext-link>) using Annotare 2.0 and are cataloged under the accession number E-MTAB-5801. Transcriptional quantitation analysis was conducted using 64-bit Debian Linux stable version 7.10 ('Wheezy’). Pseudoalignment of RNA-seq data was computed using kallisto v0.43.0 (<xref ref-type="bibr" rid="bib22">Bray et al., 2016</xref>) and differential expression of pseudoaligned sequences was calculated using the R package DEseq2 (<xref ref-type="bibr" rid="bib105">Love et al., 2014</xref>) (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_000154">SCR_000154</ext-link>).</p></sec><sec id="s4-13"><title>Statistical analysis</title><p>Unless otherwise indicated in the figure legends, differences between experimental groups or conditions were evaluated using an unpaired Student’s <italic>t</italic>-test. A p-value &lt;0.05 was considered to represent a statistically significant result. All statistical analyses were conducted using R version 3.4.1 (2017-06-30) (<xref ref-type="bibr" rid="bib36">Core Team, 2017</xref>) and plots were generated using the R package ggplot2 (<xref ref-type="bibr" rid="bib167">Wickham, 2009</xref>) with the ggstance expansion pack (<xref ref-type="bibr" rid="bib80">Henry et al., 2016</xref>). The multiple testing-adjusted FDR was calculated using the DESeq2 implementation of the Wald test (<xref ref-type="bibr" rid="bib105">Love et al., 2014</xref>). Gene pathway over-representation tests and Gene Set Enrichment Analysis (<xref ref-type="bibr" rid="bib149">Subramanian et al., 2005</xref>) were implemented using the R packages clusterProfiler (<xref ref-type="bibr" rid="bib173">Yu et al., 2012</xref>) and ReactomePA (<xref ref-type="bibr" rid="bib174">Yu and He, 2016</xref>). Analyses conducted in R were collated using Emacs v25.2 (<xref ref-type="bibr" rid="bib148">Stallman, 1981</xref>) with Org-mode v8.3.5 and the paper was written in LaTeX using Emacs. Complete analysis scripts are available on the <xref ref-type="bibr" rid="bib82">Hill, 2017a</xref> GitHub repository (copy archived at <ext-link ext-link-type="uri" xlink:href="https://github.com/elifesciences-publications/Hill_HIO_Colonization_2017">https://github.com/elifesciences-publications/Hill_HIO_Colonization_2017</ext-link>).</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>The authors would like to thank Joel Whitfield of the Immunological Monitoring Core of the University of Michigan Cancer Center, Robert Lyons and Tricia Tamsen of the University of Michigan DNA Sequencing Core, Chris Edwards of the University of Michigan Molecular Imaging Laboratory, and April Cockburn and Micah Kiedan of the University of Michigan Host Microbiome Initiative Laboratory for providing invaluable technical assistance. JRS is supported by the Intestinal Stem Cell Consortium (U01DK103141), a collaborative research project funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Institute of Allergy and Infectious Diseases (NIAID). JRS and VBY are supported by the NIAID Novel Alternative Model Systems for Enteric Diseases (NAMSED) consortium (U19AI116482). DRH is supported the Mechanisms of Microbial Pathogenesis training grant from the National Institute of Allergy and Infectious Disease (NIAID, T32AI007528) and the National Center for Advancing Translational Sciences (UL1TR000433).</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Software, Formal analysis, Investigation, Visualization, Methodology, Writing—original draft, Writing—review and editing</p></fn><fn fn-type="con" id="con2"><p>Resources, Investigation, Methodology</p></fn><fn fn-type="con" id="con3"><p>Visualization, Methodology</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Methodology</p></fn><fn fn-type="con" id="con5"><p>Resources, Methodology</p></fn><fn fn-type="con" id="con6"><p>Resources, Methodology</p></fn><fn fn-type="con" id="con7"><p>Resources, Methodology</p></fn><fn fn-type="con" id="con8"><p>Methodology</p></fn><fn fn-type="con" id="con9"><p>Methodology</p></fn><fn fn-type="con" id="con10"><p>Methodology</p></fn><fn fn-type="con" id="con11"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con12"><p>Resources</p></fn><fn fn-type="con" id="con13"><p>Resources</p></fn><fn fn-type="con" id="con14"><p>Conceptualization, Resources, Supervision, Funding acquisition, Project administration, Writing—review and editing</p></fn><fn fn-type="con" id="con15"><p>Conceptualization, Supervision, Funding acquisition, Methodology, Writing—review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other" id="fn1"><p>Human subjects: Normal, de-identified human fetal intestinal tissue was obtained from the University of Washington Laboratory of Developmental Biology. Normal, de-identified human adult intestinal issue was obtained from deceased organ donors through the Gift of Life, Michigan. All human tissue used in this work was de-identified and was conducted with approval from the University of Michigan IRB (protocol # HUM00093465 and HUM00105750).</p></fn><fn fn-type="other" id="fn2"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All animal experiments were approved by the University of Michigan Institutional Animal Care and Use Committee (IACUC; protocol # PRO00006609).</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><object-id pub-id-type="doi">10.7554/eLife.29132.022</object-id><label>Supplementary file 1</label><caption><title>List of differentially expressed genes and the Gene Set (I-IV) assignments used in the analyses presented in <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title></caption><media mime-subtype="excel" mimetype="application" xlink:href="elife-29132-supp1-v2.xls"/></supplementary-material><supplementary-material id="supp2"><object-id pub-id-type="doi">10.7554/eLife.29132.023</object-id><label>Supplementary file 2</label><caption><title>Immunostaining conditions for all immunohistochemistry data presented in this manuscript.</title><p>NDS, Normal donkey serum; PBS, phosphate buffered saline.</p></caption><media mime-subtype="excel" mimetype="application" xlink:href="elife-29132-supp2-v2.xls"/></supplementary-material><supplementary-material id="transrepform"><object-id pub-id-type="doi">10.7554/eLife.29132.024</object-id><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-29132-transrepform-v2.docx"/></supplementary-material><sec id="s7" sec-type="datasets"><title>Major datasets</title><p>The following dataset was generated:</p><p><related-object content-type="generated-dataset" id="dataset1" source-id="https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-5801/" source-id-type="uri"><collab collab-type="author">Hill DR</collab><year>2017</year><source>RNA-seq of human intestinal organoids colonized with E. coli and other immature intestinal tissues</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-5801/">https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-5801/</ext-link><comment>Publicly available at the (accession no: E-MTAB-5801)</comment></related-object></p><p>The following previously published dataset was used:</p><p><related-object content-type="generated-dataset" id="dataset2" source-id="https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-3158/" source-id-type="uri"><collab collab-type="author">Finkbeiner S</collab><collab collab-type="author">Spence JR</collab><year>2014</year><source>Transcriptional Profiling of human pluripotent stem cells and and derived tissues</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-3158/">https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-3158/</ext-link><comment>Publicly available at the (accession no: EMDataBankE-MTAB-3158)</comment></related-object></p></sec></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aagaard</surname> <given-names>K</given-names></name><name><surname>Ma</surname> <given-names>J</given-names></name><name><surname>Antony</surname> <given-names>KM</given-names></name><name><surname>Ganu</surname> <given-names>R</given-names></name><name><surname>Petrosino</surname> <given-names>J</given-names></name><name><surname>Versalovic</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The placenta harbors a unique microbiome</article-title><source>Science Translational Medicine</source><volume>6</volume><elocation-id>237ra65</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.3008599</pub-id><pub-id pub-id-type="pmid">24848255</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abrahamsson</surname> <given-names>TR</given-names></name><name><surname>Jakobsson</surname> <given-names>HE</given-names></name><name><surname>Andersson</surname> <given-names>AF</given-names></name><name><surname>Björkstén</surname> <given-names>B</given-names></name><name><surname>Engstrand</surname> <given-names>L</given-names></name><name><surname>Jenmalm</surname> <given-names>MC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Low gut microbiota diversity in early infancy precedes asthma at school age</article-title><source>Clinical &amp; Experimental Allergy</source><volume>44</volume><fpage>842</fpage><lpage>850</lpage><pub-id pub-id-type="doi">10.1111/cea.12253</pub-id><pub-id pub-id-type="pmid">24330256</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abrams</surname> <given-names>GD</given-names></name><name><surname>Bauer</surname> <given-names>H</given-names></name><name><surname>Sprinz</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="1963">1963</year><article-title>Influence of the normal flora on mucosal morphology and cellular renewal in the ileum. A comparison of germ-free and conventional mice</article-title><source>Laboratory Investigation; a Journal of Technical Methods and Pathology</source><volume>12</volume><fpage>355</fpage><lpage>364</lpage><pub-id pub-id-type="pmid">14010768</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Afrazi</surname> <given-names>A</given-names></name><name><surname>Branca</surname> <given-names>MF</given-names></name><name><surname>Sodhi</surname> <given-names>CP</given-names></name><name><surname>Good</surname> <given-names>M</given-names></name><name><surname>Yamaguchi</surname> <given-names>Y</given-names></name><name><surname>Egan</surname> <given-names>CE</given-names></name><name><surname>Lu</surname> <given-names>P</given-names></name><name><surname>Jia</surname> <given-names>H</given-names></name><name><surname>Shaffiey</surname> <given-names>S</given-names></name><name><surname>Lin</surname> <given-names>J</given-names></name><name><surname>Ma</surname> <given-names>C</given-names></name><name><surname>Vincent</surname> <given-names>G</given-names></name><name><surname>Prindle</surname> <given-names>T</given-names></name><name><surname>Weyandt</surname> <given-names>S</given-names></name><name><surname>Neal</surname> <given-names>MD</given-names></name><name><surname>Ozolek</surname> <given-names>JA</given-names></name><name><surname>Wiersch</surname> <given-names>J</given-names></name><name><surname>Tschurtschenthaler</surname> <given-names>M</given-names></name><name><surname>Shiota</surname> <given-names>C</given-names></name><name><surname>Gittes</surname> <given-names>GK</given-names></name><name><surname>Billiar</surname> <given-names>TR</given-names></name><name><surname>Mollen</surname> <given-names>K</given-names></name><name><surname>Kaser</surname> <given-names>A</given-names></name><name><surname>Blumberg</surname> <given-names>R</given-names></name><name><surname>Hackam</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Toll-like receptor 4-mediated endoplasmic reticulum stress in intestinal crypts induces necrotizing enterocolitis</article-title><source>Journal of Biological Chemistry</source><volume>289</volume><fpage>9584</fpage><lpage>9599</lpage><pub-id pub-id-type="doi">10.1074/jbc.M113.526517</pub-id><pub-id pub-id-type="pmid">24519940</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname> <given-names>R</given-names></name><name><surname>Sorrell</surname> <given-names>MF</given-names></name><name><surname>Batra</surname> <given-names>SK</given-names></name><name><surname>Dhawan</surname> <given-names>P</given-names></name><name><surname>Singh</surname> <given-names>AB</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Gut permeability and mucosal inflammation: bad, good or context dependent</article-title><source>Mucosal Immunology</source><volume>10</volume><fpage>307</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1038/mi.2016.128</pub-id><pub-id pub-id-type="pmid">28120842</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahn</surname> <given-names>DH</given-names></name><name><surname>Crawley</surname> <given-names>SC</given-names></name><name><surname>Hokari</surname> <given-names>R</given-names></name><name><surname>Kato</surname> <given-names>S</given-names></name><name><surname>Yang</surname> <given-names>SC</given-names></name><name><surname>Li</surname> <given-names>JD</given-names></name><name><surname>Kim</surname> <given-names>YS</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>TNF-alpha activates MUC2 transcription via NF-kappaB but inhibits via JNK activation</article-title><source>Cellular Physiology and Biochemistry</source><volume>15</volume><fpage>029</fpage><lpage>040</lpage><pub-id pub-id-type="doi">10.1159/000083636</pub-id><pub-id pub-id-type="pmid">15665513</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albenberg</surname> <given-names>L</given-names></name><name><surname>Esipova</surname> <given-names>TV</given-names></name><name><surname>Judge</surname> <given-names>CP</given-names></name><name><surname>Bittinger</surname> <given-names>K</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name><name><surname>Laughlin</surname> <given-names>A</given-names></name><name><surname>Grunberg</surname> <given-names>S</given-names></name><name><surname>Baldassano</surname> <given-names>RN</given-names></name><name><surname>Lewis</surname> <given-names>JD</given-names></name><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Thom</surname> <given-names>SR</given-names></name><name><surname>Bushman</surname> <given-names>FD</given-names></name><name><surname>Vinogradov</surname> <given-names>SA</given-names></name><name><surname>Wu</surname> <given-names>GD</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Correlation between intraluminal oxygen gradient and radial partitioning of intestinal microbiota</article-title><source>Gastroenterology</source><volume>147</volume><fpage>1055</fpage><lpage>1063</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2014.07.020</pub-id><pub-id pub-id-type="pmid">25046162</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alfaleh</surname> <given-names>K</given-names></name><name><surname>Anabrees</surname> <given-names>J</given-names></name><name><surname>Bassler</surname> <given-names>D</given-names></name><name><surname>Al-Kharfi</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Probiotics for prevention of necrotizing enterocolitis in preterm infants</article-title><source>The Cochrane Database of Systematic Reviews</source><volume>3</volume><elocation-id>CD005496</elocation-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arias-Loste</surname> <given-names>MT</given-names></name><name><surname>Fábrega</surname> <given-names>E</given-names></name><name><surname>López-Hoyos</surname> <given-names>M</given-names></name><name><surname>Crespo</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The Crosstalk between Hypoxia and Innate Immunity in the Development of Obesity-Related Nonalcoholic Fatty Liver Disease</article-title><source>BioMed Research International</source><volume>2015</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1155/2015/319745</pub-id><pub-id pub-id-type="pmid">26491664</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arrieta</surname> <given-names>MC</given-names></name><name><surname>Stiemsma</surname> <given-names>LT</given-names></name><name><surname>Dimitriu</surname> <given-names>PA</given-names></name><name><surname>Thorson</surname> <given-names>L</given-names></name><name><surname>Russell</surname> <given-names>S</given-names></name><name><surname>Yurist-Doutsch</surname> <given-names>S</given-names></name><name><surname>Kuzeljevic</surname> <given-names>B</given-names></name><name><surname>Gold</surname> <given-names>MJ</given-names></name><name><surname>Britton</surname> <given-names>HM</given-names></name><name><surname>Lefebvre</surname> <given-names>DL</given-names></name><name><surname>Subbarao</surname> <given-names>P</given-names></name><name><surname>Mandhane</surname> <given-names>P</given-names></name><name><surname>Becker</surname> <given-names>A</given-names></name><name><surname>McNagny</surname> <given-names>KM</given-names></name><name><surname>Sears</surname> <given-names>MR</given-names></name><name><surname>Kollmann</surname> <given-names>T</given-names></name><name><surname>Mohn</surname> <given-names>WW</given-names></name><name><surname>Turvey</surname> <given-names>SE</given-names></name><name><surname>Finlay</surname> <given-names>BB</given-names></name><name><surname>Investigators</surname> <given-names>CS</given-names></name><name><surname>Brett Finlay</surname> <given-names>B</given-names></name><collab>CHILD Study Investigators</collab></person-group><year iso-8601-date="2015">2015</year><article-title>Early infancy microbial and metabolic alterations affect risk of childhood asthma</article-title><source>Science Translational Medicine</source><volume>7</volume><elocation-id>ra152</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.aab2271</pub-id><pub-id pub-id-type="pmid">26424567</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arteel</surname> <given-names>GE</given-names></name><name><surname>Thurman</surname> <given-names>RG</given-names></name><name><surname>Raleigh</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Reductive metabolism of the hypoxia marker pimonidazole is regulated by oxygen tension independent of the pyridine nucleotide redox state</article-title><source>European Journal of Biochemistry</source><volume>253</volume><fpage>743</fpage><lpage>750</lpage><pub-id pub-id-type="doi">10.1046/j.1432-1327.1998.2530743.x</pub-id><pub-id pub-id-type="pmid">9654074</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Artis</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut</article-title><source>Nature Reviews Immunology</source><volume>8</volume><fpage>411</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1038/nri2316</pub-id><pub-id pub-id-type="pmid">18469830</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashburner</surname> <given-names>M</given-names></name><name><surname>Ball</surname> <given-names>CA</given-names></name><name><surname>Blake</surname> <given-names>JA</given-names></name><name><surname>Botstein</surname> <given-names>D</given-names></name><name><surname>Butler</surname> <given-names>H</given-names></name><name><surname>Cherry</surname> <given-names>JM</given-names></name><name><surname>Davis</surname> <given-names>AP</given-names></name><name><surname>Dolinski</surname> <given-names>K</given-names></name><name><surname>Dwight</surname> <given-names>SS</given-names></name><name><surname>Eppig</surname> <given-names>JT</given-names></name><name><surname>Harris</surname> <given-names>MA</given-names></name><name><surname>Hill</surname> <given-names>DP</given-names></name><name><surname>Issel-Tarver</surname> <given-names>L</given-names></name><name><surname>Kasarskis</surname> <given-names>A</given-names></name><name><surname>Lewis</surname> <given-names>S</given-names></name><name><surname>Matese</surname> <given-names>JC</given-names></name><name><surname>Richardson</surname> <given-names>JE</given-names></name><name><surname>Ringwald</surname> <given-names>M</given-names></name><name><surname>Rubin</surname> <given-names>GM</given-names></name><name><surname>Sherlock</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Gene ontology: tool for the unification of biology. The Gene Ontology Consortium</article-title><source>Nature Genetics</source><volume>25</volume><fpage>25</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1038/75556</pub-id><pub-id pub-id-type="pmid">10802651</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aurora</surname> <given-names>M</given-names></name><name><surname>Spence</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>hPSC-derived lung and intestinal organoids as models of human fetal tissue</article-title><source>Developmental Biology</source><volume>420</volume><fpage>230</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2016.06.006</pub-id><pub-id pub-id-type="pmid">27287882</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balimane</surname> <given-names>PV</given-names></name><name><surname>Chong</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Cell culture-based models for intestinal permeability: a critique</article-title><source>Drug Discovery Today</source><volume>10</volume><fpage>335</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1016/S1359-6446(04)03354-9</pub-id><pub-id pub-id-type="pmid">15749282</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bastide</surname> <given-names>P</given-names></name><name><surname>Darido</surname> <given-names>C</given-names></name><name><surname>Pannequin</surname> <given-names>J</given-names></name><name><surname>Kist</surname> <given-names>R</given-names></name><name><surname>Robine</surname> <given-names>S</given-names></name><name><surname>Marty-Double</surname> <given-names>C</given-names></name><name><surname>Bibeau</surname> <given-names>F</given-names></name><name><surname>Scherer</surname> <given-names>G</given-names></name><name><surname>Joubert</surname> <given-names>D</given-names></name><name><surname>Hollande</surname> <given-names>F</given-names></name><name><surname>Blache</surname> <given-names>P</given-names></name><name><surname>Jay</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Sox9 regulates cell proliferation and is required for Paneth cell differentiation in the intestinal epithelium</article-title><source>The Journal of Cell Biology</source><volume>178</volume><fpage>635</fpage><lpage>648</lpage><pub-id pub-id-type="doi">10.1083/jcb.200704152</pub-id><pub-id pub-id-type="pmid">17698607</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bates</surname> <given-names>JM</given-names></name><name><surname>Mittge</surname> <given-names>E</given-names></name><name><surname>Kuhlman</surname> <given-names>J</given-names></name><name><surname>Baden</surname> <given-names>KN</given-names></name><name><surname>Cheesman</surname> <given-names>SE</given-names></name><name><surname>Guillemin</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Distinct signals from the microbiota promote different aspects of zebrafish gut differentiation</article-title><source>Developmental Biology</source><volume>297</volume><fpage>374</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2006.05.006</pub-id><pub-id pub-id-type="pmid">16781702</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergstrom</surname> <given-names>KS</given-names></name><name><surname>Xia</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Mucin-type O-glycans and their roles in intestinal homeostasis</article-title><source>Glycobiology</source><volume>23</volume><fpage>1026</fpage><lpage>1037</lpage><pub-id pub-id-type="doi">10.1093/glycob/cwt045</pub-id><pub-id pub-id-type="pmid">23752712</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bevins</surname> <given-names>CL</given-names></name><name><surname>Salzman</surname> <given-names>NH</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis</article-title><source>Nature Reviews Microbiology</source><volume>9</volume><fpage>356</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1038/nrmicro2546</pub-id><pub-id pub-id-type="pmid">21423246</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bischoff</surname> <given-names>SC</given-names></name><name><surname>Barbara</surname> <given-names>G</given-names></name><name><surname>Buurman</surname> <given-names>W</given-names></name><name><surname>Ockhuizen</surname> <given-names>T</given-names></name><name><surname>Schulzke</surname> <given-names>JD</given-names></name><name><surname>Serino</surname> <given-names>M</given-names></name><name><surname>Tilg</surname> <given-names>H</given-names></name><name><surname>Watson</surname> <given-names>A</given-names></name><name><surname>Wells</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Intestinal permeability--a new target for disease prevention and therapy</article-title><source>BMC Gastroenterology</source><volume>14</volume><elocation-id>189</elocation-id><pub-id pub-id-type="doi">10.1186/s12876-014-0189-7</pub-id><pub-id pub-id-type="pmid">25407511</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borre</surname> <given-names>YE</given-names></name><name><surname>O'Keeffe</surname> <given-names>GW</given-names></name><name><surname>Clarke</surname> <given-names>G</given-names></name><name><surname>Stanton</surname> <given-names>C</given-names></name><name><surname>Dinan</surname> <given-names>TG</given-names></name><name><surname>Cryan</surname> <given-names>JF</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Microbiota and neurodevelopmental windows: implications for brain disorders</article-title><source>Trends in Molecular Medicine</source><volume>20</volume><fpage>509</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.1016/j.molmed.2014.05.002</pub-id><pub-id pub-id-type="pmid">24956966</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bray</surname> <given-names>NL</given-names></name><name><surname>Pimentel</surname> <given-names>H</given-names></name><name><surname>Melsted</surname> <given-names>P</given-names></name><name><surname>Pachter</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Near-optimal probabilistic RNA-seq quantification</article-title><source>Nature Biotechnology</source><volume>34</volume><fpage>525</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1038/nbt.3519</pub-id><pub-id pub-id-type="pmid">27043002</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broderick</surname> <given-names>NA</given-names></name><name><surname>Buchon</surname> <given-names>N</given-names></name><name><surname>Lemaitre</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Microbiota-induced changes in drosophila melanogaster host gene expression and gut morphology</article-title><source>mBio</source><volume>5</volume><elocation-id>e01117-14</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.01117-14</pub-id><pub-id pub-id-type="pmid">24865556</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brogden</surname> <given-names>KA</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?</article-title><source>Nature Reviews Microbiology</source><volume>3</volume><fpage>238</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.1038/nrmicro1098</pub-id><pub-id pub-id-type="pmid">15703760</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bry</surname> <given-names>L</given-names></name><name><surname>Falk</surname> <given-names>PG</given-names></name><name><surname>Midtvedt</surname> <given-names>T</given-names></name><name><surname>Gordon</surname> <given-names>JI</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>A model of host-microbial interactions in an open mammalian ecosystem</article-title><source>Science</source><volume>273</volume><fpage>1380</fpage><lpage>1383</lpage><pub-id pub-id-type="doi">10.1126/science.273.5280.1380</pub-id><pub-id pub-id-type="pmid">8703071</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buffie</surname> <given-names>CG</given-names></name><name><surname>Pamer</surname> <given-names>EG</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Microbiota-mediated colonization resistance against intestinal pathogens</article-title><source>Nature Reviews Immunology</source><volume>13</volume><fpage>790</fpage><lpage>801</lpage><pub-id pub-id-type="doi">10.1038/nri3535</pub-id><pub-id pub-id-type="pmid">24096337</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buisine</surname> <given-names>MP</given-names></name><name><surname>Devisme</surname> <given-names>L</given-names></name><name><surname>Savidge</surname> <given-names>TC</given-names></name><name><surname>Gespach</surname> <given-names>C</given-names></name><name><surname>Gosselin</surname> <given-names>B</given-names></name><name><surname>Porchet</surname> <given-names>N</given-names></name><name><surname>Aubert</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Mucin gene expression in human embryonic and fetal intestine</article-title><source>Gut</source><volume>43</volume><fpage>519</fpage><lpage>524</lpage><pub-id pub-id-type="doi">10.1136/gut.43.4.519</pub-id><pub-id pub-id-type="pmid">9824580</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buisine</surname> <given-names>MP</given-names></name><name><surname>Desreumaux</surname> <given-names>P</given-names></name><name><surname>Leteurtre</surname> <given-names>E</given-names></name><name><surname>Copin</surname> <given-names>MC</given-names></name><name><surname>Colombel</surname> <given-names>JF</given-names></name><name><surname>Porchet</surname> <given-names>N</given-names></name><name><surname>Aubert</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Mucin gene expression in intestinal epithelial cells in Crohn's disease</article-title><source>Gut</source><volume>49</volume><fpage>544</fpage><lpage>551</lpage><pub-id pub-id-type="doi">10.1136/gut.49.4.544</pub-id><pub-id pub-id-type="pmid">11559653</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bäckhed</surname> <given-names>F</given-names></name><name><surname>Roswall</surname> <given-names>J</given-names></name><name><surname>Peng</surname> <given-names>Y</given-names></name><name><surname>Feng</surname> <given-names>Q</given-names></name><name><surname>Jia</surname> <given-names>H</given-names></name><name><surname>Kovatcheva-Datchary</surname> <given-names>P</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Xia</surname> <given-names>Y</given-names></name><name><surname>Xie</surname> <given-names>H</given-names></name><name><surname>Zhong</surname> <given-names>H</given-names></name><name><surname>Khan</surname> <given-names>MT</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Xiao</surname> <given-names>L</given-names></name><name><surname>Al-Aama</surname> <given-names>J</given-names></name><name><surname>Zhang</surname> <given-names>D</given-names></name><name><surname>Lee</surname> <given-names>YS</given-names></name><name><surname>Kotowska</surname> <given-names>D</given-names></name><name><surname>Colding</surname> <given-names>C</given-names></name><name><surname>Tremaroli</surname> <given-names>V</given-names></name><name><surname>Yin</surname> <given-names>Y</given-names></name><name><surname>Bergman</surname> <given-names>S</given-names></name><name><surname>Xu</surname> <given-names>X</given-names></name><name><surname>Madsen</surname> <given-names>L</given-names></name><name><surname>Kristiansen</surname> <given-names>K</given-names></name><name><surname>Dahlgren</surname> <given-names>J</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life</article-title><source>Cell Host &amp; Microbe</source><volume>17</volume><elocation-id>852</elocation-id><pub-id pub-id-type="doi">10.1016/j.chom.2015.05.012</pub-id><pub-id pub-id-type="pmid">26308884</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cash</surname> <given-names>HL</given-names></name><name><surname>Whitham</surname> <given-names>CV</given-names></name><name><surname>Behrendt</surname> <given-names>CL</given-names></name><name><surname>Hooper</surname> <given-names>LV</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Symbiotic bacteria direct expression of an intestinal bactericidal lectin</article-title><source>Science</source><volume>313</volume><fpage>1126</fpage><lpage>1130</lpage><pub-id pub-id-type="doi">10.1126/science.1127119</pub-id><pub-id pub-id-type="pmid">16931762</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheesman</surname> <given-names>SE</given-names></name><name><surname>Neal</surname> <given-names>JT</given-names></name><name><surname>Mittge</surname> <given-names>E</given-names></name><name><surname>Seredick</surname> <given-names>BM</given-names></name><name><surname>Guillemin</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Epithelial cell proliferation in the developing zebrafish intestine is regulated by the Wnt pathway and microbial signaling via Myd88</article-title><source>PNAS</source><volume>108</volume><fpage>4570</fpage><lpage>4577</lpage><pub-id pub-id-type="doi">10.1073/pnas.1000072107</pub-id><pub-id pub-id-type="pmid">20921418</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chin</surname> <given-names>AM</given-names></name><name><surname>Hill</surname> <given-names>DR</given-names></name><name><surname>Aurora</surname> <given-names>M</given-names></name><name><surname>Spence</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Morphogenesis and maturation of the embryonic and postnatal intestine</article-title><source>Seminars in Cell &amp; Developmental Biology</source><volume>66</volume><fpage>81</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2017.01.011</pub-id><pub-id pub-id-type="pmid">28161556</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname> <given-names>I</given-names></name><name><surname>Yamanishi</surname> <given-names>S</given-names></name><name><surname>Cox</surname> <given-names>L</given-names></name><name><surname>Methé</surname> <given-names>BA</given-names></name><name><surname>Zavadil</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>K</given-names></name><name><surname>Gao</surname> <given-names>Z</given-names></name><name><surname>Mahana</surname> <given-names>D</given-names></name><name><surname>Raju</surname> <given-names>K</given-names></name><name><surname>Teitler</surname> <given-names>I</given-names></name><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Alekseyenko</surname> <given-names>AV</given-names></name><name><surname>Blaser</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Antibiotics in early life alter the murine colonic microbiome and adiposity</article-title><source>Nature</source><volume>488</volume><fpage>621</fpage><lpage>626</lpage><pub-id pub-id-type="doi">10.1038/nature11400</pub-id><pub-id pub-id-type="pmid">22914093</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clarke</surname> <given-names>G</given-names></name><name><surname>O'Mahony</surname> <given-names>SM</given-names></name><name><surname>Dinan</surname> <given-names>TG</given-names></name><name><surname>Cryan</surname> <given-names>JF</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Priming for health: gut microbiota acquired in early life regulates physiology, brain and behaviour</article-title><source>Acta Paediatrica</source><volume>103</volume><fpage>812</fpage><lpage>819</lpage><pub-id pub-id-type="doi">10.1111/apa.12674</pub-id><pub-id pub-id-type="pmid">24798884</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colgan</surname> <given-names>SP</given-names></name><name><surname>Curtis</surname> <given-names>VF</given-names></name><name><surname>Campbell</surname> <given-names>EL</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The inflammatory tissue microenvironment in IBD</article-title><source>Inflammatory Bowel Diseases</source><volume>19</volume><fpage>2238</fpage><lpage>2244</lpage><pub-id pub-id-type="doi">10.1097/MIB.0b013e31828dcaaf</pub-id><pub-id pub-id-type="pmid">23702808</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Core Team</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><data-title>R: a language and environment for statistical computing</data-title><publisher-loc>Vienna, Austria</publisher-loc><publisher-name>R Foundation for Statistical Computing</publisher-name></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornick</surname> <given-names>S</given-names></name><name><surname>Tawiah</surname> <given-names>A</given-names></name><name><surname>Chadee</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Roles and regulation of the mucus barrier in the gut</article-title><source>Tissue Barriers</source><volume>3</volume><elocation-id>e982426</elocation-id><pub-id pub-id-type="doi">10.4161/21688370.2014.982426</pub-id><pub-id pub-id-type="pmid">25838985</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costello</surname> <given-names>EK</given-names></name><name><surname>Stagaman</surname> <given-names>K</given-names></name><name><surname>Dethlefsen</surname> <given-names>L</given-names></name><name><surname>Bohannan</surname> <given-names>BJ</given-names></name><name><surname>Relman</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The application of ecological theory toward an understanding of the human microbiome</article-title><source>Science</source><volume>336</volume><fpage>1255</fpage><lpage>1262</lpage><pub-id pub-id-type="doi">10.1126/science.1224203</pub-id><pub-id pub-id-type="pmid">22674335</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Croft</surname> <given-names>D</given-names></name><name><surname>Mundo</surname> <given-names>AF</given-names></name><name><surname>Haw</surname> <given-names>R</given-names></name><name><surname>Milacic</surname> <given-names>M</given-names></name><name><surname>Weiser</surname> <given-names>J</given-names></name><name><surname>Wu</surname> <given-names>G</given-names></name><name><surname>Caudy</surname> <given-names>M</given-names></name><name><surname>Garapati</surname> <given-names>P</given-names></name><name><surname>Gillespie</surname> <given-names>M</given-names></name><name><surname>Kamdar</surname> <given-names>MR</given-names></name><name><surname>Jassal</surname> <given-names>B</given-names></name><name><surname>Jupe</surname> <given-names>S</given-names></name><name><surname>Matthews</surname> <given-names>L</given-names></name><name><surname>May</surname> <given-names>B</given-names></name><name><surname>Palatnik</surname> <given-names>S</given-names></name><name><surname>Rothfels</surname> <given-names>K</given-names></name><name><surname>Shamovsky</surname> <given-names>V</given-names></name><name><surname>Song</surname> <given-names>H</given-names></name><name><surname>Williams</surname> <given-names>M</given-names></name><name><surname>Birney</surname> <given-names>E</given-names></name><name><surname>Hermjakob</surname> <given-names>H</given-names></name><name><surname>Stein</surname> <given-names>L</given-names></name><name><surname>D'Eustachio</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The Reactome pathway knowledgebase</article-title><source>Nucleic Acids Research</source><volume>42</volume><fpage>D472</fpage><lpage>D477</lpage><pub-id pub-id-type="doi">10.1093/nar/gkt1102</pub-id><pub-id pub-id-type="pmid">24243840</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cullen</surname> <given-names>TW</given-names></name><name><surname>Schofield</surname> <given-names>WB</given-names></name><name><surname>Barry</surname> <given-names>NA</given-names></name><name><surname>Putnam</surname> <given-names>EE</given-names></name><name><surname>Rundell</surname> <given-names>EA</given-names></name><name><surname>Trent</surname> <given-names>MS</given-names></name><name><surname>Degnan</surname> <given-names>PH</given-names></name><name><surname>Booth</surname> <given-names>CJ</given-names></name><name><surname>Yu</surname> <given-names>H</given-names></name><name><surname>Goodman</surname> <given-names>AL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Gut microbiota. antimicrobial peptide resistance mediates resilience of prominent gut commensals during inflammation</article-title><source>Science</source><volume>347</volume><fpage>170</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1126/science.1260580</pub-id><pub-id pub-id-type="pmid">25574022</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dedhia</surname> <given-names>PH</given-names></name><name><surname>Bertaux-Skeirik</surname> <given-names>N</given-names></name><name><surname>Zavros</surname> <given-names>Y</given-names></name><name><surname>Spence</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Organoid models of human gastrointestinal development and disease</article-title><source>Gastroenterology</source><volume>150</volume><fpage>1098</fpage><lpage>1112</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2015.12.042</pub-id><pub-id pub-id-type="pmid">26774180</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desai</surname> <given-names>MS</given-names></name><name><surname>Seekatz</surname> <given-names>AM</given-names></name><name><surname>Koropatkin</surname> <given-names>NM</given-names></name><name><surname>Kamada</surname> <given-names>N</given-names></name><name><surname>Hickey</surname> <given-names>CA</given-names></name><name><surname>Wolter</surname> <given-names>M</given-names></name><name><surname>Pudlo</surname> <given-names>NA</given-names></name><name><surname>Kitamoto</surname> <given-names>S</given-names></name><name><surname>Terrapon</surname> <given-names>N</given-names></name><name><surname>Muller</surname> <given-names>A</given-names></name><name><surname>Young</surname> <given-names>VB</given-names></name><name><surname>Henrissat</surname> <given-names>B</given-names></name><name><surname>Wilmes</surname> <given-names>P</given-names></name><name><surname>Stappenbeck</surname> <given-names>TS</given-names></name><name><surname>Núñez</surname> <given-names>G</given-names></name><name><surname>Martens</surname> <given-names>EC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A Dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility</article-title><source>Cell</source><volume>167</volume><fpage>1339</fpage><lpage>1353</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.10.043</pub-id><pub-id pub-id-type="pmid">27863247</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desbonnet</surname> <given-names>L</given-names></name><name><surname>Clarke</surname> <given-names>G</given-names></name><name><surname>Shanahan</surname> <given-names>F</given-names></name><name><surname>Dinan</surname> <given-names>TG</given-names></name><name><surname>Cryan</surname> <given-names>JF</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Microbiota is essential for social development in the mouse</article-title><source>Molecular Psychiatry</source><volume>19</volume><fpage>146</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1038/mp.2013.65</pub-id><pub-id pub-id-type="pmid">23689536</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diaz Heijtz</surname> <given-names>R</given-names></name><name><surname>Wang</surname> <given-names>S</given-names></name><name><surname>Anuar</surname> <given-names>F</given-names></name><name><surname>Qian</surname> <given-names>Y</given-names></name><name><surname>Björkholm</surname> <given-names>B</given-names></name><name><surname>Samuelsson</surname> <given-names>A</given-names></name><name><surname>Hibberd</surname> <given-names>ML</given-names></name><name><surname>Forssberg</surname> <given-names>H</given-names></name><name><surname>Pettersson</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Normal gut microbiota modulates brain development and behavior</article-title><source>PNAS</source><volume>108</volume><fpage>3047</fpage><lpage>3052</lpage><pub-id pub-id-type="doi">10.1073/pnas.1010529108</pub-id><pub-id pub-id-type="pmid">21282636</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donaldson</surname> <given-names>GP</given-names></name><name><surname>Lee</surname> <given-names>SM</given-names></name><name><surname>Mazmanian</surname> <given-names>SK</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Gut biogeography of the bacterial microbiota</article-title><source>Nature Reviews Microbiology</source><volume>14</volume><fpage>20</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1038/nrmicro3552</pub-id><pub-id pub-id-type="pmid">26499895</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dupont</surname> <given-names>A</given-names></name><name><surname>Heinbockel</surname> <given-names>L</given-names></name><name><surname>Brandenburg</surname> <given-names>K</given-names></name><name><surname>Hornef</surname> <given-names>MW</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Antimicrobial peptides and the enteric mucus layer act in concert to protect the intestinal mucosa</article-title><source>Gut Microbes</source><volume>5</volume><fpage>761</fpage><lpage>765</lpage><pub-id pub-id-type="doi">10.4161/19490976.2014.972238</pub-id><pub-id pub-id-type="pmid">25483327</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dye</surname> <given-names>BR</given-names></name><name><surname>Dedhia</surname> <given-names>PH</given-names></name><name><surname>Miller</surname> <given-names>AJ</given-names></name><name><surname>Nagy</surname> <given-names>MS</given-names></name><name><surname>White</surname> <given-names>ES</given-names></name><name><surname>Shea</surname> <given-names>LD</given-names></name><name><surname>Spence</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A bioengineered niche promotes in vivo engraftment and maturation of pluripotent stem cell derived human lung organoids</article-title><source>eLife</source><volume>5</volume><elocation-id>e19732</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.19732</pub-id><pub-id pub-id-type="pmid">27677847</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emami</surname> <given-names>CN</given-names></name><name><surname>Mittal</surname> <given-names>R</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Ford</surname> <given-names>HR</given-names></name><name><surname>Prasadarao</surname> <given-names>NV</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Role of neutrophils and macrophages in the pathogenesis of necrotizing enterocolitis caused by Cronobacter sakazakii</article-title><source>Journal of Surgical Research</source><volume>172</volume><fpage>18</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/j.jss.2011.04.019</pub-id><pub-id pub-id-type="pmid">21601887</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engevik</surname> <given-names>MA</given-names></name><name><surname>Yacyshyn</surname> <given-names>MB</given-names></name><name><surname>Engevik</surname> <given-names>KA</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Darien</surname> <given-names>B</given-names></name><name><surname>Hassett</surname> <given-names>DJ</given-names></name><name><surname>Yacyshyn</surname> <given-names>BR</given-names></name><name><surname>Worrell</surname> <given-names>RT</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Human Clostridium difficile infection: altered mucus production and composition</article-title><source>American Journal of Physiology - Gastrointestinal and Liver Physiology</source><volume>308</volume><fpage>G510</fpage><lpage>G524</lpage><pub-id pub-id-type="doi">10.1152/ajpgi.00091.2014</pub-id><pub-id pub-id-type="pmid">25552581</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erkosar</surname> <given-names>B</given-names></name><name><surname>Storelli</surname> <given-names>G</given-names></name><name><surname>Mitchell</surname> <given-names>M</given-names></name><name><surname>Bozonnet</surname> <given-names>L</given-names></name><name><surname>Bozonnet</surname> <given-names>N</given-names></name><name><surname>Leulier</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Pathogen virulence impedes mutualist-mediated enhancement of host juvenile growth via inhibition of protein digestion</article-title><source>Cell Host &amp; Microbe</source><volume>18</volume><fpage>445</fpage><lpage>455</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2015.09.001</pub-id><pub-id pub-id-type="pmid">26439865</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Espey</surname> <given-names>MG</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Role of oxygen gradients in shaping redox relationships between the human intestine and its microbiota</article-title><source>Free Radical Biology and Medicine</source><volume>55</volume><fpage>130</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2012.10.554</pub-id><pub-id pub-id-type="pmid">23127782</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fabregat</surname> <given-names>A</given-names></name><name><surname>Sidiropoulos</surname> <given-names>K</given-names></name><name><surname>Garapati</surname> <given-names>P</given-names></name><name><surname>Gillespie</surname> <given-names>M</given-names></name><name><surname>Hausmann</surname> <given-names>K</given-names></name><name><surname>Haw</surname> <given-names>R</given-names></name><name><surname>Jassal</surname> <given-names>B</given-names></name><name><surname>Jupe</surname> <given-names>S</given-names></name><name><surname>Korninger</surname> <given-names>F</given-names></name><name><surname>McKay</surname> <given-names>S</given-names></name><name><surname>Matthews</surname> <given-names>L</given-names></name><name><surname>May</surname> <given-names>B</given-names></name><name><surname>Milacic</surname> <given-names>M</given-names></name><name><surname>Rothfels</surname> <given-names>K</given-names></name><name><surname>Shamovsky</surname> <given-names>V</given-names></name><name><surname>Webber</surname> <given-names>M</given-names></name><name><surname>Weiser</surname> <given-names>J</given-names></name><name><surname>Williams</surname> <given-names>M</given-names></name><name><surname>Wu</surname> <given-names>G</given-names></name><name><surname>Stein</surname> <given-names>L</given-names></name><name><surname>Hermjakob</surname> <given-names>H</given-names></name><name><surname>D'Eustachio</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The Reactome pathway Knowledgebase</article-title><source>Nucleic Acids Research</source><volume>44</volume><fpage>D481</fpage><lpage>D487</lpage><pub-id pub-id-type="doi">10.1093/nar/gkv1351</pub-id><pub-id pub-id-type="pmid">26656494</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fanaro</surname> <given-names>S</given-names></name><name><surname>Chierici</surname> <given-names>R</given-names></name><name><surname>Guerrini</surname> <given-names>P</given-names></name><name><surname>Vigi</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Intestinal microflora in early infancy: composition and development</article-title><source>Acta Paediatrica</source><volume>91</volume><fpage>48</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1111/j.1651-2227.2003.tb00646.x</pub-id><pub-id pub-id-type="pmid">14599042</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Favier</surname> <given-names>CF</given-names></name><name><surname>Vaughan</surname> <given-names>EE</given-names></name><name><surname>De Vos</surname> <given-names>WM</given-names></name><name><surname>Akkermans</surname> <given-names>AD</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Molecular monitoring of succession of bacterial communities in human neonates</article-title><source>Applied and Environmental Microbiology</source><volume>68</volume><fpage>219</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1128/AEM.68.1.219-226.2002</pub-id><pub-id pub-id-type="pmid">11772630</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finkbeiner</surname> <given-names>SR</given-names></name><name><surname>Zeng</surname> <given-names>XL</given-names></name><name><surname>Utama</surname> <given-names>B</given-names></name><name><surname>Atmar</surname> <given-names>RL</given-names></name><name><surname>Shroyer</surname> <given-names>NF</given-names></name><name><surname>Estes</surname> <given-names>MK</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Stem cell-derived human intestinal organoids as an infection model for rotaviruses</article-title><source>mBio</source><volume>3</volume><fpage>e00159-12</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1128/mBio.00159-12</pub-id><pub-id pub-id-type="pmid">22761392</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finkbeiner</surname> <given-names>SR</given-names></name><name><surname>Hill</surname> <given-names>DR</given-names></name><name><surname>Altheim</surname> <given-names>CH</given-names></name><name><surname>Dedhia</surname> <given-names>PH</given-names></name><name><surname>Taylor</surname> <given-names>MJ</given-names></name><name><surname>Tsai</surname> <given-names>YH</given-names></name><name><surname>Chin</surname> <given-names>AM</given-names></name><name><surname>Mahe</surname> <given-names>MM</given-names></name><name><surname>Watson</surname> <given-names>CL</given-names></name><name><surname>Freeman</surname> <given-names>JJ</given-names></name><name><surname>Nattiv</surname> <given-names>R</given-names></name><name><surname>Thomson</surname> <given-names>M</given-names></name><name><surname>Klein</surname> <given-names>OD</given-names></name><name><surname>Shroyer</surname> <given-names>NF</given-names></name><name><surname>Helmrath</surname> <given-names>MA</given-names></name><name><surname>Teitelbaum</surname> <given-names>DH</given-names></name><name><surname>Dempsey</surname> <given-names>PJ</given-names></name><name><surname>Spence</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Transcriptome-wide Analysis Reveals Hallmarks of Human Intestine Development and Maturation In Vitro and In Vivo</article-title><source>Stem Cell Reports</source><fpage>1140</fpage><lpage>1155</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2015.04.010</pub-id><pub-id pub-id-type="pmid">26050928</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname> <given-names>EM</given-names></name><name><surname>Khan</surname> <given-names>M</given-names></name><name><surname>Salisbury</surname> <given-names>R</given-names></name><name><surname>Kuppusamy</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Noninvasive monitoring of small intestinal oxygen in a rat model of chronic mesenteric ischemia</article-title><source>Cell Biochemistry and Biophysics</source><volume>67</volume><fpage>451</fpage><lpage>459</lpage><pub-id pub-id-type="doi">10.1007/s12013-013-9611-y</pub-id><pub-id pub-id-type="pmid">23636684</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forbester</surname> <given-names>JL</given-names></name><name><surname>Goulding</surname> <given-names>D</given-names></name><name><surname>Vallier</surname> <given-names>L</given-names></name><name><surname>Hannan</surname> <given-names>N</given-names></name><name><surname>Hale</surname> <given-names>C</given-names></name><name><surname>Pickard</surname> <given-names>D</given-names></name><name><surname>Mukhopadhyay</surname> <given-names>S</given-names></name><name><surname>Dougan</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Interaction of salmonella enterica serovar typhimurium with intestinal organoids derived from human induced pluripotent stem cells</article-title><source>Infection and Immunity</source><volume>83</volume><fpage>2926</fpage><lpage>2934</lpage><pub-id pub-id-type="doi">10.1128/IAI.00161-15</pub-id><pub-id pub-id-type="pmid">25964470</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ford</surname> <given-names>HR</given-names></name><name><surname>Sorrells</surname> <given-names>DL</given-names></name><name><surname>Knisely</surname> <given-names>AS</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Inflammatory cytokines, nitric oxide, and necrotizing enterocolitis</article-title><source>Seminars in pediatric surgery</source><volume>5</volume><fpage>155</fpage><lpage>159</lpage><pub-id pub-id-type="pmid">8858761</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ford</surname> <given-names>H</given-names></name><name><surname>Watkins</surname> <given-names>S</given-names></name><name><surname>Reblock</surname> <given-names>K</given-names></name><name><surname>Rowe</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>The role of inflammatory cytokines and nitric oxide in the pathogenesis of necrotizing enterocolitis</article-title><source>Journal of Pediatric Surgery</source><volume>32</volume><fpage>275</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1016/S0022-3468(97)90194-9</pub-id><pub-id pub-id-type="pmid">9044137</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forster</surname> <given-names>R</given-names></name><name><surname>Chiba</surname> <given-names>K</given-names></name><name><surname>Schaeffer</surname> <given-names>L</given-names></name><name><surname>Regalado</surname> <given-names>SG</given-names></name><name><surname>Lai</surname> <given-names>CS</given-names></name><name><surname>Gao</surname> <given-names>Q</given-names></name><name><surname>Kiani</surname> <given-names>S</given-names></name><name><surname>Farin</surname> <given-names>HF</given-names></name><name><surname>Clevers</surname> <given-names>H</given-names></name><name><surname>Cost</surname> <given-names>GJ</given-names></name><name><surname>Chan</surname> <given-names>A</given-names></name><name><surname>Rebar</surname> <given-names>EJ</given-names></name><name><surname>Urnov</surname> <given-names>FD</given-names></name><name><surname>Gregory</surname> <given-names>PD</given-names></name><name><surname>Pachter</surname> <given-names>L</given-names></name><name><surname>Jaenisch</surname> <given-names>R</given-names></name><name><surname>Hockemeyer</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Human intestinal tissue with adult stem cell properties derived from pluripotent stem cells</article-title><source>Stem Cell Reports</source><volume>2</volume><fpage>838</fpage><lpage>852</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2014.05.001</pub-id><pub-id pub-id-type="pmid">24936470</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furuyama</surname> <given-names>K</given-names></name><name><surname>Kawaguchi</surname> <given-names>Y</given-names></name><name><surname>Akiyama</surname> <given-names>H</given-names></name><name><surname>Horiguchi</surname> <given-names>M</given-names></name><name><surname>Kodama</surname> <given-names>S</given-names></name><name><surname>Kuhara</surname> <given-names>T</given-names></name><name><surname>Hosokawa</surname> <given-names>S</given-names></name><name><surname>Elbahrawy</surname> <given-names>A</given-names></name><name><surname>Soeda</surname> <given-names>T</given-names></name><name><surname>Koizumi</surname> <given-names>M</given-names></name><name><surname>Masui</surname> <given-names>T</given-names></name><name><surname>Kawaguchi</surname> <given-names>M</given-names></name><name><surname>Takaori</surname> <given-names>K</given-names></name><name><surname>Doi</surname> <given-names>R</given-names></name><name><surname>Nishi</surname> <given-names>E</given-names></name><name><surname>Kakinoki</surname> <given-names>R</given-names></name><name><surname>Deng</surname> <given-names>JM</given-names></name><name><surname>Behringer</surname> <given-names>RR</given-names></name><name><surname>Nakamura</surname> <given-names>T</given-names></name><name><surname>Uemoto</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine</article-title><source>Nature Genetics</source><volume>43</volume><fpage>34</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1038/ng.722</pub-id><pub-id pub-id-type="pmid">21113154</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fusunyan</surname> <given-names>RD</given-names></name><name><surname>Nanthakumar</surname> <given-names>NN</given-names></name><name><surname>Baldeon</surname> <given-names>ME</given-names></name><name><surname>Walker</surname> <given-names>WA</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Evidence for an innate immune response in the immature human intestine: toll-like receptors on fetal enterocytes</article-title><source>Pediatric Research</source><volume>49</volume><fpage>589</fpage><lpage>593</lpage><pub-id pub-id-type="doi">10.1203/00006450-200104000-00023</pub-id><pub-id pub-id-type="pmid">11264445</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganz</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Defensins: antimicrobial peptides of innate immunity</article-title><source>Nature Reviews Immunology</source><volume>3</volume><fpage>710</fpage><lpage>720</lpage><pub-id pub-id-type="doi">10.1038/nri1180</pub-id><pub-id pub-id-type="pmid">12949495</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>García-Lafuente</surname> <given-names>A</given-names></name><name><surname>Antolín</surname> <given-names>M</given-names></name><name><surname>Guarner</surname> <given-names>F</given-names></name><name><surname>Crespo</surname> <given-names>E</given-names></name><name><surname>Malagelada</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Modulation of colonic barrier function by the composition of the commensal flora in the rat</article-title><source>Gut</source><volume>48</volume><fpage>503</fpage><lpage>507</lpage><pub-id pub-id-type="doi">10.1136/gut.48.4.503</pub-id><pub-id pub-id-type="pmid">11247894</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Gene Ontology Consortium</collab></person-group><year iso-8601-date="2015">2015</year><article-title>Gene ontology consortium: going forward</article-title><source>Nucleic acids research</source><volume>43</volume><fpage>D1049</fpage><lpage>1056</lpage><pub-id pub-id-type="doi">10.1093/nar/gku1179</pub-id><pub-id pub-id-type="pmid">25428369</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gensollen</surname> <given-names>T</given-names></name><name><surname>Iyer</surname> <given-names>SS</given-names></name><name><surname>Kasper</surname> <given-names>DL</given-names></name><name><surname>Blumberg</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>How colonization by microbiota in early life shapes the immune system</article-title><source>Science</source><volume>352</volume><fpage>539</fpage><lpage>544</lpage><pub-id pub-id-type="doi">10.1126/science.aad9378</pub-id><pub-id pub-id-type="pmid">27126036</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerdes</surname> <given-names>J</given-names></name><name><surname>Lemke</surname> <given-names>H</given-names></name><name><surname>Baisch</surname> <given-names>H</given-names></name><name><surname>Wacker</surname> <given-names>HH</given-names></name><name><surname>Schwab</surname> <given-names>U</given-names></name><name><surname>Stein</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="1984">1984</year><article-title>Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67</article-title><source>Journal of immunology</source><volume>133</volume><fpage>1710</fpage><lpage>1715</lpage><pub-id pub-id-type="pmid">6206131</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilmore</surname> <given-names>TD</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Introduction to NF-kappaB: players, pathways, perspectives</article-title><source>Oncogene</source><volume>25</volume><fpage>6680</fpage><lpage>6684</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1209954</pub-id><pub-id pub-id-type="pmid">17072321</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glover</surname> <given-names>LE</given-names></name><name><surname>Lee</surname> <given-names>JS</given-names></name><name><surname>Colgan</surname> <given-names>SP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Oxygen metabolism and barrier regulation in the intestinal mucosa</article-title><source>Journal of Clinical Investigation</source><volume>126</volume><fpage>3680</fpage><lpage>3688</lpage><pub-id pub-id-type="doi">10.1172/JCI84429</pub-id><pub-id pub-id-type="pmid">27500494</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gosalbes</surname> <given-names>MJ</given-names></name><name><surname>Llop</surname> <given-names>S</given-names></name><name><surname>Vallès</surname> <given-names>Y</given-names></name><name><surname>Moya</surname> <given-names>A</given-names></name><name><surname>Ballester</surname> <given-names>F</given-names></name><name><surname>Francino</surname> <given-names>MP</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Meconium microbiota types dominated by lactic acid or enteric bacteria are differentially associated with maternal eczema and respiratory problems in infants</article-title><source>Clinical &amp; Experimental Allergy</source><volume>43</volume><fpage>198</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1111/cea.12063</pub-id><pub-id pub-id-type="pmid">23331561</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goto</surname> <given-names>Y</given-names></name><name><surname>Obata</surname> <given-names>T</given-names></name><name><surname>Kunisawa</surname> <given-names>J</given-names></name><name><surname>Sato</surname> <given-names>S</given-names></name><name><surname>Ivanov</surname> <given-names>II</given-names></name><name><surname>Lamichhane</surname> <given-names>A</given-names></name><name><surname>Takeyama</surname> <given-names>N</given-names></name><name><surname>Kamioka</surname> <given-names>M</given-names></name><name><surname>Sakamoto</surname> <given-names>M</given-names></name><name><surname>Matsuki</surname> <given-names>T</given-names></name><name><surname>Setoyama</surname> <given-names>H</given-names></name><name><surname>Imaoka</surname> <given-names>A</given-names></name><name><surname>Uematsu</surname> <given-names>S</given-names></name><name><surname>Akira</surname> <given-names>S</given-names></name><name><surname>Domino</surname> <given-names>SE</given-names></name><name><surname>Kulig</surname> <given-names>P</given-names></name><name><surname>Becher</surname> <given-names>B</given-names></name><name><surname>Renauld</surname> <given-names>JC</given-names></name><name><surname>Sasakawa</surname> <given-names>C</given-names></name><name><surname>Umesaki</surname> <given-names>Y</given-names></name><name><surname>Benno</surname> <given-names>Y</given-names></name><name><surname>Kiyono</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Innate lymphoid cells regulate intestinal epithelial cell glycosylation</article-title><source>Science</source><volume>345</volume><elocation-id>1254009</elocation-id><pub-id pub-id-type="doi">10.1126/science.1254009</pub-id><pub-id pub-id-type="pmid">25214634</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenwood</surname> <given-names>C</given-names></name><name><surname>Morrow</surname> <given-names>AL</given-names></name><name><surname>Lagomarcino</surname> <given-names>AJ</given-names></name><name><surname>Altaye</surname> <given-names>M</given-names></name><name><surname>Taft</surname> <given-names>DH</given-names></name><name><surname>Yu</surname> <given-names>Z</given-names></name><name><surname>Newburg</surname> <given-names>DS</given-names></name><name><surname>Ward</surname> <given-names>DV</given-names></name><name><surname>Schibler</surname> <given-names>KR</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Early empiric antibiotic use in preterm infants is associated with lower bacterial diversity and higher relative abundance of Enterobacter</article-title><source>The Journal of Pediatrics</source><volume>165</volume><fpage>23</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/j.jpeds.2014.01.010</pub-id><pub-id pub-id-type="pmid">24529620</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grenz</surname> <given-names>A</given-names></name><name><surname>Clambey</surname> <given-names>E</given-names></name><name><surname>Eltzschig</surname> <given-names>HK</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Hypoxia signaling during intestinal ischemia and inflammation</article-title><source>Current Opinion in Critical Care</source><volume>18</volume><fpage>178</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1097/MCC.0b013e3283514bd0</pub-id><pub-id pub-id-type="pmid">22322265</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gruette</surname> <given-names>FK</given-names></name><name><surname>Horn</surname> <given-names>R</given-names></name><name><surname>Haenel</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="1965">1965</year><article-title>[Nutrition and biochemical micro-ecological processes in the rectum of infants]</article-title><source>Zeitschrift Fur Kinderheilkunde</source><volume>93</volume><fpage>28</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">14322781</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hackam</surname> <given-names>DJ</given-names></name><name><surname>Good</surname> <given-names>M</given-names></name><name><surname>Sodhi</surname> <given-names>CP</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Mechanisms of gut barrier failure in the pathogenesis of necrotizing enterocolitis: Toll-like receptors throw the switch</article-title><source>Seminars in Pediatric Surgery</source><volume>22</volume><fpage>76</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1053/j.sempedsurg.2013.01.003</pub-id><pub-id pub-id-type="pmid">23611610</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halpern</surname> <given-names>MD</given-names></name><name><surname>Holubec</surname> <given-names>H</given-names></name><name><surname>Dominguez</surname> <given-names>JA</given-names></name><name><surname>Meza</surname> <given-names>YG</given-names></name><name><surname>Williams</surname> <given-names>CS</given-names></name><name><surname>Ruth</surname> <given-names>MC</given-names></name><name><surname>McCuskey</surname> <given-names>RS</given-names></name><name><surname>Dvorak</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Hepatic inflammatory mediators contribute to intestinal damage in necrotizing enterocolitis</article-title><source>American Journal of Physiology - Gastrointestinal and Liver Physiology</source><volume>284</volume><fpage>G695</fpage><lpage>G702</lpage><pub-id pub-id-type="doi">10.1152/ajpgi.00353.2002</pub-id><pub-id pub-id-type="pmid">12529262</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansson</surname> <given-names>GC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Role of mucus layers in gut infection and inflammation</article-title><source>Current Opinion in Microbiology</source><volume>15</volume><fpage>57</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2011.11.002</pub-id><pub-id pub-id-type="pmid">22177113</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harder</surname> <given-names>J</given-names></name><name><surname>Siebert</surname> <given-names>R</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Matthiesen</surname> <given-names>P</given-names></name><name><surname>Christophers</surname> <given-names>E</given-names></name><name><surname>Schlegelberger</surname> <given-names>B</given-names></name><name><surname>Schröder</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Mapping of the gene encoding human beta-defensin-2 (DEFB2) to chromosome region 8p22-p23.1</article-title><source>Genomics</source><volume>46</volume><fpage>472</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1006/geno.1997.5074</pub-id><pub-id pub-id-type="pmid">9441752</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henry</surname> <given-names>L</given-names></name><name><surname>Wickham</surname> <given-names>H</given-names></name><name><surname>Chang</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Ggstance: horizontal ’ggplot2’ components</article-title><source>Note: R package version 0.3</source></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname> <given-names>DR</given-names></name><name><surname>Spence</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Gastrointestinal Organoids: Understanding the molecular basis of the host-microbe interface</article-title><source>Cellular and Molecular Gastroenterology and Hepatology</source><volume>3</volume><fpage>138</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1016/j.jcmgh.2016.11.007</pub-id><pub-id pub-id-type="pmid">28275681</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Hill</surname> <given-names>DR</given-names></name></person-group><year iso-8601-date="2017">2017a</year><data-title>Hill_HIO_Colonization_2017</data-title><source>Github</source><version designator="0a563a">0a563a</version><ext-link ext-link-type="uri" xlink:href="https://github.com/hilldr/Hill_HIO_Colonization_2017">https://github.com/hilldr/Hill_HIO_Colonization_2017</ext-link></element-citation></ref><ref id="bib83"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Hill</surname> <given-names>DR</given-names></name></person-group><year iso-8601-date="2017">2017b</year><data-title>HIO_microinjection</data-title><source>Github</source><version designator="49ef21c">49ef21c</version><ext-link ext-link-type="uri" xlink:href="https://github.com/hilldr/HIO_microinjection">https://github.com/hilldr/HIO_microinjection</ext-link></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hooper</surname> <given-names>LV</given-names></name><name><surname>Xu</surname> <given-names>J</given-names></name><name><surname>Falk</surname> <given-names>PG</given-names></name><name><surname>Midtvedt</surname> <given-names>T</given-names></name><name><surname>Gordon</surname> <given-names>JI</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem</article-title><source>PNAS</source><volume>96</volume><fpage>9833</fpage><lpage>9838</lpage><pub-id pub-id-type="doi">10.1073/pnas.96.17.9833</pub-id><pub-id pub-id-type="pmid">10449780</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hviid</surname> <given-names>A</given-names></name><name><surname>Svanström</surname> <given-names>H</given-names></name><name><surname>Frisch</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Antibiotic use and inflammatory bowel diseases in childhood</article-title><source>Gut</source><volume>60</volume><fpage>49</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1136/gut.2010.219683</pub-id><pub-id pub-id-type="pmid">20966024</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ijssennagger</surname> <given-names>N</given-names></name><name><surname>Belzer</surname> <given-names>C</given-names></name><name><surname>Hooiveld</surname> <given-names>GJ</given-names></name><name><surname>Dekker</surname> <given-names>J</given-names></name><name><surname>van Mil</surname> <given-names>SW</given-names></name><name><surname>Müller</surname> <given-names>M</given-names></name><name><surname>Kleerebezem</surname> <given-names>M</given-names></name><name><surname>van der Meer</surname> <given-names>R</given-names></name><name><surname>MÃ¼ller</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Gut microbiota facilitates dietary heme-induced epithelial hyperproliferation by opening the mucus barrier in colon</article-title><source>PNAS</source><volume>112</volume><fpage>10038</fpage><lpage>10043</lpage><pub-id pub-id-type="doi">10.1073/pnas.1507645112</pub-id><pub-id pub-id-type="pmid">26216954</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johansson</surname> <given-names>ME</given-names></name><name><surname>Hansson</surname> <given-names>GC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Immunological aspects of intestinal mucus and mucins</article-title><source>Nature Reviews Immunology</source><volume>16</volume><fpage>639</fpage><lpage>649</lpage><pub-id pub-id-type="doi">10.1038/nri.2016.88</pub-id><pub-id pub-id-type="pmid">27498766</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Josephson</surname> <given-names>R</given-names></name><name><surname>Sykes</surname> <given-names>G</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Ording</surname> <given-names>C</given-names></name><name><surname>Xu</surname> <given-names>W</given-names></name><name><surname>Zeng</surname> <given-names>X</given-names></name><name><surname>Shin</surname> <given-names>S</given-names></name><name><surname>Loring</surname> <given-names>J</given-names></name><name><surname>Maitra</surname> <given-names>A</given-names></name><name><surname>Rao</surname> <given-names>MS</given-names></name><name><surname>Auerbach</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>A molecular scheme for improved characterization of human embryonic stem cell lines</article-title><source>BMC Biology</source><volume>4</volume><elocation-id>28</elocation-id><pub-id pub-id-type="doi">10.1186/1741-7007-4-28</pub-id><pub-id pub-id-type="pmid">16919167</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaiko</surname> <given-names>GE</given-names></name><name><surname>Ryu</surname> <given-names>SH</given-names></name><name><surname>Koues</surname> <given-names>OI</given-names></name><name><surname>Collins</surname> <given-names>PL</given-names></name><name><surname>Solnica-Krezel</surname> <given-names>L</given-names></name><name><surname>Pearce</surname> <given-names>EJ</given-names></name><name><surname>Pearce</surname> <given-names>EL</given-names></name><name><surname>Oltz</surname> <given-names>EM</given-names></name><name><surname>Stappenbeck</surname> <given-names>TS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The colonic crypt protects stem cells from microbiota-derived metabolites</article-title><source>Cell</source><volume>165</volume><fpage>1708</fpage><lpage>1720</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.05.018</pub-id><pub-id pub-id-type="pmid">27264604</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanehisa</surname> <given-names>M</given-names></name><name><surname>Goto</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>KEGG: kyoto encyclopedia of genes and genomes</article-title><source>Nucleic Acids Research</source><volume>28</volume><fpage>27</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1093/nar/28.1.27</pub-id><pub-id pub-id-type="pmid">10592173</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawai</surname> <given-names>T</given-names></name><name><surname>Akira</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Signaling to NF-kappaB by Toll-like receptors</article-title><source>Trends in Molecular Medicine</source><volume>13</volume><fpage>460</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1016/j.molmed.2007.09.002</pub-id><pub-id pub-id-type="pmid">18029230</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname> <given-names>CJ</given-names></name><name><surname>Zheng</surname> <given-names>L</given-names></name><name><surname>Campbell</surname> <given-names>EL</given-names></name><name><surname>Saeedi</surname> <given-names>B</given-names></name><name><surname>Scholz</surname> <given-names>CC</given-names></name><name><surname>Bayless</surname> <given-names>AJ</given-names></name><name><surname>Wilson</surname> <given-names>KE</given-names></name><name><surname>Glover</surname> <given-names>LE</given-names></name><name><surname>Kominsky</surname> <given-names>DJ</given-names></name><name><surname>Magnuson</surname> <given-names>A</given-names></name><name><surname>Weir</surname> <given-names>TL</given-names></name><name><surname>Ehrentraut</surname> <given-names>SF</given-names></name><name><surname>Pickel</surname> <given-names>C</given-names></name><name><surname>Kuhn</surname> <given-names>KA</given-names></name><name><surname>Lanis</surname> <given-names>JM</given-names></name><name><surname>Nguyen</surname> <given-names>V</given-names></name><name><surname>Taylor</surname> <given-names>CT</given-names></name><name><surname>Colgan</surname> <given-names>SP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial hif augments tissue barrier function</article-title><source>Cell Host &amp; Microbe</source><volume>17</volume><fpage>662</fpage><lpage>671</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2015.03.005</pub-id><pub-id pub-id-type="pmid">25865369</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khailova</surname> <given-names>L</given-names></name><name><surname>Dvorak</surname> <given-names>K</given-names></name><name><surname>Arganbright</surname> <given-names>KM</given-names></name><name><surname>Halpern</surname> <given-names>MD</given-names></name><name><surname>Kinouchi</surname> <given-names>T</given-names></name><name><surname>Yajima</surname> <given-names>M</given-names></name><name><surname>Dvorak</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis</article-title><source>AJP: Gastrointestinal and Liver Physiology</source><volume>297</volume><fpage>G940</fpage><lpage>G949</lpage><pub-id pub-id-type="doi">10.1152/ajpgi.00141.2009</pub-id><pub-id pub-id-type="pmid">20501441</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>YS</given-names></name><name><surname>Ho</surname> <given-names>SB</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Intestinal goblet cells and mucins in health and disease: recent insights and progress</article-title><source>Current Gastroenterology Reports</source><volume>12</volume><fpage>319</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1007/s11894-010-0131-2</pub-id><pub-id pub-id-type="pmid">20703838</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>YG</given-names></name><name><surname>Sakamoto</surname> <given-names>K</given-names></name><name><surname>Seo</surname> <given-names>SU</given-names></name><name><surname>Pickard</surname> <given-names>JM</given-names></name><name><surname>Gillilland</surname> <given-names>MG</given-names></name><name><surname>Pudlo</surname> <given-names>NA</given-names></name><name><surname>Hoostal</surname> <given-names>M</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Wang</surname> <given-names>TD</given-names></name><name><surname>Feehley</surname> <given-names>T</given-names></name><name><surname>Stefka</surname> <given-names>AT</given-names></name><name><surname>Schmidt</surname> <given-names>TM</given-names></name><name><surname>Martens</surname> <given-names>EC</given-names></name><name><surname>Fukuda</surname> <given-names>S</given-names></name><name><surname>Inohara</surname> <given-names>N</given-names></name><name><surname>Nagler</surname> <given-names>CR</given-names></name><name><surname>Núñez</surname> <given-names>G</given-names></name><name><surname>NÃ°Ã±ez</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Neonatal acquisition of Clostridia species protects against colonization by bacterial pathogens</article-title><source>Science</source><volume>356</volume><fpage>315</fpage><lpage>319</lpage><pub-id pub-id-type="doi">10.1126/science.aag2029</pub-id><pub-id pub-id-type="pmid">28428425</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kishore</surname> <given-names>N</given-names></name><name><surname>Sommers</surname> <given-names>C</given-names></name><name><surname>Mathialagan</surname> <given-names>S</given-names></name><name><surname>Guzova</surname> <given-names>J</given-names></name><name><surname>Yao</surname> <given-names>M</given-names></name><name><surname>Hauser</surname> <given-names>S</given-names></name><name><surname>Huynh</surname> <given-names>K</given-names></name><name><surname>Bonar</surname> <given-names>S</given-names></name><name><surname>Mielke</surname> <given-names>C</given-names></name><name><surname>Albee</surname> <given-names>L</given-names></name><name><surname>Weier</surname> <given-names>R</given-names></name><name><surname>Graneto</surname> <given-names>M</given-names></name><name><surname>Hanau</surname> <given-names>C</given-names></name><name><surname>Perry</surname> <given-names>T</given-names></name><name><surname>Tripp</surname> <given-names>CS</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>A selective IKK-2 inhibitor blocks NF-kappa B-dependent gene expression in interleukin-1 beta-stimulated synovial fibroblasts</article-title><source>Journal of Biological Chemistry</source><volume>278</volume><fpage>32861</fpage><lpage>32871</lpage><pub-id pub-id-type="doi">10.1074/jbc.M211439200</pub-id><pub-id pub-id-type="pmid">12813046</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kisich</surname> <given-names>KO</given-names></name><name><surname>Heifets</surname> <given-names>L</given-names></name><name><surname>Higgins</surname> <given-names>M</given-names></name><name><surname>Diamond</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Antimycobacterial agent based on mRNA encoding human beta-defensin 2 enables primary macrophages to restrict growth of Mycobacterium tuberculosis</article-title><source>Infection and Immunity</source><volume>69</volume><fpage>2692</fpage><lpage>2699</lpage><pub-id pub-id-type="doi">10.1128/IAI.69.4.2692-2699.2001</pub-id><pub-id pub-id-type="pmid">11254636</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koenig</surname> <given-names>JE</given-names></name><name><surname>Spor</surname> <given-names>A</given-names></name><name><surname>Scalfone</surname> <given-names>N</given-names></name><name><surname>Fricker</surname> <given-names>AD</given-names></name><name><surname>Stombaugh</surname> <given-names>J</given-names></name><name><surname>Knight</surname> <given-names>R</given-names></name><name><surname>Angenent</surname> <given-names>LT</given-names></name><name><surname>Ley</surname> <given-names>RE</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Succession of microbial consortia in the developing infant gut microbiome</article-title><source>PNAS</source><volume>108 Suppl 1</volume><fpage>4578</fpage><lpage>4585</lpage><pub-id pub-id-type="doi">10.1073/pnas.1000081107</pub-id><pub-id pub-id-type="pmid">20668239</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koong</surname> <given-names>AC</given-names></name><name><surname>Chen</surname> <given-names>EY</given-names></name><name><surname>Giaccia</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues</article-title><source>Cancer Research</source><volume>54</volume><fpage>1425</fpage><lpage>1430</lpage><pub-id pub-id-type="pmid">8137243</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kremer</surname> <given-names>N</given-names></name><name><surname>Philipp</surname> <given-names>EE</given-names></name><name><surname>Carpentier</surname> <given-names>MC</given-names></name><name><surname>Brennan</surname> <given-names>CA</given-names></name><name><surname>Kraemer</surname> <given-names>L</given-names></name><name><surname>Altura</surname> <given-names>MA</given-names></name><name><surname>Augustin</surname> <given-names>R</given-names></name><name><surname>Häsler</surname> <given-names>R</given-names></name><name><surname>Heath-Heckman</surname> <given-names>EA</given-names></name><name><surname>Peyer</surname> <given-names>SM</given-names></name><name><surname>Schwartzman</surname> <given-names>J</given-names></name><name><surname>Rader</surname> <given-names>BA</given-names></name><name><surname>Ruby</surname> <given-names>EG</given-names></name><name><surname>Rosenstiel</surname> <given-names>P</given-names></name><name><surname>McFall-Ngai</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Initial symbiont contact orchestrates host-organ-wide transcriptional changes that prime tissue colonization</article-title><source>Cell Host &amp; Microbe</source><volume>14</volume><fpage>183</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2013.07.006</pub-id><pub-id pub-id-type="pmid">23954157</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lebenthal</surname> <given-names>A</given-names></name><name><surname>Lebenthal</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>The ontogeny of the small intestinal epithelium</article-title><source>Journal of Parenteral and Enteral Nutrition</source><volume>23</volume><fpage>S3</fpage><lpage>S6</lpage><pub-id pub-id-type="doi">10.1177/014860719902300502</pub-id><pub-id pub-id-type="pmid">10483884</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leslie</surname> <given-names>JL</given-names></name><name><surname>Huang</surname> <given-names>S</given-names></name><name><surname>Opp</surname> <given-names>JS</given-names></name><name><surname>Nagy</surname> <given-names>MS</given-names></name><name><surname>Kobayashi</surname> <given-names>M</given-names></name><name><surname>Young</surname> <given-names>VB</given-names></name><name><surname>Spence</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Persistence and toxin production by Clostridium difficile within human intestinal organoids result in disruption of epithelial paracellular barrier function</article-title><source>Infection and Immunity</source><volume>83</volume><fpage>138</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1128/IAI.02561-14</pub-id><pub-id pub-id-type="pmid">25312952</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Limenitakis</surname> <given-names>JP</given-names></name><name><surname>Fuhrer</surname> <given-names>T</given-names></name><name><surname>Geuking</surname> <given-names>MB</given-names></name><name><surname>Lawson</surname> <given-names>MA</given-names></name><name><surname>Wyss</surname> <given-names>M</given-names></name><name><surname>Brugiroux</surname> <given-names>S</given-names></name><name><surname>Keller</surname> <given-names>I</given-names></name><name><surname>Macpherson</surname> <given-names>JA</given-names></name><name><surname>Rupp</surname> <given-names>S</given-names></name><name><surname>Stolp</surname> <given-names>B</given-names></name><name><surname>Stein</surname> <given-names>JV</given-names></name><name><surname>Stecher</surname> <given-names>B</given-names></name><name><surname>Sauer</surname> <given-names>U</given-names></name><name><surname>McCoy</surname> <given-names>KD</given-names></name><name><surname>Macpherson</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The outer mucus layer hosts a distinct intestinal microbial niche</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>8292</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms9292</pub-id><pub-id pub-id-type="pmid">26392213</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Litvak</surname> <given-names>V</given-names></name><name><surname>Ramsey</surname> <given-names>SA</given-names></name><name><surname>Rust</surname> <given-names>AG</given-names></name><name><surname>Zak</surname> <given-names>DE</given-names></name><name><surname>Kennedy</surname> <given-names>KA</given-names></name><name><surname>Lampano</surname> <given-names>AE</given-names></name><name><surname>Nykter</surname> <given-names>M</given-names></name><name><surname>Shmulevich</surname> <given-names>I</given-names></name><name><surname>Aderem</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Function of C/EBPdelta in a regulatory circuit that discriminates between transient and persistent TLR4-induced signals</article-title><source>Nature Immunology</source><volume>10</volume><fpage>437</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1038/ni.1721</pub-id><pub-id pub-id-type="pmid">19270711</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname> <given-names>MI</given-names></name><name><surname>Huber</surname> <given-names>W</given-names></name><name><surname>Anders</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname> <given-names>W</given-names></name><name><surname>Brouwer</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Pathview: an R/Bioconductor package for pathway-based data integration and visualization</article-title><source>Bioinformatics</source><volume>29</volume><fpage>1830</fpage><lpage>1831</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btt285</pub-id><pub-id pub-id-type="pmid">23740750</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malago</surname> <given-names>JJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Contribution of microbiota to the intestinal physicochemical barrier</article-title><source>Beneficial Microbes</source><volume>6</volume><fpage>295</fpage><lpage>311</lpage><pub-id pub-id-type="doi">10.3920/BM2014.0041</pub-id><pub-id pub-id-type="pmid">25273548</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcobal</surname> <given-names>A</given-names></name><name><surname>Southwick</surname> <given-names>AM</given-names></name><name><surname>Earle</surname> <given-names>KA</given-names></name><name><surname>Sonnenburg</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A refined palate: bacterial consumption of host glycans in the gut</article-title><source>Glycobiology</source><volume>23</volume><fpage>1038</fpage><lpage>1046</lpage><pub-id pub-id-type="doi">10.1093/glycob/cwt040</pub-id><pub-id pub-id-type="pmid">23720460</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuo</surname> <given-names>Y</given-names></name><name><surname>Nishizaki</surname> <given-names>C</given-names></name><name><surname>Drexler</surname> <given-names>HG</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Efficient DNA fingerprinting method for the identification of cross-culture contamination of cell lines</article-title><source>Human cell</source><volume>12</volume><fpage>149</fpage><lpage>154</lpage><pub-id pub-id-type="pmid">10695022</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCracken</surname> <given-names>KW</given-names></name><name><surname>Howell</surname> <given-names>JC</given-names></name><name><surname>Wells</surname> <given-names>JM</given-names></name><name><surname>Spence</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Generating human intestinal tissue from pluripotent stem cells in vitro</article-title><source>Nature Protocols</source><volume>6</volume><fpage>1920</fpage><lpage>1928</lpage><pub-id pub-id-type="doi">10.1038/nprot.2011.410</pub-id><pub-id pub-id-type="pmid">22082986</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCracken</surname> <given-names>KW</given-names></name><name><surname>Catá</surname> <given-names>EM</given-names></name><name><surname>Crawford</surname> <given-names>CM</given-names></name><name><surname>Sinagoga</surname> <given-names>KL</given-names></name><name><surname>Schumacher</surname> <given-names>M</given-names></name><name><surname>Rockich</surname> <given-names>BE</given-names></name><name><surname>Tsai</surname> <given-names>YH</given-names></name><name><surname>Mayhew</surname> <given-names>CN</given-names></name><name><surname>Spence</surname> <given-names>JR</given-names></name><name><surname>Zavros</surname> <given-names>Y</given-names></name><name><surname>Wells</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Modelling human development and disease in pluripotent stem-cell-derived gastric organoids</article-title><source>Nature</source><volume>516</volume><fpage>400</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1038/nature13863</pub-id><pub-id pub-id-type="pmid">25363776</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLoughlin</surname> <given-names>K</given-names></name><name><surname>Schluter</surname> <given-names>J</given-names></name><name><surname>Rakoff-Nahoum</surname> <given-names>S</given-names></name><name><surname>Smith</surname> <given-names>AL</given-names></name><name><surname>Foster</surname> <given-names>KR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Host selection of microbiota via differential adhesion</article-title><source>Cell Host &amp; Microbe</source><volume>19</volume><fpage>550</fpage><lpage>559</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2016.02.021</pub-id><pub-id pub-id-type="pmid">27053168</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michielan</surname> <given-names>A</given-names></name><name><surname>D'Incà</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Intestinal Permeability in Inflammatory bowel disease: pathogenesis, clinical evaluation, and therapy of leaky gut</article-title><source>Mediators of inflammation</source><volume>2015</volume><elocation-id>628157</elocation-id><pub-id pub-id-type="doi">10.1155/2015/628157</pub-id><pub-id pub-id-type="pmid">26582965</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyoshi</surname> <given-names>H</given-names></name><name><surname>Ajima</surname> <given-names>R</given-names></name><name><surname>Luo</surname> <given-names>CT</given-names></name><name><surname>Yamaguchi</surname> <given-names>TP</given-names></name><name><surname>Stappenbeck</surname> <given-names>TS</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Wnt5a potentiates TGF-β signaling to promote colonic crypt regeneration after tissue injury</article-title><source>Science</source><volume>338</volume><fpage>108</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1126/science.1223821</pub-id><pub-id pub-id-type="pmid">22956684</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyoshi</surname> <given-names>H</given-names></name><name><surname>Stappenbeck</surname> <given-names>TS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>In vitro expansion and genetic modification of gastrointestinal stem cells in spheroid culture</article-title><source>Nature Protocols</source><volume>8</volume><fpage>2471</fpage><lpage>2482</lpage><pub-id pub-id-type="doi">10.1038/nprot.2013.153</pub-id><pub-id pub-id-type="pmid">24232249</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori-Akiyama</surname> <given-names>Y</given-names></name><name><surname>van den Born</surname> <given-names>M</given-names></name><name><surname>van Es</surname> <given-names>JH</given-names></name><name><surname>Hamilton</surname> <given-names>SR</given-names></name><name><surname>Adams</surname> <given-names>HP</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Clevers</surname> <given-names>H</given-names></name><name><surname>de Crombrugghe</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>SOX9 is required for the differentiation of paneth cells in the intestinal epithelium</article-title><source>Gastroenterology</source><volume>133</volume><fpage>539</fpage><lpage>546</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2007.05.020</pub-id><pub-id pub-id-type="pmid">17681175</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morrow</surname> <given-names>AL</given-names></name><name><surname>Lagomarcino</surname> <given-names>AJ</given-names></name><name><surname>Schibler</surname> <given-names>KR</given-names></name><name><surname>Taft</surname> <given-names>DH</given-names></name><name><surname>Yu</surname> <given-names>Z</given-names></name><name><surname>Wang</surname> <given-names>B</given-names></name><name><surname>Altaye</surname> <given-names>M</given-names></name><name><surname>Wagner</surname> <given-names>M</given-names></name><name><surname>Gevers</surname> <given-names>D</given-names></name><name><surname>Ward</surname> <given-names>DV</given-names></name><name><surname>Kennedy</surname> <given-names>MA</given-names></name><name><surname>Huttenhower</surname> <given-names>C</given-names></name><name><surname>Newburg</surname> <given-names>DS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Early microbial and metabolomic signatures predict later onset of necrotizing enterocolitis in preterm infants</article-title><source>Microbiome</source><volume>1</volume><elocation-id>13</elocation-id><pub-id pub-id-type="doi">10.1186/2049-2618-1-13</pub-id><pub-id pub-id-type="pmid">24450576</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muniz</surname> <given-names>LR</given-names></name><name><surname>Knosp</surname> <given-names>C</given-names></name><name><surname>Yeretssian</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Intestinal antimicrobial peptides during homeostasis, infection, and disease</article-title><source>Frontiers in Immunology</source><volume>3</volume><elocation-id>310</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2012.00310</pub-id><pub-id pub-id-type="pmid">23087688</pub-id></element-citation></ref><ref id="bib119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ménard</surname> <given-names>S</given-names></name><name><surname>Förster</surname> <given-names>V</given-names></name><name><surname>Lotz</surname> <given-names>M</given-names></name><name><surname>Gütle</surname> <given-names>D</given-names></name><name><surname>Duerr</surname> <given-names>CU</given-names></name><name><surname>Gallo</surname> <given-names>RL</given-names></name><name><surname>Henriques-Normark</surname> <given-names>B</given-names></name><name><surname>Pütsep</surname> <given-names>K</given-names></name><name><surname>Andersson</surname> <given-names>M</given-names></name><name><surname>Glocker</surname> <given-names>EO</given-names></name><name><surname>Hornef</surname> <given-names>MW</given-names></name><name><surname>MÃ©nard</surname> <given-names>S</given-names></name><name><surname>FÃ¶rster</surname> <given-names>V</given-names></name><name><surname>GÃ¼tle</surname> <given-names>D</given-names></name><name><surname>PÃ¼tsep</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Developmental switch of intestinal antimicrobial peptide expression</article-title><source>The Journal of Experimental Medicine</source><volume>205</volume><fpage>183</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1084/jem.20071022</pub-id><pub-id pub-id-type="pmid">18180308</pub-id></element-citation></ref><ref id="bib120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nanthakumar</surname> <given-names>N</given-names></name><name><surname>Meng</surname> <given-names>D</given-names></name><name><surname>Goldstein</surname> <given-names>AM</given-names></name><name><surname>Zhu</surname> <given-names>W</given-names></name><name><surname>Lu</surname> <given-names>L</given-names></name><name><surname>Uauy</surname> <given-names>R</given-names></name><name><surname>Llanos</surname> <given-names>A</given-names></name><name><surname>Claud</surname> <given-names>EC</given-names></name><name><surname>Walker</surname> <given-names>WA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The mechanism of excessive intestinal inflammation in necrotizing enterocolitis: an immature innate immune response</article-title><source>PLoS One</source><volume>6</volume><elocation-id>e17776</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0017776</pub-id><pub-id pub-id-type="pmid">21445298</pub-id></element-citation></ref><ref id="bib121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neal</surname> <given-names>JT</given-names></name><name><surname>Peterson</surname> <given-names>TS</given-names></name><name><surname>Kent</surname> <given-names>ML</given-names></name><name><surname>Guillemin</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>H. pylori virulence factor CagA increases intestinal cell proliferation by Wnt pathway activation in a transgenic zebrafish model</article-title><source>Disease Models &amp; Mechanisms</source><volume>6</volume><fpage>802</fpage><lpage>810</lpage><pub-id pub-id-type="doi">10.1242/dmm.011163</pub-id><pub-id pub-id-type="pmid">23471915</pub-id></element-citation></ref><ref id="bib122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neu</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Gastrointestinal maturation and implications for infant feeding</article-title><source>Early Human Development</source><volume>83</volume><fpage>767</fpage><lpage>775</lpage><pub-id pub-id-type="doi">10.1016/j.earlhumdev.2007.09.009</pub-id><pub-id pub-id-type="pmid">17913404</pub-id></element-citation></ref><ref id="bib123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neu</surname> <given-names>J</given-names></name><name><surname>Walker</surname> <given-names>WA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Necrotizing enterocolitis</article-title><source>New England Journal of Medicine</source><volume>364</volume><fpage>255</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1056/NEJMra1005408</pub-id><pub-id pub-id-type="pmid">21247316</pub-id></element-citation></ref><ref id="bib124"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname> <given-names>TL</given-names></name><name><surname>Vieira-Silva</surname> <given-names>S</given-names></name><name><surname>Liston</surname> <given-names>A</given-names></name><name><surname>Raes</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>How informative is the mouse for human gut microbiota research?</article-title><source>Disease Models &amp; Mechanisms</source><volume>8</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1242/dmm.017400</pub-id><pub-id pub-id-type="pmid">25561744</pub-id></element-citation></ref><ref id="bib125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Neil</surname> <given-names>DA</given-names></name><name><surname>O’Neil</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Regulation of expression of beta-defensins: endogenous enteric peptide antibiotics</article-title><source>Molecular Immunology</source><volume>40</volume><fpage>445</fpage><lpage>450</lpage><pub-id pub-id-type="doi">10.1016/S0161-5890(03)00161-5</pub-id><pub-id pub-id-type="pmid">14568390</pub-id></element-citation></ref><ref id="bib126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ochman</surname> <given-names>H</given-names></name><name><surname>Selander</surname> <given-names>RK</given-names></name></person-group><year iso-8601-date="1984">1984</year><article-title>Standard reference strains of Escherichia coli from natural populations</article-title><source>Journal of Bacteriology</source><volume>157</volume><fpage>690</fpage><lpage>693</lpage><pub-id pub-id-type="pmid">6363394</pub-id></element-citation></ref><ref id="bib127"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliver</surname> <given-names>KM</given-names></name><name><surname>Taylor</surname> <given-names>CT</given-names></name><name><surname>Cummins</surname> <given-names>EP</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Hypoxia. regulation of nfkappab signalling during inflammation: the role of hydroxylases</article-title><source>Arthritis Research &amp; Therapy</source><volume>11</volume><fpage>215</fpage><pub-id pub-id-type="doi">10.1186/ar2575</pub-id><pub-id pub-id-type="pmid">19291263</pub-id></element-citation></ref><ref id="bib128"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ostaff</surname> <given-names>MJ</given-names></name><name><surname>Stange</surname> <given-names>EF</given-names></name><name><surname>Wehkamp</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Antimicrobial peptides and gut microbiota in homeostasis and pathology</article-title><source>EMBO Molecular Medicine</source><volume>5</volume><fpage>1465</fpage><lpage>1483</lpage><pub-id pub-id-type="doi">10.1002/emmm.201201773</pub-id><pub-id pub-id-type="pmid">24039130</pub-id></element-citation></ref><ref id="bib129"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname> <given-names>C</given-names></name><name><surname>Bik</surname> <given-names>EM</given-names></name><name><surname>DiGiulio</surname> <given-names>DB</given-names></name><name><surname>Relman</surname> <given-names>DA</given-names></name><name><surname>Brown</surname> <given-names>PO</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Development of the human infant intestinal microbiota</article-title><source>PLoS Biology</source><volume>5</volume><elocation-id>e177</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.0050177</pub-id><pub-id pub-id-type="pmid">17594176</pub-id></element-citation></ref><ref id="bib130"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname> <given-names>LW</given-names></name><name><surname>Artis</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Intestinal epithelial cells: regulators of barrier function and immune homeostasis</article-title><source>Nature Reviews Immunology</source><volume>14</volume><fpage>141</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1038/nri3608</pub-id><pub-id pub-id-type="pmid">24566914</pub-id></element-citation></ref><ref id="bib131"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renz</surname> <given-names>H</given-names></name><name><surname>Brandtzaeg</surname> <given-names>P</given-names></name><name><surname>Hornef</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The impact of perinatal immune development on mucosal homeostasis and chronic inflammation</article-title><source>Nature Reviews Immunology</source><volume>12</volume><fpage>9</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1038/nri3112</pub-id><pub-id pub-id-type="pmid">22158411</pub-id></element-citation></ref><ref id="bib132"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhee</surname> <given-names>SJ</given-names></name><name><surname>Walker</surname> <given-names>WA</given-names></name><name><surname>Cherayil</surname> <given-names>BJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Developmentally regulated intestinal expression of IFN-gamma and its target genes and the age-specific response to enteric Salmonella infection</article-title><source>The Journal of Immunology</source><volume>175</volume><fpage>1127</fpage><lpage>1136</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.175.2.1127</pub-id><pub-id pub-id-type="pmid">16002714</pub-id></element-citation></ref><ref id="bib133"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rius</surname> <given-names>J</given-names></name><name><surname>Guma</surname> <given-names>M</given-names></name><name><surname>Schachtrup</surname> <given-names>C</given-names></name><name><surname>Akassoglou</surname> <given-names>K</given-names></name><name><surname>Zinkernagel</surname> <given-names>AS</given-names></name><name><surname>Nizet</surname> <given-names>V</given-names></name><name><surname>Johnson</surname> <given-names>RS</given-names></name><name><surname>Haddad</surname> <given-names>GG</given-names></name><name><surname>Karin</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha</article-title><source>Nature</source><volume>453</volume><fpage>807</fpage><lpage>811</lpage><pub-id pub-id-type="doi">10.1038/nature06905</pub-id><pub-id pub-id-type="pmid">18432192</pub-id></element-citation></ref><ref id="bib134"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivera-Chávez</surname> <given-names>F</given-names></name><name><surname>Zhang</surname> <given-names>LF</given-names></name><name><surname>Faber</surname> <given-names>F</given-names></name><name><surname>Lopez</surname> <given-names>CA</given-names></name><name><surname>Byndloss</surname> <given-names>MX</given-names></name><name><surname>Olsan</surname> <given-names>EE</given-names></name><name><surname>Xu</surname> <given-names>G</given-names></name><name><surname>Velazquez</surname> <given-names>EM</given-names></name><name><surname>Lebrilla</surname> <given-names>CB</given-names></name><name><surname>Winter</surname> <given-names>SE</given-names></name><name><surname>Bäumler</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Depletion of butyrate-producing clostridia from the gut microbiota drives an aerobic luminal expansion of salmonella</article-title><source>Cell Host &amp; Microbe</source><volume>19</volume><fpage>443</fpage><lpage>454</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2016.03.004</pub-id><pub-id pub-id-type="pmid">27078066</pub-id></element-citation></ref><ref id="bib135"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Cochrane in context: probiotics for prevention of necrotizing enterocolitis in preterm infants</article-title><source>Evidence-Based Child Health: A Cochrane Review Journal</source><volume>9</volume><fpage>672</fpage><lpage>674</lpage><pub-id pub-id-type="doi">10.1002/ebch.1977</pub-id><pub-id pub-id-type="pmid">25236308</pub-id></element-citation></ref><ref id="bib136"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodríguez-Piñeiro</surname> <given-names>AM</given-names></name><name><surname>Bergström</surname> <given-names>JH</given-names></name><name><surname>Ermund</surname> <given-names>A</given-names></name><name><surname>Gustafsson</surname> <given-names>JK</given-names></name><name><surname>Schütte</surname> <given-names>A</given-names></name><name><surname>Johansson</surname> <given-names>ME</given-names></name><name><surname>Hansson</surname> <given-names>GC</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Studies of mucus in mouse stomach, small intestine, and colon. II. Gastrointestinal mucus proteome reveals Muc2 and Muc5ac accompanied by a set of core proteins</article-title><source>AJP: Gastrointestinal and Liver Physiology</source><volume>305</volume><fpage>G348</fpage><lpage>G356</lpage><pub-id pub-id-type="doi">10.1152/ajpgi.00047.2013</pub-id><pub-id pub-id-type="pmid">23832517</pub-id></element-citation></ref><ref id="bib137"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Round</surname> <given-names>JL</given-names></name><name><surname>Mazmanian</surname> <given-names>SK</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The gut microbiota shapes intestinal immune responses during health and disease</article-title><source>Nature Reviews Immunology</source><volume>9</volume><fpage>313</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.1038/nri2515</pub-id><pub-id pub-id-type="pmid">19343057</pub-id></element-citation></ref><ref id="bib138"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salzman</surname> <given-names>NH</given-names></name><name><surname>Ghosh</surname> <given-names>D</given-names></name><name><surname>Huttner</surname> <given-names>KM</given-names></name><name><surname>Paterson</surname> <given-names>Y</given-names></name><name><surname>Bevins</surname> <given-names>CL</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin</article-title><source>Nature</source><volume>422</volume><fpage>522</fpage><lpage>526</lpage><pub-id pub-id-type="doi">10.1038/nature01520</pub-id><pub-id pub-id-type="pmid">12660734</pub-id></element-citation></ref><ref id="bib139"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salzman</surname> <given-names>NH</given-names></name><name><surname>Hung</surname> <given-names>K</given-names></name><name><surname>Haribhai</surname> <given-names>D</given-names></name><name><surname>Chu</surname> <given-names>H</given-names></name><name><surname>Karlsson-Sjöberg</surname> <given-names>J</given-names></name><name><surname>Amir</surname> <given-names>E</given-names></name><name><surname>Teggatz</surname> <given-names>P</given-names></name><name><surname>Barman</surname> <given-names>M</given-names></name><name><surname>Hayward</surname> <given-names>M</given-names></name><name><surname>Eastwood</surname> <given-names>D</given-names></name><name><surname>Stoel</surname> <given-names>M</given-names></name><name><surname>Zhou</surname> <given-names>Y</given-names></name><name><surname>Sodergren</surname> <given-names>E</given-names></name><name><surname>Weinstock</surname> <given-names>GM</given-names></name><name><surname>Bevins</surname> <given-names>CL</given-names></name><name><surname>Williams</surname> <given-names>CB</given-names></name><name><surname>Bos</surname> <given-names>NA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Enteric defensins are essential regulators of intestinal microbial ecology</article-title><source>Nature Immunology</source><volume>11</volume><fpage>76</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1038/ni.1825</pub-id><pub-id pub-id-type="pmid">19855381</pub-id></element-citation></ref><ref id="bib140"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sander</surname> <given-names>LE</given-names></name><name><surname>Davis</surname> <given-names>MJ</given-names></name><name><surname>Boekschoten</surname> <given-names>MV</given-names></name><name><surname>Amsen</surname> <given-names>D</given-names></name><name><surname>Dascher</surname> <given-names>CC</given-names></name><name><surname>Ryffel</surname> <given-names>B</given-names></name><name><surname>Swanson</surname> <given-names>JA</given-names></name><name><surname>Müller</surname> <given-names>M</given-names></name><name><surname>Blander</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Detection of prokaryotic mRNA signifies microbial viability and promotes immunity</article-title><source>Nature</source><volume>474</volume><fpage>385</fpage><lpage>389</lpage><pub-id pub-id-type="doi">10.1038/nature10072</pub-id><pub-id pub-id-type="pmid">21602824</pub-id></element-citation></ref><ref id="bib141"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sanderson</surname> <given-names>IR</given-names></name><name><surname>Walker</surname> <given-names>WA</given-names></name></person-group><year iso-8601-date="2000">2000</year><source>Development of the Gastrointestinal Tract</source><publisher-loc>Hamilton, Canada</publisher-loc><publisher-name>BC Decker</publisher-name></element-citation></ref><ref id="bib142"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname> <given-names>TM</given-names></name><name><surname>Kao</surname> <given-names>JY</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A little O2 may go a long way in structuring the GI microbiome</article-title><source>Gastroenterology</source><volume>147</volume><fpage>956</fpage><lpage>959</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2014.09.025</pub-id><pub-id pub-id-type="pmid">25265578</pub-id></element-citation></ref><ref id="bib143"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname> <given-names>SY</given-names></name><name><surname>Blanchard</surname> <given-names>JF</given-names></name><name><surname>Bernstein</surname> <given-names>CN</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease</article-title><source>The American Journal of Gastroenterology</source><volume>105</volume><fpage>2687</fpage><lpage>2692</lpage><pub-id pub-id-type="doi">10.1038/ajg.2010.398</pub-id><pub-id pub-id-type="pmid">20940708</pub-id></element-citation></ref><ref id="bib144"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shawki</surname> <given-names>A</given-names></name><name><surname>McCole</surname> <given-names>DF</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mechanisms of intestinal epithelial barrier dysfunction by adherent-invasive escherichia coli</article-title><source>Cellular and Molecular Gastroenterology and Hepatology</source><volume>3</volume><fpage>41</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1016/j.jcmgh.2016.10.004</pub-id><pub-id pub-id-type="pmid">28174756</pub-id></element-citation></ref><ref id="bib145"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shreiner</surname> <given-names>AB</given-names></name><name><surname>Kao</surname> <given-names>JY</given-names></name><name><surname>Young</surname> <given-names>VB</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The gut microbiome in health and in disease</article-title><source>Current Opinion in Gastroenterology</source><volume>31</volume><fpage>69</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1097/MOG.0000000000000139</pub-id><pub-id pub-id-type="pmid">25394236</pub-id></element-citation></ref><ref id="bib146"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sommer</surname> <given-names>F</given-names></name><name><surname>Nookaew</surname> <given-names>I</given-names></name><name><surname>Sommer</surname> <given-names>N</given-names></name><name><surname>Fogelstrand</surname> <given-names>P</given-names></name><name><surname>Bäckhed</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Site-specific programming of the host epithelial transcriptome by the gut microbiota</article-title><source>Genome Biology</source><volume>16</volume><elocation-id>62</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-015-0614-4</pub-id><pub-id pub-id-type="pmid">25887251</pub-id></element-citation></ref><ref id="bib147"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spence</surname> <given-names>JR</given-names></name><name><surname>Mayhew</surname> <given-names>CN</given-names></name><name><surname>Rankin</surname> <given-names>SA</given-names></name><name><surname>Kuhar</surname> <given-names>MF</given-names></name><name><surname>Vallance</surname> <given-names>JE</given-names></name><name><surname>Tolle</surname> <given-names>K</given-names></name><name><surname>Hoskins</surname> <given-names>EE</given-names></name><name><surname>Kalinichenko</surname> <given-names>VV</given-names></name><name><surname>Wells</surname> <given-names>SI</given-names></name><name><surname>Zorn</surname> <given-names>AM</given-names></name><name><surname>Shroyer</surname> <given-names>NF</given-names></name><name><surname>Wells</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro</article-title><source>Nature</source><volume>470</volume><fpage>105</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1038/nature09691</pub-id><pub-id pub-id-type="pmid">21151107</pub-id></element-citation></ref><ref id="bib148"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stallman</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="1981">1981</year><article-title>EMACS the extensible, customizable self-documenting display editor</article-title><source>ACM SIGOA Newsletter</source><volume>2</volume><fpage>147</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1145/1159890.806466</pub-id></element-citation></ref><ref id="bib149"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname> <given-names>A</given-names></name><name><surname>Tamayo</surname> <given-names>P</given-names></name><name><surname>Mootha</surname> <given-names>VK</given-names></name><name><surname>Mukherjee</surname> <given-names>S</given-names></name><name><surname>Ebert</surname> <given-names>BL</given-names></name><name><surname>Gillette</surname> <given-names>MA</given-names></name><name><surname>Paulovich</surname> <given-names>A</given-names></name><name><surname>Pomeroy</surname> <given-names>SL</given-names></name><name><surname>Golub</surname> <given-names>TR</given-names></name><name><surname>Lander</surname> <given-names>ES</given-names></name><name><surname>Mesirov</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</article-title><source>PNAS</source><volume>102</volume><fpage>15545</fpage><lpage>15550</lpage><pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id><pub-id pub-id-type="pmid">16199517</pub-id></element-citation></ref><ref id="bib150"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname> <given-names>X</given-names></name><name><surname>Hsueh</surname> <given-names>W</given-names></name><name><surname>Gonzalez-Crussi</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Cellular localization of tumor necrosis factor (TNF)-alpha transcripts in normal bowel and in necrotizing enterocolitis. TNF gene expression by Paneth cells, intestinal eosinophils, and macrophages</article-title><source>The American Journal of Pathology</source><volume>142</volume><fpage>1858</fpage><lpage>1865</lpage><pub-id pub-id-type="pmid">8506954</pub-id></element-citation></ref><ref id="bib151"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanner</surname> <given-names>SM</given-names></name><name><surname>Berryhill</surname> <given-names>TF</given-names></name><name><surname>Ellenburg</surname> <given-names>JL</given-names></name><name><surname>Jilling</surname> <given-names>T</given-names></name><name><surname>Cleveland</surname> <given-names>DS</given-names></name><name><surname>Lorenz</surname> <given-names>RG</given-names></name><name><surname>Martin</surname> <given-names>CA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Pathogenesis of necrotizing enterocolitis: modeling the innate immune response</article-title><source>The American journal of pathology</source><volume>185</volume><fpage>4</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2014.08.028</pub-id><pub-id pub-id-type="pmid">25447054</pub-id></element-citation></ref><ref id="bib152"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname> <given-names>YH</given-names></name><name><surname>Nattiv</surname> <given-names>R</given-names></name><name><surname>Dedhia</surname> <given-names>PH</given-names></name><name><surname>Nagy</surname> <given-names>MS</given-names></name><name><surname>Chin</surname> <given-names>AM</given-names></name><name><surname>Thomson</surname> <given-names>M</given-names></name><name><surname>Klein</surname> <given-names>OD</given-names></name><name><surname>Spence</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>In vitro patterning of pluripotent stem cell-derived intestine recapitulates in vivo human development</article-title><source>Development</source><volume>144</volume><fpage>1045</fpage><lpage>1055</lpage><pub-id pub-id-type="doi">10.1242/dev.138453</pub-id><pub-id pub-id-type="pmid">27927684</pub-id></element-citation></ref><ref id="bib153"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsutsumi-Ishii</surname> <given-names>Y</given-names></name><name><surname>Nagaoka</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>NF-kappa B-mediated transcriptional regulation of human beta-defensin-2 gene following lipopolysaccharide stimulation</article-title><source>Journal of Leukocyte Biology</source><volume>71</volume><fpage>154</fpage><lpage>162</lpage><pub-id pub-id-type="pmid">11781391</pub-id></element-citation></ref><ref id="bib154"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Intestinal mucosal barrier function in health and disease</article-title><source>Nature Reviews Immunology</source><volume>9</volume><fpage>799</fpage><lpage>809</lpage><pub-id pub-id-type="doi">10.1038/nri2653</pub-id><pub-id pub-id-type="pmid">19855405</pub-id></element-citation></ref><ref id="bib155"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Underwood</surname> <given-names>MA</given-names></name><name><surname>Arriola</surname> <given-names>J</given-names></name><name><surname>Gerber</surname> <given-names>CW</given-names></name><name><surname>Kaveti</surname> <given-names>A</given-names></name><name><surname>Kalanetra</surname> <given-names>KM</given-names></name><name><surname>Kananurak</surname> <given-names>A</given-names></name><name><surname>Bevins</surname> <given-names>CL</given-names></name><name><surname>Mills</surname> <given-names>DA</given-names></name><name><surname>Dvorak</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Bifidobacterium longum subsp. infantis in experimental necrotizing enterocolitis: alterations in inflammation, innate immune response, and the microbiota</article-title><source>Pediatric Research</source><volume>76</volume><fpage>326</fpage><lpage>333</lpage><pub-id pub-id-type="doi">10.1038/pr.2014.102</pub-id><pub-id pub-id-type="pmid">25000347</pub-id></element-citation></ref><ref id="bib156"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Upperman</surname> <given-names>JS</given-names></name><name><surname>Potoka</surname> <given-names>D</given-names></name><name><surname>Grishin</surname> <given-names>A</given-names></name><name><surname>Hackam</surname> <given-names>D</given-names></name><name><surname>Zamora</surname> <given-names>R</given-names></name><name><surname>Ford</surname> <given-names>HR</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Mechanisms of nitric oxide-mediated intestinal barrier failure in necrotizing enterocolitis</article-title><source>Seminars in Pediatric Surgery</source><volume>14</volume><fpage>159</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1053/j.sempedsurg.2005.05.004</pub-id><pub-id pub-id-type="pmid">16084403</pub-id></element-citation></ref><ref id="bib157"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaishnava</surname> <given-names>S</given-names></name><name><surname>Behrendt</surname> <given-names>CL</given-names></name><name><surname>Ismail</surname> <given-names>AS</given-names></name><name><surname>Eckmann</surname> <given-names>L</given-names></name><name><surname>Hooper</surname> <given-names>LV</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface</article-title><source>PNAS</source><volume>105</volume><fpage>20858</fpage><lpage>20863</lpage><pub-id pub-id-type="doi">10.1073/pnas.0808723105</pub-id><pub-id pub-id-type="pmid">19075245</pub-id></element-citation></ref><ref id="bib158"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Varki</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><source>Essentials of Glycobiology</source><publisher-loc>Cold Spring Harbor, New York</publisher-loc><publisher-name>Cold Spring Harbor Laboratory Press</publisher-name></element-citation></ref><ref id="bib159"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veereman-Wauters</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Neonatal gut development and postnatal adaptation</article-title><source>European Journal of Pediatrics</source><volume>155</volume><fpage>627</fpage><lpage>632</lpage><pub-id pub-id-type="doi">10.1007/BF01957141</pub-id><pub-id pub-id-type="pmid">8839713</pub-id></element-citation></ref><ref id="bib160"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vora</surname> <given-names>P</given-names></name><name><surname>Youdim</surname> <given-names>A</given-names></name><name><surname>Thomas</surname> <given-names>LS</given-names></name><name><surname>Fukata</surname> <given-names>M</given-names></name><name><surname>Tesfay</surname> <given-names>SY</given-names></name><name><surname>Lukasek</surname> <given-names>K</given-names></name><name><surname>Michelsen</surname> <given-names>KS</given-names></name><name><surname>Wada</surname> <given-names>A</given-names></name><name><surname>Hirayama</surname> <given-names>T</given-names></name><name><surname>Arditi</surname> <given-names>M</given-names></name><name><surname>Abreu</surname> <given-names>MT</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells</article-title><source>The Journal of Immunology</source><volume>173</volume><fpage>5398</fpage><lpage>5405</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.173.9.5398</pub-id><pub-id pub-id-type="pmid">15494486</pub-id></element-citation></ref><ref id="bib161"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>F</given-names></name><name><surname>Graham</surname> <given-names>WV</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Witkowski</surname> <given-names>ED</given-names></name><name><surname>Schwarz</surname> <given-names>BT</given-names></name><name><surname>Turner</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression</article-title><source>The American Journal of Pathology</source><volume>166</volume><fpage>409</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.1016/S0002-9440(10)62264-X</pub-id><pub-id pub-id-type="pmid">15681825</pub-id></element-citation></ref><ref id="bib162"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>F</given-names></name><name><surname>Schwarz</surname> <given-names>BT</given-names></name><name><surname>Graham</surname> <given-names>WV</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Su</surname> <given-names>L</given-names></name><name><surname>Clayburgh</surname> <given-names>DR</given-names></name><name><surname>Abraham</surname> <given-names>C</given-names></name><name><surname>Turner</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>IFN-gamma-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction</article-title><source>Gastroenterology</source><volume>131</volume><fpage>1153</fpage><lpage>1163</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2006.08.022</pub-id><pub-id pub-id-type="pmid">17030185</pub-id></element-citation></ref><ref id="bib163"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>G</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Wang</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>APD3: the antimicrobial peptide database as a tool for research and education</article-title><source>Nucleic Acids Research</source><volume>44</volume><fpage>D1087</fpage><lpage>D1093</lpage><pub-id pub-id-type="doi">10.1093/nar/gkv1278</pub-id><pub-id pub-id-type="pmid">26602694</pub-id></element-citation></ref><ref id="bib164"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname> <given-names>DV</given-names></name><name><surname>Scholz</surname> <given-names>M</given-names></name><name><surname>Zolfo</surname> <given-names>M</given-names></name><name><surname>Taft</surname> <given-names>DH</given-names></name><name><surname>Schibler</surname> <given-names>KR</given-names></name><name><surname>Tett</surname> <given-names>A</given-names></name><name><surname>Segata</surname> <given-names>N</given-names></name><name><surname>Morrow</surname> <given-names>AL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Metagenomic sequencing with strain-level resolution implicates uropathogenic e. coli in necrotizing enterocolitis and mortality in preterm infants</article-title><source>Cell Reports</source><volume>14</volume><fpage>2912</fpage><lpage>2924</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.03.015</pub-id><pub-id pub-id-type="pmid">26997279</pub-id></element-citation></ref><ref id="bib165"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname> <given-names>CL</given-names></name><name><surname>Mahe</surname> <given-names>MM</given-names></name><name><surname>Múnera</surname> <given-names>J</given-names></name><name><surname>Howell</surname> <given-names>JC</given-names></name><name><surname>Sundaram</surname> <given-names>N</given-names></name><name><surname>Poling</surname> <given-names>HM</given-names></name><name><surname>Schweitzer</surname> <given-names>JI</given-names></name><name><surname>Vallance</surname> <given-names>JE</given-names></name><name><surname>Mayhew</surname> <given-names>CN</given-names></name><name><surname>Sun</surname> <given-names>Y</given-names></name><name><surname>Grabowski</surname> <given-names>G</given-names></name><name><surname>Finkbeiner</surname> <given-names>SR</given-names></name><name><surname>Spence</surname> <given-names>JR</given-names></name><name><surname>Shroyer</surname> <given-names>NF</given-names></name><name><surname>Wells</surname> <given-names>JM</given-names></name><name><surname>Helmrath</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>An in vivo model of human small intestine using pluripotent stem cells</article-title><source>Nature Medicine</source><volume>20</volume><fpage>1310</fpage><lpage>1314</lpage><pub-id pub-id-type="doi">10.1038/nm.3737</pub-id><pub-id pub-id-type="pmid">25326803</pub-id></element-citation></ref><ref id="bib166"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wattam</surname> <given-names>AR</given-names></name><name><surname>Davis</surname> <given-names>JJ</given-names></name><name><surname>Assaf</surname> <given-names>R</given-names></name><name><surname>Boisvert</surname> <given-names>S</given-names></name><name><surname>Brettin</surname> <given-names>T</given-names></name><name><surname>Bun</surname> <given-names>C</given-names></name><name><surname>Conrad</surname> <given-names>N</given-names></name><name><surname>Dietrich</surname> <given-names>EM</given-names></name><name><surname>Disz</surname> <given-names>T</given-names></name><name><surname>Gabbard</surname> <given-names>JL</given-names></name><name><surname>Gerdes</surname> <given-names>S</given-names></name><name><surname>Henry</surname> <given-names>CS</given-names></name><name><surname>Kenyon</surname> <given-names>RW</given-names></name><name><surname>Machi</surname> <given-names>D</given-names></name><name><surname>Mao</surname> <given-names>C</given-names></name><name><surname>Nordberg</surname> <given-names>EK</given-names></name><name><surname>Olsen</surname> <given-names>GJ</given-names></name><name><surname>Murphy-Olson</surname> <given-names>DE</given-names></name><name><surname>Olson</surname> <given-names>R</given-names></name><name><surname>Overbeek</surname> <given-names>R</given-names></name><name><surname>Parrello</surname> <given-names>B</given-names></name><name><surname>Pusch</surname> <given-names>GD</given-names></name><name><surname>Shukla</surname> <given-names>M</given-names></name><name><surname>Vonstein</surname> <given-names>V</given-names></name><name><surname>Warren</surname> <given-names>A</given-names></name><name><surname>Xia</surname> <given-names>F</given-names></name><name><surname>Yoo</surname> <given-names>H</given-names></name><name><surname>Stevens</surname> <given-names>RL</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Improvements to patric, the all-bacterial bioinformatics database and analysis resource center</article-title><source>Nucleic Acids Research</source><volume>45</volume><fpage>D535</fpage><lpage>D542</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw1017</pub-id><pub-id pub-id-type="pmid">27899627</pub-id></element-citation></ref><ref id="bib167"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wickham</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Ggplot2: elegant graphics for data analysis</article-title><source>Springer-Verlag New York</source></element-citation></ref><ref id="bib168"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wopereis</surname> <given-names>H</given-names></name><name><surname>Oozeer</surname> <given-names>R</given-names></name><name><surname>Knipping</surname> <given-names>K</given-names></name><name><surname>Belzer</surname> <given-names>C</given-names></name><name><surname>Knol</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The first thousand days - intestinal microbiology of early life: establishing a symbiosis</article-title><source>Pediatric Allergy and Immunology</source><volume>25</volume><fpage>428</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1111/pai.12232</pub-id><pub-id pub-id-type="pmid">24899389</pub-id></element-citation></ref><ref id="bib169"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wullaert</surname> <given-names>A</given-names></name><name><surname>Bonnet</surname> <given-names>MC</given-names></name><name><surname>Pasparakis</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>NF-κB in the regulation of epithelial homeostasis and inflammation</article-title><source>Cell Research</source><volume>21</volume><fpage>146</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1038/cr.2010.175</pub-id><pub-id pub-id-type="pmid">21151201</pub-id></element-citation></ref><ref id="bib170"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname> <given-names>C</given-names></name><name><surname>Ghosh</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>NF-kappaB, an evolutionarily conserved mediator of immune and inflammatory responses</article-title><source>Advances in Experimental Medicine and Biology</source><volume>560</volume><fpage>41</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1007/0-387-24180-9_5</pub-id><pub-id pub-id-type="pmid">15932018</pub-id></element-citation></ref><ref id="bib171"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname> <given-names>L</given-names></name><name><surname>Xue</surname> <given-names>X</given-names></name><name><surname>Taylor</surname> <given-names>M</given-names></name><name><surname>Ramakrishnan</surname> <given-names>SK</given-names></name><name><surname>Nagaoka</surname> <given-names>K</given-names></name><name><surname>Hao</surname> <given-names>C</given-names></name><name><surname>Gonzalez</surname> <given-names>FJ</given-names></name><name><surname>Shah</surname> <given-names>YM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Hypoxia-inducible factor/MAZ-dependent induction of caveolin-1 regulates colon permeability through suppression of occludin, leading to hypoxia-induced inflammation</article-title><source>Molecular and Cellular Biology</source><volume>34</volume><fpage>3013</fpage><lpage>3023</lpage><pub-id pub-id-type="doi">10.1128/MCB.00324-14</pub-id><pub-id pub-id-type="pmid">24891620</pub-id></element-citation></ref><ref id="bib172"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yassour</surname> <given-names>M</given-names></name><name><surname>Vatanen</surname> <given-names>T</given-names></name><name><surname>Siljander</surname> <given-names>H</given-names></name><name><surname>Hämäläinen</surname> <given-names>AM</given-names></name><name><surname>Härkönen</surname> <given-names>T</given-names></name><name><surname>Ryhänen</surname> <given-names>SJ</given-names></name><name><surname>Franzosa</surname> <given-names>EA</given-names></name><name><surname>Vlamakis</surname> <given-names>H</given-names></name><name><surname>Huttenhower</surname> <given-names>C</given-names></name><name><surname>Gevers</surname> <given-names>D</given-names></name><name><surname>Lander</surname> <given-names>ES</given-names></name><name><surname>Knip</surname> <given-names>M</given-names></name><name><surname>Xavier</surname> <given-names>RJ</given-names></name><collab>DIABIMMUNE Study Group</collab></person-group><year iso-8601-date="2016">2016</year><article-title>Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability</article-title><source>Science Translational Medicine</source><volume>8</volume><elocation-id>343ra81</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.aad0917</pub-id><pub-id pub-id-type="pmid">27306663</pub-id></element-citation></ref><ref id="bib173"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>G</given-names></name><name><surname>Wang</surname> <given-names>LG</given-names></name><name><surname>Han</surname> <given-names>Y</given-names></name><name><surname>He</surname> <given-names>QY</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>clusterProfiler: an R package for comparing biological themes among gene clusters</article-title><source>OMICS: A Journal of Integrative Biology</source><volume>16</volume><fpage>284</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1089/omi.2011.0118</pub-id><pub-id pub-id-type="pmid">22455463</pub-id></element-citation></ref><ref id="bib174"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>G</given-names></name><name><surname>He</surname> <given-names>QY</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>ReactomePA: an R/Bioconductor package for reactome pathway analysis and visualization</article-title><source>Mol. BioSyst.</source><volume>12</volume><fpage>477</fpage><lpage>479</lpage><pub-id pub-id-type="doi">10.1039/C5MB00663E</pub-id><pub-id pub-id-type="pmid">26661513</pub-id></element-citation></ref><ref id="bib175"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeitouni</surname> <given-names>NE</given-names></name><name><surname>Chotikatum</surname> <given-names>S</given-names></name><name><surname>von Köckritz-Blickwede</surname> <given-names>M</given-names></name><name><surname>Naim</surname> <given-names>HY</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The impact of hypoxia on intestinal epithelial cell functions: consequences for invasion by bacterial pathogens</article-title><source>Molecular and Cellular Pediatrics</source><volume>3</volume><elocation-id>14</elocation-id><pub-id pub-id-type="doi">10.1186/s40348-016-0041-y</pub-id><pub-id pub-id-type="pmid">27002817</pub-id></element-citation></ref><ref id="bib176"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>G</given-names></name><name><surname>Ghosh</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity</article-title><source>Journal of Clinical Investigation</source><volume>107</volume><fpage>13</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1172/JCI11837</pub-id><pub-id pub-id-type="pmid">11134172</pub-id></element-citation></ref><ref id="bib177"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname> <given-names>L</given-names></name><name><surname>Kelly</surname> <given-names>CJ</given-names></name><name><surname>Colgan</surname> <given-names>SP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Physiologic hypoxia and oxygen homeostasis in the healthy intestine. A Review in the Theme: Cellular Responses to Hypoxia</article-title><source>American Journal of Physiology - Cell Physiology</source><volume>309</volume><fpage>C350</fpage><lpage>C360</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00191.2015</pub-id><pub-id pub-id-type="pmid">26179603</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.29132.030</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>MacPherson</surname><given-names>Andrew J</given-names></name><role>Reviewing Editor</role><aff><institution>University of Bern</institution><country>Switzerland</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;Bacterial colonization stimulates a complex physiological response in the immature human intestinal epithelium&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Wendy Garrett as the Senior Editor. One of the reviewers, Emma Slack, has agreed to share her identity.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission. There was consensus among the reviewers that your manuscript would be most appropriate, if adequately revised, for our Tools and Resources section.</p><p>Summary:</p><p>Human intestinal organoids (HIOs) were used to investigate host microbial interactions at the epithelial surface. Using live or dead <italic>Escherichia coli</italic> they report contact and hypoxia driven responses with antimicrobial peptide production, maturation of the mucus layer and improved paracellular barrier function. The paper represents a technical development of the HIO system, with findings that are aligned with interpretations from previous culture systems.</p><p>Essential revisions:</p><p><italic>General comments on presentation in the paper</italic> </p><p>Especially for a paper where the main point is development of an experimental system, the technical validation and reporting of the methods and results in the paper must be completely solid. The reviewers noted missing information on the number of biological and technical repeats, concentrations of stimuli, number of injected bacteria from the figure legends. The Materials and methods section was considered incomplete to allow a researcher from a related field to exactly reproduce every experiment shown – concentrations, solvents and timings – e.g. <xref ref-type="fig" rid="fig7">Figure 7</xref>, how much TNF, how much IFNgamma? It was unclear exactly how the false discovery rate was assessed – which algorithm was used? What sample numbers were used in the calculations and how reproducible were the experiments? Specific information about the <italic>E. coli</italic> strain should be given, and whether it is motile.</p><p>The model depends on selective injection of live bacteria into HIOs and evidence is provided in <xref ref-type="fig" rid="fig1">Figure 1</xref> about this. The experimental protocol needs to be far more explicit in the main body of the text: in the Materials and methods under 'HIO culture' it is stated 'HIOs were maintained in ENR media without antibiotics prior to microinjection experiments'; then under 'Microinjection', '…cultures were rinsed with PBS and treated with ENR media containing penicillin and streptomycin…'. Controls that assess the potential influence of carry-over of antibiotics of the readouts reported in <xref ref-type="fig" rid="fig1">Figure 1</xref> are required.</p><p><italic>Further issues on <xref ref-type="fig" rid="fig1">Figure 1</xref></italic></p><p>A) <xref ref-type="fig" rid="fig1">Figure 1B</xref> appears to be compromised by fixation and/or freezing artifacts.</p><p>B) In <xref ref-type="fig" rid="fig1">Figure 1C</xref> the y axis is labelled 24h δ CFU. Given that the scale becomes fractional, it seems likely that ratios rather than differences are being used.</p><p>C) What dose(s) of injections were used for 1D?</p><p>D) As a main panel of <xref ref-type="fig" rid="fig1">Figure 1E</xref>, showing two agar plates does not add much, especially when the legend does not give details of exactly when are how they were generated. Further, the final sentence of the third paragraph in subsection “HIOs can be stably associated with commensal <italic>E. coli</italic>” and the results quoted in the following paragraph after day 3 are contradictory. Controls are absolutely necessary to ensure that these findings are not simply due to antibiotic carry-over.</p><p>The transcriptomic approach does not capture all basic information about the system. Does the <italic>E. coli</italic> injection alter the size, morphology and longevity of the HIOs? Does it alter the rate of epithelial cell turnover (which could be easily tested by BrdU labeling, and would be predicted from e.g. Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4570-7)? Does it alter the pattern of epithelial cell maturation, i.e. the fraction of mature paneth cells, goblet cells, enteroendocrine cells etc?</p><p>It is accepted that enteroids are 3 dimensional structures, and the study has been productive in the evaluation of stem cell dynamics and other tissue level events. However, organoids are not vascularized with a capillary network that generate O2 gradients in vivo, thus organism level physiological events such as hypoxia are difficult to address and these caveats must be included in the discussion</p><p>Using the pathway analysis from the GO and REACTOME databases limits the insight that the reader is given into the changes in gene expression. For example, in <xref ref-type="fig" rid="fig2">Figure 2C</xref> 'muscle cell differentiation' is shown as a pathway. It would be possible to report detailed network analyses at least in the supporting material so that the contribution of different transcripts to the overall analysis is clear. This would allow considerable refinement of the time-dependent transcriptional response descriptions in the text.</p><p>In <xref ref-type="fig" rid="fig3">Figure 3C</xref> it is difficult to appreciate whether the cadherin stain has worked in the PBS panel. How reproducible are these results? What happens with a hypoxic control?</p><p>The data analysis shown in <xref ref-type="fig" rid="fig4">Figure 4</xref> was complex and challenging for the reviewers to appreciate in its current form. The subset organisation must be clear and specific.</p><p>A) Why is there no PBS control with the NFkB inhibitor? Many cell survival/cell death pathways converge on NFkB signalling and the inhibitor may exert effects already at baseline which would then fall into gene set 1 and gene set 2? From the Venn-diagrams shown in panel A, it appears that genes in set 1 and 2 are mutually exclusive, which would make the lacking control less problematic, but apparently the hypoxia-responsive genes are highly enriched in both (of course these may be different genes in the same pathway? But this would be slightly surprising if a statistical exclusion had been made).</p><p>B) For the discussion of the analysis, it appears that an assumption is made that the effect of live <italic>E. coli</italic> is identical to dead <italic>E. coli</italic> combined with hypoxia. There is a large body of literature on &quot;vital PAMPs&quot; (e.g. Nature. 2011 May 22;474(7351):385-9), which might suggest there is more to it. Nevertheless, there appears to be an excellent correlation between genes regulated by live and dead <italic>E. coli</italic> in the plots in <xref ref-type="fig" rid="fig4">Figure 4B</xref>. If the hypothesis is correct, then injecting dead <italic>E. coli</italic> and then immediately transferring the organoids to a hypoxic chamber should produce a gene-expression profile that correlates better that the dead <italic>E. coli</italic> alone. Noticeably the gradient of the correlation between hypoxia/PBS and live <italic>E. coli</italic>/PBS seems to be close to zero?</p><p>C) Is there some sort of statistical significance cut-off for the genes identified for each set in panel B? The clouds appear to very closely approach a log2-FC of zero, suggesting genes showing very small changes in expression are included? Would it be logical to show the data pre-filtered for p-value? Or show the limits of the region and color-code for p-value?</p><p>D) In panel C, is it right that &quot;% genes matched to pathway&quot; is this the percentage of genes from each set (e.g. the full 1940 genes in Set 1) that map to the indicated pathway? Thus 5%, i.e. around 400 genes from set 1 map to &quot;regulation of cytoskeleton organization&quot;? Please clarify. Also, as the plots in B suggest that many genes are included with a very small up- or down-regulation, it would be important to have some handle on not just the significance, but also the average absolute size of the change observed. A second set of graphs, or a supplementary figure with more information would be helpful.</p><p>E) In the legend, were pathways with enrichment P-values greater than 0.01 excluded?</p><p>In <xref ref-type="fig" rid="fig5">Figure 5B and C</xref>, it would be important to include a group microinjected with dead <italic>E. coli</italic>, immediately followed by hypoxia, to conclude that both factors act together to induce b-defensins. For <xref ref-type="fig" rid="fig5">Figure 5D</xref>, does hBD-2 require a reducing agent for activity as hBD1 does (Nature 469, 419-423)? Typically, these pore-forming AMPs to exert a stronger effect on the rapidly growing bacteria than in the stationary phase, and in fact, your maximum growth rate (i.e. maximum curve gradient) is even higher where the BD-2 is added, suggesting that something in the BD-2 may even permit faster <italic>E. coli</italic> growth in LB. Death over several hours in late stationary phase may be rather due to accumulation of a toxic metabolite. To control for these effects, it will be important to show growth data with heat-inactivation of the BD-2. To focus on killing in the stationary phase a late stationary-phase culture could be treated with differing concentrations of BD-2 over short time-courses (including the inactivated controls), measuring loss of membrane integrity by Sytox-green uptake by flow cytometry or microscopy. As O-antigens can inhibit AMP function, <italic>E. coli</italic> K-12 could be included in these experiments.</p><p>In relation to <xref ref-type="fig" rid="fig6">Figure 6</xref>, can induction of mucus production and induction of goblet cell differentiation be delineated? The slow appearance of mucin gene upregulation appears more consistent with a differentiation phenotype than simple gene expression?</p><p>The interpretation that 'Epithelial barrier integrity is enhanced following bacterial association' (p13) is rather at odds with the data in <xref ref-type="fig" rid="fig7">Figure 7 B and D</xref> where the PBS and <italic>E. coli</italic> treated permeability is the same. Is the meaning that NFkappaB signaling is required for the compensatory effects of the barrier in <italic>E. coli</italic>-treated organoids? What is the effect of the inhibitor alone?</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.29132.031</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><p>General comments on presentation in the paper</p><disp-quote content-type="editor-comment"><p>Especially for a paper where the main point is development of an experimental system, the technical validation and reporting of the methods and results in the paper must be completely solid. The reviewers noted missing information on the number of biological and technical repeats, concentrations of stimuli, number of injected bacteria from the figure legends. The Materials and methods section was considered incomplete to allow a researcher from a related field to exactly reproduce every experiment shown – concentrations, solvents and timings – e.g. <xref ref-type="fig" rid="fig7">Figure 7</xref>, how much TNF, how much IFNgamma?</p></disp-quote><p>Thank you for highlighting our oversight to include more details on the experimental methods and design. All figure legends have been revised to include the number of replicates and relevant details regarding the experimental setup. Given that microinjecting HIOs is not trivial, we had decided to write a methods paper dedicated to describing this technique in painful detail. Thus, we recently submitted a revised version of a manuscript describing the methodology for microinjecting and measuring FITC-dextran permeability in HIOs, which was accepted at the Journal of Visualized Experiments today (see attached letter of acceptance). We have deposited a pre-print version of this manuscript, which is available at https://github.com/hilldr/HIO_microinjection. We have referenced to this website in the Materials and methods with the hopes that interested readers will have access to all of the details necessary to repeat our procedures. Finally, recognizing the Editor's decision to consider this manuscript for the Tools and Resources section, we have devised a schematic illustrating our experimental setup for the HIO colonization experiments (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>). We hope that this will help the reader conceptualize the experimental scheme, evaluate the experiments presented, and devise new experiments to follow up on this work.</p><disp-quote content-type="editor-comment"><p>It was unclear exactly how the false discovery rate was assessed – which algorithm was used? What sample numbers were used in the calculations and how reproducible were the experiments?</p></disp-quote><p>The multiple testing-adjusted FDR was calculated using the DESeq2 (Love et al., 2014) implementation of the Wald test, a method for differential analysis of count data using shrinkage estimation for dispersions and fold changes to improve stability and interpretability of estimates. This allows us to incorporate the degree of uncertainty present in the alignment of any one 50 bp RNA-seq read to the annotated genome, so that counts of reads per gene are weighted according to the level of confidence in the alignment. An additional comment has been added to the Materials and methods to clarify this. The complete analysis and custom scripts have been made available at</p><p>https://github.com/hilldr/Hill_HIO_Colonization_2017, and we have also noted access to this information in the Materials and methods section.</p><disp-quote content-type="editor-comment"><p>Specific information about the E. coli strain should be given, and whether it is motile.</p></disp-quote><p>Regarding the <italic>E. coli</italic> strain ECOR2 that was used for these studies, we have performed whole geneome sequencing, annotation, and assembly. Details are given in the Materials and methods and this data is available using the PATRIC online bacterial genomics platform. Phylogenetic analysis of the complete genome (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>) indicates that ECOR2 is closely related to the well-studied <italic>E. coli</italic> type strain K-12 MG1655 and other nonpathogenic <italic>E. coli</italic> isolates. <italic>E. coli</italic> strain ECOR2 is available from ATCC. We have also indicated in the manuscript that we are willing to share isolates of this organism with interested researchers pending appropriate permissions of ATCC, who owns the strain.</p><disp-quote content-type="editor-comment"><p>The model depends on selective injection of live bacteria into HIOs and evidence is provided in <xref ref-type="fig" rid="fig1">Figure 1</xref> about this. The experimental protocol needs to be far more explicit in the main body of the text: in the Materials and methods under 'HIO culture' it is stated 'HIOs were maintained in ENR media without antibiotics prior to microinjection experiments'; then under 'Microinjection', '…cultures were rinsed with PBS and treated with ENR media containing penicillin and streptomycin…'. Controls that assess the potential influence of carry-over of antibiotics of the readouts reported in <xref ref-type="fig" rid="fig1">Figure 1</xref> are required.</p></disp-quote><p>In the interest of brevity, we originally aimed to write a concise description of the methodology. However, clarity is more important than conciseness in this case, particularly given the Editor's proposal to publish this work under the Tools and Resources section. We have made a concerted effort to improve the level of detail in our reported HIO culture methods. Notably, we have added a supplement to <xref ref-type="fig" rid="fig1">Figure 1</xref> (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>) containing a schematic representation of our bacterial microinjection and co-culture scheme and data supporting our methodology. As illustrated in <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3B</xref>, by comparing LB vs PBS as a vehicle for microinjection, we determined that the solution used to dilute <italic>E. coli</italic> cultures for microinjections could have a marked effect on the growth of <italic>E. coli</italic> within the HIO. Thus, all <italic>E. coli</italic> microinjections were performed using <italic>E. coli</italic> diluted in PB. Furthermore, we show that while maintaining antibiotics in HIO cultures for the duration of a co-culture experiment does not prevent <italic>E. coli</italic> growth in the HIO lumen, the average <italic>E. coli</italic> density was significantly reduced in HIO cultures in the presence of antibiotics (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3C</xref>). As a result, we decided to perform only a brief 1 h antibiotic incubation immediately following microinjection to limit potential growth in the media outside of the HIO. However, this raised concerns that antibiotic carryover could potentially account for the apparent low rate bacterial translocation in HIOs microinjected with <italic>E. coli.</italic> To address this concern, we tested the bacterial growth inhibition potential of culture media collected from HIOs during the 1 h antibiotic incubation that follows microinjection relative to HIO media samples collected after a PBS wash and replacement with fresh, antibiotic-free media. ENR media containing antibiotics precluded growth of <italic>E. coli</italic> str ECOR2, while antibiotic-free media collected after the culture washout had no inhibitory effect on <italic>E. coli</italic> growth (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3D</xref>). Furthermore, antibiotic-free HIO media was changed daily for the experiments presented in <xref ref-type="fig" rid="fig1">Figure 1E</xref> and <xref ref-type="fig" rid="fig8">8C</xref>, meaning that any carryover antibiotic activity (undetectable in the experiments presented in <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3D</xref>) would be reduced many fold within a day or two. By performing these additional experiments to validate our experimental workflow, we are now more confident that our results reflect the influence of the bacterial interaction with HIO, and are not influenced by antibiotic carryover.</p><p>Further issues on <xref ref-type="fig" rid="fig1">Figure 1</xref></p><disp-quote content-type="editor-comment"><p>A) <xref ref-type="fig" rid="fig1">Figure 1B</xref> appears to be compromised by fixation and/or freezing artifacts.</p></disp-quote><p>This was a good observation, as the data presented was taken from a frozen section. We have replaced this figure with a high magnification confocal micrograph of an HIO at 24 hours after microinjection with live <italic>E. coli</italic> from a separate experiment, and from a sample that was processed through paraffin embedding and sectioning. We hope the use of this alternative data will allow the reader to see the physical relationship between the HIO and <italic>E. coli</italic> with greater clarity.</p><disp-quote content-type="editor-comment"><p>B) In <xref ref-type="fig" rid="fig1">Figure 1C</xref> the y axis is labelled 24h δ CFU. Given that the scale becomes fractional, it seems likely that ratios rather than differences are being used.</p></disp-quote><p>The reviewers are correct in pointing out that the y-axis label in <xref ref-type="fig" rid="fig1">Figure 1C</xref> was inaccurate. This has been amended in the revised manuscript. In addition, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref> has been provided to clarify the exact relationship between the input CFU at t=0 and the CFU harvested from the lumen at 24 hours post microinjection.</p><disp-quote content-type="editor-comment"><p>C) What dose(s) of injections were used for 1D?</p></disp-quote><p>For <xref ref-type="fig" rid="fig1">Figure 1D</xref>, the HIOs were microinjected with 10 CFU <italic>E. coli</italic> each. The figure legend has been amended to fix this.</p><disp-quote content-type="editor-comment"><p>D) As a main panel of <xref ref-type="fig" rid="fig1">Figure 1E</xref>, showing two agar plates does not add much, especially when the legend does not give details of exactly when are how they were generated. Further, the final sentence of the third paragraph in subsection “HIOs can be stably associated with commensal E. coli” and the results quoted in the following paragraph after day 3 are contradictory. Controls are absolutely necessary to ensure that these findings are not simply due to antibiotic carry-over.</p></disp-quote><p><xref ref-type="fig" rid="fig1">Figure 1E</xref> has been removed from the main figure. Our intended purpose was to illustrate the growth of <italic>E. coli</italic> within the HIO lumen and the absence of growth in the external media, findings that are made clear in <xref ref-type="fig" rid="fig1">Figures 1D and 1F</xref> (now 1E).</p><disp-quote content-type="editor-comment"><p>The transcriptomic approach does not capture all basic information about the system. Does the E. coli injection alter the size, morphology and longevity of the HIOs? Does it alter the rate of epithelial cell turnover (which could be easily tested by BrdU labeling, and would be predicted from e.g. Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4570-7)? Does it alter the pattern of epithelial cell maturation, i.e. the fraction of mature paneth cells, goblet cells, enteroendocrine cells etc?</p></disp-quote><p>While the transcriptional analysis demonstrated a time-dependent change in the molecular content of the cells that comprise the HIO following <italic>E. coli</italic> colonization, bacteria could alter the cellular composition of the HIO tissue as well. As mentioned by the reviewers, previous studies have demonstrated that bacterial colonization promotes epithelial proliferation in model organisms. We conducted an experiment to examine epithelial proliferation and differentiation in HIOs over a timecourse of 96 hours, resulting in a new figure being added to the main text (<xref ref-type="fig" rid="fig3">Figure 3</xref>). The number of proliferating epithelial cells was elevated by as much as 3-fold in <italic>E. coli</italic>-colonized HIOs relative to PBS-treated HIOs at 24 h. However, at 48 h post-microinjection, the proportion of proliferating epithelial cells was significantly decreased in <italic>E. coli</italic> colonized HIOs relative to control treated HIOs. This observation was supported by RNA-seq data demonstrating an overall suppression of cell cycle genes in <italic>E. coli</italic> colonized HIOs relative to PBS-injected HIOs at 48 h post-microinjection (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). By 96 h post-microinjection the proportion of EdU+ epithelial cells was nearly identical in <italic>E. coli</italic> and PBS-treated HIOs (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). These results suggest that <italic>E. coli</italic> colonization is associated with a rapid burst of epithelial proliferation, but that relatively few of the resulting daughter cells are retained subsequently within the epithelium.</p><p>We also examined <italic>Sox9</italic> expression in HIOs following microinjection with <italic>E. coli</italic> or PBS alone. <italic>Sox9</italic> is known to mark the progenitor domain in the immature intestine, and its expression was dramatically reduced in <italic>E. coli</italic>-colonized HIOs at 48-96 h after microinjection and was notably distributed in distinct clusters directly adjacent to the underlying mesenchyme. This observation indicates an overall reduction in the number of progenitor cells in the HIO epithelium following <italic>E. coli</italic> colonization and implies that other epithelial types may account for a greater proportion of the HIO epithelium at later time points postcolonization. Although we saw no difference in the proportion of epithelial cells expressing goblet, Paneth, or enteroendocrine cell markers (MUC2, DEFA5, and CHGA, respectively), expression of the enterocyte brush border enzyme dipeptidyl peptidase-4 (DPPIV) was found only in the <italic>E. coli</italic>-colonized HIOs at 48 and 96 h post-microinjection. We interpret these data to mean that /<italic>E. coli</italic>/ colonization induces a transient increase in the rate of epithelial proliferation followed by a subsequent reduction in proliferation, progenitor cells and an increase in the enterocyte-like population.</p><p><italic>It is accepted that enteroids are 3 dimensional structures, and the study has been productive in the evaluation of stem cell dynamics and other tissue level events. However, organoids are not vascularized with a capillary network that generate O2 gradients</italic> in vivo<italic>, thus organism level physiological events such as hypoxia are difficult to address and these caveats must be included in the discussion.</italic></p><p>In the intestine oxygen is supplied to the epithelium via a network of capillaries that extend into the lamina propria underlying the epithelium. Recent work has demonstrated that healthy intestinal epithelium exists in a state of relative hypoxia in comparison to the underlying mucosae due to the impact of the anaerobic luminal environment (Glover, Lee and Colgan, 2016, Kelly et al., 2015, Schmidt and Kao, 2014), although the molecular mecahnisms that allow the epithelium to fluorish under these conditions remain unclear. Stem cell derived human intestinal organoids (or enteroids) lack endothelial tissue and oxygen is apparently supplied to the tissue via diffusion through the media, similar to traditional cell culture systems. However, our work suggests that HIOs may be an excellent model system for studying the hypoxia gradient that exists between the lumen and the intestinal epithelium and underlying lamina propria and the changes in the relative state of oxygenation that occur during bacterial colonization (<xref ref-type="fig" rid="fig4">Figure 4</xref>) and under other conditions such as inflammation. We have added comments to the discussion clarifying the distinction between localized epithelial hypoxia and tissue hypoxia that occurs as a result of changes in blood flow, which cannot be modeled in the HIO at present.</p><disp-quote content-type="editor-comment"><p>Using the pathway analysis from the GO and REACTOME databases limits the insight that the reader is given into the changes in gene expression. For example, in <xref ref-type="fig" rid="fig2">Figure 2C</xref> 'muscle cell differentiation' is shown as a pathway. It would be possible to report detailed network analyses at least in the supporting material so that the contribution of different transcripts to the overall analysis is clear. This would allow considerable refinement of the time-dependent transcriptional response descriptions in the text.</p></disp-quote><p>With the GSEA analysis presented in <xref ref-type="fig" rid="fig2">Figure 2</xref>, we aimed to present a broad scale overview of the coordinated, time-dependent transcriptional response to <italic>E. coli</italic> colonization based on GO and REACTOME databases. Gene-level pathway analysis may compliment this approach by illustrating the interactions between genes and suggesting mechanistic relationships. Based on the reviewer's suggestion, we have performed a variety of gene level analysis of previously annotated KEGG pathways using the Pathview software package (R/Bioconductor). This resulted in a pathway diagram demonstrating broad reduction in the expression of cell cycle genes at 48 h post-microinjection in <italic>E. coli</italic> colonized HIOs, consistent with our findings in <xref ref-type="fig" rid="fig3">Figure 3</xref>, and has been included as <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref> in the revised manuscript. We thank the reviewers for this valuable suggestion.</p><p>The KEGG, GO and REACTOME databases are valuable resources for understanding the relationships between genes and interpreting large scale transcriptional changes. However, these tools are inherently limited to known pathways and may fail to identify novel interactions between networks of genes. We performed a gene regulatory network inference analysis of our <italic>E. coli</italic> colonization timecourse data using the method described by Simoes and EmmertStreib (<italic>PLOS</italic> 2012). This analysis identified a large network of genes that are dynamically expressed over 24-96 h post-microinjection that was highly enriched for tissue development, metabolism, carbohydrate transport, and glycotransferases. A preliminary figure illustrating this network is provided below. We feel that this analysis is valuable; however, in order to glean meaningful insights from the data we will need to spend significant additional time interrogating it using these methods. We feel that in its current from it is preliminary and may not add meaningful information to our manuscript. Interested readers will find that the genes included in each of the pathways shown in <xref ref-type="fig" rid="fig2">Figure 2C</xref> are listed in the supplemental data table and in the analysis materials at https://github.com/hilldr/Hill_HIO_Colonization_2017.</p><disp-quote content-type="editor-comment"><p>In <xref ref-type="fig" rid="fig3">Figure 3C</xref> it is difficult to appreciate whether the cadherin stain has worked in the PBS panel. How reproducible are these results? What happens with a hypoxic control?</p></disp-quote><p>We have repeated the experiment in a new cohort of HIOs and included new representative immunostaining for all conditions, including heat-inactivated <italic>E. coli</italic> and hypoxic culture controls (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). In addition, we tabulated the number of PMDZ+ HIOs in each condition from two combined experiments and have included this data as a sub-panel of <xref ref-type="fig" rid="fig4">Figure 4C</xref>. In our hands, the PMDZ staining is quite reliable and demonstrates an apparent decrease in epithelial oxygen content in HIOs injected with live <italic>E. coli</italic> or HIOs subjected to 1% O2 for 24 hours relative to HIOs injected with heat-inactivated <italic>E. coli</italic> or PBS. We are pleased with the results of the control staining and appreciate the reviewers for bringing this oversight to our attention.</p><disp-quote content-type="editor-comment"><p>The data analysis shown in <xref ref-type="fig" rid="fig4">Figure 4</xref> was complex and challenging for the reviewers to appreciate in its current form. The subset organisation must be clear and specific.</p><p>A) Why is there no PBS control with the NFkB inhibitor? Many cell survival/cell death pathways converge on NFkB signalling and the inhibitor may exert effects already at baseline which would then fall into gene set 1 and gene set 2?</p></disp-quote><p>We included control HIOs injected with PBS and treated with SC-514 in our initial experiment and uploaded the relevant RNA-seq data to the public repository at EMBL (E-MTAB-5801), however we did not address this dimension of the experiment in our original manuscript out of concerns that it might over-complicate the presentation of our analysis. However, in response to concerns from the reviewers, we have added supplemental figures, which we hope will clarify the baseline effects of the NF-κB inhibitor SC-514. <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref> shows the log2-transformed fold-change in gene expression relative to PBS-injected controls for all 7 experimental conditions examined in this set of experiments: live <italic>E. coli</italic> +/- SC-514, heatkilled <italic>E. coli</italic> +/- SC-514, and hypoxic culture +/- SC-514, and PBS + SC-514. This figure shows that the number of genes altered by treatment with SC-514 alone is comparable to the set of genes altered in other experimental conditions, although there are generally more genes that are down-regulated by SC-514 exposure than there are genes that are upregulated by SC-514. We examined over-represented genes sets from the GO, KEGG, and REACTOME databases in genes that were significantly up- or down-regulated by treatment with SC-514 alone (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>) in order to better understand the types of processes that might be influenced by SC-514 exposure. We plotted the pathways that were in the top 90 percentile based on statistical significance, indicating a high degree of enrichment in the gene subsets regulated by NF-κB inhibitor SC-514 at baseline. The data indicates that SC-514 may suppress some aspects of transcription and translation and may up-regulate authophagy and translation-associated processes. Notably, SC-514 does not appear to have a strong effect at baseline on the pathways identified in <xref ref-type="fig" rid="fig5">Figure 5</xref> as key NFkB-dependent responses to bacterial contact and/or hypoxia, namely innate and adaptive defense, epithelial barrier integrity, angiogenesis and hypoxia signaling, or intestinal development.</p><disp-quote content-type="editor-comment"><p>From the Venn-diagrams shown in panel A, it appears that genes in set 1 and 2 are mutually exclusive, which would make the lacking control less problematic, but apparently the hypoxia-responsive genes are highly enriched in both (of course these may be different genes in the same pathway? But this would be slightly surprising if a statistical exclusion had been made).</p></disp-quote><p>This is an important oversight on our part, as the original version of <xref ref-type="fig" rid="fig5">Figure 5A</xref> implied that there were no overlapping genes between Gene Set I and Gene Set II. This was not our intention, as it is perfectly feasible that some genes may be induced by either bacterial contact OR hypoxia via NF-κB. In <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1E</xref>, we plotted a Venn diagram showing the degree of overlap between Gene Set I, Gene Set II, and the set of genes that are significantly down-regulated in PBS-injected HIOs treated with SC-514. In fact, the Venn diagram shown as <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1E</xref> demonstrates that there are 603 genes that are indeed induced by either hypoxia OR bacterial-contact in an NF-κB dependent manner. This analysis demonstrates that the majority of contact- or hypoxia-induced genes that are NF-κB dependent are not significantly down-regulated in PBS-injected HIOs treated with SC-514 only. However, some genes suppressed by SC-514 at baseline may be biologically significant. Therefore, we examined over-represented genes sets from the GO, KEGG, and REACTOME databases in genes that were shared between Gene Set I or II and the set of genes that are significantly down-regulated in PBS-injected HIOs treated with SC-514 (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1F</xref>). This analysis indicates that the biggest effects of SC-514 at baseline among Gene Set I and Gene Set II genes are related to metabolism, redox state, and transcription/translation. SC-514 may also have an effect of suppressing the response to hypoxia at baseline, which is not surprising given the relatively low oxygen conditions of HIO culture even prior to treatment (<xref ref-type="fig" rid="fig4">Figure 4</xref>). Thus, while SC-514 does have some potentially interesting effects on transcription in the HIO even at baseline, the effect of SC-514 alone cannot account for the major NF-κB dependent responses induced by contact and/or hypoxia. We appreciate that the reviewers brought this important point to our attention and we feel that this additional analysis strengthens our conclusion in <xref ref-type="fig" rid="fig5">Figure 5</xref> that NF-κB-dependent responses to bacterial contact and/or hypoxia include innate and adaptive defense, epithelial barrier integrity, angiogenesis and hypoxia signaling, or intestinal development.</p><disp-quote content-type="editor-comment"><p>B) For the discussion of the analysis, it appears that an assumption is made that the effect of live E. coli is identical to dead E. coli combined with hypoxia. There is a large body of literature on &quot;vital PAMPs&quot; (e.g. Nature. 2011 May 22;474(7351):385-9), which might suggest there is more to it. Nevertheless, there appears to be an excellent correlation between genes regulated by live and dead E. coli in the plots in <xref ref-type="fig" rid="fig4">Figure 4B</xref>. If the hypothesis is correct, then injecting dead E. coli and then immediately transferring the organoids to a hypoxic chamber should produce a gene-expression profile that correlates better that the dead E. coli alone. Noticeably the gradient of the correlation between hypoxia/PBS and live E. coli/PBS seems to be close to zero?</p></disp-quote><p>The reviewers have clarified an underlying implication of our analysis of microbial contact and hypoxia presented in <xref ref-type="fig" rid="fig5">Figure 5</xref>: contact with microbial products under hypoxic conditions may recapitulate the effects of colonization with metabolically active live bacteria. Although this condition was not included in our original RNA-seq analysis and the limited time alotted for revision prevents us from completing a follow-up transcriptional analysis, we have examined this hypothesis by evaluating the role of microbial contact and microbe-associated hypoxia in colonization-induced changes in AMP, cytokine, and growth factor secretion (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). The results indicate a complex interplay between hypoxia and bacterial contact stimuli that shapes protein expression during bacterial colonization, with some factors induced by either microbial contact or hypoxia alone (IL-6), other cases in which either bacterial contact or hypoxia appears to be the dominant stimuli (BD-2), and a third regulatory paradigm in which the response to live <italic>E. coli</italic> evidently results from the cumulative influence of bacterial contact and hypoxia (BD-1, IL-8, VEGF). Taken together with our transcriptional analysis, this analysis demonstrates that association of immature intestinal epithelium with live <italic>E. coli</italic> results in a complex interplay between microbial contact and microbe-associated hypoxia induced gene expression and protein secretion.</p><disp-quote content-type="editor-comment"><p>C) Is there some sort of statistical significance cut-off for the genes identified for each set in panel B? The clouds appear to very closely approach a log2-FC of zero, suggesting genes showing very small changes in expression are included? Would it be logical to show the data pre-filtered for p-value? Or show the limits of the region and color-code for p-value?</p></disp-quote><p>We apologize that this was not made more clear in the initial submission. We did use p-value as a pre-filter for this analysis and we also used only genes that were up-regulated in a treatment group, relative to control. We have revised the text to ensure that this information on how we filtered the data is made more explicit.</p><p>Since we used p-values as a filter, some genes that had very modest fold change differences were included in the analysis, explaining the log2-FC values that approach zero. We hope that the clarification around this text makes the data presented sufficiently clear.</p><disp-quote content-type="editor-comment"><p>D) In panel C, is it right that &quot;% genes matched to pathway&quot; is this the percentage of genes from each set (e.g. the full 1940 genes in Set 1) that map to the indicated pathway? Thus 5%, i.e. around 400 genes from set 1 map to &quot;regulation of cytoskeleton organization&quot;? Please clarify.</p></disp-quote><p>Yes, that is the correct interpretation of the x-axis label. We have revised the label to read &quot;% genes from input set matched to pathway&quot;, which we hope will improve clarity for the reader. The plotted value is the proportion of input genes (i.e. the 1,940 genes in Gene Set I) that are included in the given GO or REACTOME pathway set. Therefore if ~4% of genes in Gene Set I map to &quot;regulation of cytoskeleton organization&quot; this would be the equivalent of 0.04 x 1,940 = 97 genes. Note that many genes are assigned to multiple GO and REACTOME terms, and while have tried to avoid redundancy in our choice of pathways in the plot, several of these terms will contain overlapping genes. The complete dataset table of results is available on the GitHub repository (https://github.com/hilldr/Hill_HIO_Colonization_2017).</p><disp-quote content-type="editor-comment"><p>Also, as the plots in B suggest that many genes are included with a very small up- or down-regulation, it would be important to have some handle on not just the significance, but also the average absolute size of the change observed. A second set of graphs, or a supplementary figure with more information would be helpful.</p></disp-quote><p>To address this concern, we have generated a plot of the log2-transformed fold-change in gene expression relative to PBS-injected controls for all 7 experimental conditions examined in this set of experiments: live <italic>E. coli</italic> +/- SC-514, heat-killed <italic>E. coli</italic> +/- SC-514, and hypoxic culture +/- SC-514, and PBS + SC-514 (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>). The format of the plot is identical to the plot shown in <xref ref-type="fig" rid="fig2">Figure 2A</xref>, and shows the fold-change in expression of all transcripts measured in a given condition relative to PBS treatment alone (grey) with significantly up- and down-regulated transcripts colored in red and blue, respectively. This figure reveals that the scale of the global transcriptional response varies somewhat between experimental conditions. This may be expected, given, for example, that hypoxic culture would be expected to permeate both epithelial and mesenchymal cells throughout the HIO, whereas the impact of heat-inactivated <italic>E. coli</italic> injected into the HIO lumen may be more limited.</p><disp-quote content-type="editor-comment"><p>E) In the legend, were pathways with enrichment P-values greater than 0.01 excluded?</p></disp-quote><p>This was a typographical error. Pathways with P-values &gt; 0.01 were excluded from the plot and the legend has been amended to fix this.</p><disp-quote content-type="editor-comment"><p>In <xref ref-type="fig" rid="fig5">Figure 5B and C</xref>, it would be important to include a group microinjected with dead E. coli, immediately followed by hypoxia, to conclude that both factors act together to induce b-defensins. For <xref ref-type="fig" rid="fig5">Figure 5D</xref>, does hBD-2 require a reducing agent for activity as hBD1 does (Nature 469, 419-423)? Typically, these pore-forming AMPs to exert a stronger effect on the rapidly growing bacteria than in the stationary phase, and in fact, your maximum growth rate (i.e. maximum curve gradient) is even higher where the BD-2 is added, suggesting that something in the BD-2 may even permit faster E. coli growth in LB. Death over several hours in late stationary phase may be rather due to accumulation of a toxic metabolite. To control for these effects, it will be important to show growth data with heat-inactivation of the BD-2. To focus on killing in the stationary phase a late stationary-phase culture could be treated with differing concentrations of BD-2 over short time-courses (including the inactivated controls), measuring loss of membrane integrity by Sytox-green uptake by flow cytometry or microscopy. As O-antigens can inhibit AMP function, E. coli K-12 could be included in these experiments.</p></disp-quote><p>Following the reviewers’ suggestion, we have performed in vitro <italic>E. coli</italic> experiments utilizing heat-inactivated BD-2 as a control (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). We found that heat inactivation of the recombinant BD-2 peptide completely abrogated the reduction in <italic>E. coli</italic> growth caused by addition of BD-2 to the cultures. Furthermore, we confirmed that this recombinant BD-2 has similar inhibitory activity against <italic>E. coli</italic> K-12, suggesting that the effects of BD-2 are not strain specific. We have also included data on the effect of BD-2 on bacterial carrying capacity derived from the growth curves (<xref ref-type="fig" rid="fig5">Figure 5D</xref> and <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). Our original hypothesis was that up-regulation of AMP expression in HIOs following <italic>E. coli</italic> microinjection (<xref ref-type="fig" rid="fig2">Figures 2E</xref>, <xref ref-type="fig" rid="fig5">5A-C</xref>) may contribute to limited <italic>E. coli</italic> growth in the HIO lumen (<xref ref-type="fig" rid="fig1">Figure 1C-D</xref>). BD-2 significantly reduces carrying capacity in vitro at concentrations consistent with conditions in the HIO (<xref ref-type="fig" rid="fig5">Figure 5D</xref> and <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2B</xref>). This demonstrates that an AMP expressed by HIOs in response to <italic>E. coli</italic> colonization has the potential to reduce microbial growth in the HIO. As pointed out by the reviewer, questions remain as to the mechanism of action of human β defensins. Multiple mechanisms of action have been proposed in the literature (Ulm et al. <italic>Front. Immunol</italic>. 2012, Brogden, 2005) including pore formation, transcriptional and metabolic inhibition, inhibition of membrane transporters, etc., which vary between defensin family members and specific bacterial targets and can be influenced by the local biochemical conditions such as redox state (<italic>Nature</italic> 469, 419-423). While we agree that this presents an interesting question, we have not defined the specific mechanism(s) of action for BD-2 against <italic>E. coli</italic> str. ECOR2. Such mechanistic studies involve complex structural biology and bacterial genetics experiments and lie outside of our expertise, the time limitations on this revision, and are somewhat outside the intended scope of this manuscript.</p><disp-quote content-type="editor-comment"><p>In relation to <xref ref-type="fig" rid="fig6">Figure 6</xref>, can induction of mucus production and induction of goblet cell differentiation be delineated? The slow appearance of mucin gene upregulation appears more consistent with a differentiation phenotype than simple gene expression?</p></disp-quote><p>This is a question that we have asked ourselves from an early point in this project. To date, we have found no evidence that the increase in mucus production is associated with an increase in the number of goblet cells. As mentioned above, we saw no difference in the proportion of epithelial cells expressing goblet, Paneth, or enteroendocrine cell markers (MUC2, DEFA5, and CHGA, respectively). Based on staining and RNA-seq transcript counts, Mucin 5AC appears to be more abundant than Mucin 2 in <italic>E. coli</italic> colonized HIOs (<xref ref-type="fig" rid="fig7">Figure 7</xref> and <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>). This may be significant, as Mucin 5AC is not specific to the goblet cell but is widely expressed by the small intestinal enterocytes. The increase in Mucin expression correlates with the emergence of DPPIV+ epithelial cells, suggesting that the mature enterocyte population contributes to the increase in mucus production.</p><disp-quote content-type="editor-comment"><p>The interpretation that 'Epithelial barrier integrity is enhanced following bacterial association' (p13) is rather at odds with the data in <xref ref-type="fig" rid="fig7">Figure 7 B and D</xref> where the PBS and E. coli treated permeability is the same. Is the meaning that NFkappaB signaling is required for the compensatory effects of the barrier in E. coli-treated organoids? What is the effect of the inhibitor alone?</p></disp-quote><p>The reviewers are correct to note that <italic>E. coli</italic> colonization itself does not result in a decrease in barrier permeability compared to PBS, and that the presence of NF-κB inhibitor results in increased barrier permeability. This implies that NF-κB is required for the mediating the response to <italic>E. coli</italic> colonization. Our original intention was to highlight two findings: 1) that maintenance of epithelial barrier integrity following <italic>E. coli</italic> colonization is NF-κB dependent, and 2) that bacterial colonization mitigates damage to the epithelial barrier and increases in epithelial barrier permeability following exposure to pro-inflammatory cytokines. We originally highlighted these two findings under a single header, stating that both were evidence of enhanced barrier integrity. The reviewer's comments, however, make it clear that these data are probably best presented as two distinct findings, and that is the approach we took in the Discussion. We have therefore separated our description of these results into two distinct headers in the Results section. We hope that this will clarify and highlight the effects of bacterial colonization on HIO barrier function and improve consistency with the interpretation we have laid out in the Discussion.</p><p>We have also added an additional treatment group to <xref ref-type="fig" rid="fig8">Figure 8B</xref>. HIOs were microinjected with PBS alone 24 h prior to microinjection with FITC-dextran and the addition of HIO media containing SC-514 ('PBS + SC-514'). Treatment with SC-514 alone had no detrimental effect on barrier function. We interpret this data as demonstrating that inhibition of the NF-κB pathway prevents the epithelial response to bacterial stimuli (both bacterial contact and hypoxia) that normally bolsters barrier function. The result is increased epithelial barrier permeability (<xref ref-type="fig" rid="fig8">Figure 8B</xref>) and a higher incidence of bacterial translocation (<xref ref-type="fig" rid="fig8">Figure 8C</xref>).</p></body></sub-article></article>